International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors (original) (raw)

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (1,127)

1. CCR2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
2. Drug development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
3. CCR3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 Drug development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
4. CCR4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31 Drug development. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
5. CCR5 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32 Drug development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
6. CCR6 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36 Drug development. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
7. CCR7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 Drug development. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
8. CCR8 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38 Drug development. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
9. CCR9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40 Drug development. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
10. CCR10 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41 Drug development. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
11. C. CX3C Chemokine Receptors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
12. CX3CR1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42 Drug development. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
13. D. XC Chemokine Receptors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
14. XCR1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44 Drug development. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46 III. Host Atypical Chemokine Receptors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46 A. ACKR1 (Previously Duffy Antigen Receptor for Chemokines) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
15. Drug Development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
16. B. ACKR2 (Formerly D6 or CCBP2). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47 Drug Development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
17. C. ACKR3 (Alias CXCR7) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49 Drug Development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
18. D. ACKR4 (Formerly CCRL1 and CCX CKR). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
19. Drug Development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
20. E. CCRL2 (ACKR5, Reserved) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51 Drug Development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
21. F. PITPNM3 (Also Known as the CCL18/PARC Receptor; New Name: ACKR6, Reserved) . . . . . 52
22. Drug Development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
23. G. C5L2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52 Drug Development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53 IV. Microbial Chemokine Receptors and Chemokine-Binding Proteins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53 A. Virus-Encoded Chemokine Receptors and Chemokine-Binding Proteins . . . . . . . . . . . . . . . . . . . . 53
24. US28 from Human Cytomegalovirus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
25. U12 and U51 from HHV6 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
26. U12 and U51 from HHV7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
27. E1 from EHV2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54 5. 7L from Yaba-like Disease Virus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
28. ECRF3 from Herpesvirus saimiri . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
29. ORF74 from Human Herpesvirus 8 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
30. ORF74 from Murine Gammaherpesvirus-68. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
31. ORF74 from Equine Herpesvirus 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
32. Virus-Encoded Chemokines and Chemokine-Binding Proteins . . . . . . . . . . . . . . . . . . . . . . . . . 56
33. B. Protozoan Chemokine-Binding Proteins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
34. V. Tick Chemokine-Binding Proteins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57 VI. Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59 References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
35. References Abbadie C, Lindia JA, Cumiskey AM, Peterson LB, Mudgett JS, Bayne EK, DeMartino JA, MacIntyre DE, and Forrest MJ (2003) Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci USA 100:7947-7952.
36. Abel S, Hundhausen C, Mentlein R, Schulte A, Berkhout TA, Broadway N, Hart- mann D, Sedlacek R, Dietrich S, and Muetze B, et al. (2004) The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol 172: 6362-6372.
37. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, Sallusto F, and Napolitani G (2007) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8:639- 646. Addison CL, Daniel TO, Burdick MD, Liu H, Ehlert JE, Xue YY, Buechi L, Walz A, Richmond A, and Strieter RM (2000) The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J Immunol 165:5269-5277.
38. Ahern D, Lloyd CM, and Robinson DS (2009) Chemokine responsiveness of CD4+ CD25+ regulatory and CD4+ CD25-T cells from atopic and nonatopic donors. Allergy 64:1121-1129.
39. Ahuja SK, Gao JL, and Murphy PM (1994) Chemokine receptors and molecular mimicry. Immunol Today 15:281-287.
40. Ahuja SK and Murphy PM (1993) Molecular piracy of mammalian interleukin-8 receptor type B by herpesvirus saimiri. J Biol Chem 268:20691-20694.
41. Albini A, Ferrini S, Benelli R, Sforzini S, Giunciuglio D, Aluigi MG, Proudfoot AE, Alouani S, Wells TN, and Mariani G, et al. (1998) HIV-1 Tat protein mimicry of chemokines. Proc Natl Acad Sci USA 95:13153-13158.
42. Albrecht JC (2000) Primary structure of the Herpesvirus ateles genome. J Virol 74: 1033-1037.
43. Alexander JM, Nelson CA, van Berkel V, Lau EK, Studts JM, Brett TJ, Speck SH, Handel TM, Virgin HW, and Fremont DH (2002) Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell 111:343-356.
44. Algood HM and Flynn JL (2004) CCR5-deficient mice control Mycobacterium tu- berculosis infection despite increased pulmonary lymphocytic infiltration. J Immunol 173:3287-3296.
45. Aliberti J, Valenzuela JG, Carruthers VB, Hieny S, Andersen J, Charest H, Reis e Sousa C, Fairlamb A, Ribeiro JM, and Sher A (2003) Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat Immunol 4: 485-490.
46. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, and Berger EA (1996) CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-1958.
47. Alkhatib G, Liao F, Berger EA, Farber JM, and Peden KW (1997) A new SIV co- receptor, STRL33. Nature 388:238.
48. Allegretti M, Bertini R, Cesta MC, Bizzarri C, Di Bitondo R, Di Cioccio V, Galliera E, Berdini V, Topai A, and Zampella G, et al. (2005) 2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors. J Med Chem 48:4312-4331.
49. Alonzo F 3rd, Kozhaya L, Rawlings SA, Reyes-Robles T, DuMont AL, Myszka DG, Landau NR, Unutmaz D, and Torres VJ (2013) CCR5 is a receptor for Staphylo- coccus aureus leukotoxin ED. Nature 493:51-55.
50. Alvarez D, Arkinson JL, Sun J, Fattouh R, Walker T, and Jordana M (2007) Th2 differentiation in distinct lymph nodes influences the site of mucosal Th2 immune- inflammatory responses. J Immunol 179:3287-3296.
51. Alves-Filho JC, Freitas A, Souto FO, Spiller F, Paula-Neto H, Silva JS, Gazzinelli RT, Teixeira MM, Ferreira SH, and Cunha FQ (2009) Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to poly- microbial sepsis. Proc Natl Acad Sci USA 106:4018-4023.
52. Amanatidou V, Sourvinos G, Apostolakis S, Tsilimigaki A, and Spandidos DA (2006) T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J 25:410-414.
53. Ambati J, Anand A, Fernandez S, Sakurai E, Lynn BC, Kuziel WA, Rollins BJ, and Ambati BK (2003) An animal model of age-related macular degeneration in senescent Ccl-2-or Ccr-2-deficient mice. Nat Med 9:1390-1397.
54. Amersi FF, Terando AM, Goto Y, Scolyer RA, Thompson JF, Tran AN, Faries MB, Morton DL, and Hoon DS (2008) Activation of CCR9/CCL25 in cutaneous mela- noma mediates preferential metastasis to the small intestine. Clin Cancer Res 14: 638-645.
55. An P, Li R, Wang JM, Yoshimura T, Takahashi M, Samudralal R, O'Brien SJ, Phair J, Goedert JJ, and Kirk GD, et al. (2011) Role of exonic variation in chemokine receptor genes on AIDS: CCRL2 F167Y association with pneumocystis pneumonia. PLoS Genet 7:e1002328.
56. Anatriello E, Ribeiro JM, de Miranda-Santos IK, Brandão LG, Anderson JM, Valenzuela JG, Maruyama SR, Silva JS, and Ferreira BR (2010) An insight into the sialotranscriptome of the brown dog tick, Rhipicephalus sanguineus. BMC Genomics 11:450.
57. Andjelkovic AV, Kerkovich D, Shanley J, Pulliam L, and Pachter JS (1999) Ex- pression of binding sites for beta chemokines on human astrocytes. Glia 28: 225-235.
58. Andres PG, Beck PL, Mizoguchi E, Mizoguchi A, Bhan AK, Dawson T, Kuziel WA, Maeda N, MacDermott RP, and Podolsky DK, et al. (2000) Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine. J Immunol 164:6303-6312.
59. Andrew DP, Ruffing N, Kim CH, Miao W, Heath H, Li Y, Murphy K, Campbell JJ, Butcher EC, and Wu L (2001) C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential. J Immunol 166:103-111.
60. Annunziato F, Cosmi L, Liotta F, Lazzeri E, Manetti R, Vanini V, Romagnani P, Maggi E, and Romagnani S (2002) Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes. J Exp Med 196:379-387.
61. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, Parente E, Filì L, Ferri S, and Frosali F, et al. (2007) Phenotypic and functional features of human Th17 cells. J Exp Med 204:1849-1861.
62. Ansel KM, Harris RB, and Cyster JG (2002) CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 16:67-76.
63. Antoniu SA (2010) Mogamulizumab, a humanized mAb against C-C chemokine re- ceptor 4 for the potential treatment of T-cell lymphomas and asthma. Curr Opin Mol Ther 12:770-779.
64. Arias MA, Jaramillo G, López YP, Mejía N, Mejía C, Pantoja AE, Shattock RJ, García LF, and Griffin GE (2007) Mycobacterium tuberculosis antigens specifically mod- ulate CCR2 and MCP-1/CCL2 on lymphoid cells from human pulmonary hilar lymph nodes. J Immunol 179:8381-8391.
65. Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, and Cesarman E (1997) Human herpesvirus KSHV encodes a constitutively active G-protein-coupled re- ceptor linked to cell proliferation. Nature 385:347-350.
66. Aslanian AM and Charo IF (2006) Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. Circulation 114:583-590.
67. Atamas SP, Luzina IG, Choi J, Tsymbalyuk N, Carbonetti NH, Singh IS, Troja- nowska M, Jimenez SA, and White B (2003) Pulmonary and activation-regulated chemokine stimulates collagen production in lung fibroblasts. Am J Respir Cell Mol Biol 29:743-749.
68. Atchison RE, Gosling J, Monteclaro FS, Franci C, Digilio L, Charo IF, and Goldsmith MA (1996) Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science 274:1924-1926.
69. Attal H, Cohen-Hillel E, Meshel T, Wang JM, Gong W, and Ben-Baruch A (2008) Intracellular cross-talk between the GPCR CXCR1 and CXCR2: role of carboxyl terminus phosphorylation sites. Exp Cell Res 314:352-365.
70. Auffray C, Fogg DK, Narni-Mancinelli E, Senechal B, Trouillet C, Saederup N, Leemput J, Bigot K, Campisi L, and Abitbol M, et al. (2009) CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their re- sponse to inflammation. J Exp Med 206:595-606.
71. Aukrust P, Halvorsen B, Yndestad A, Ueland T, Øie E, Otterdal K, Gullestad L, and Damås JK (2008) Chemokines and cardiovascular risk. Arterioscler Thromb Vasc Biol 28:1909-1919.
72. Azab AK, Runnels JM, Pitsillides C, Moreau AS, Azab F, Leleu X, Jia X, Wright R, Ospina B, and Carlson AL, et al. (2009) CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. Blood 113:4341-4351.
73. Azzaoui I, Yahia SA, Chang Y, Vorng H, Morales O, Fan Y, Delhem N, Ple C, Tonnel AB, and Wallaert B, et al. (2011) CCL18 differentiates dendritic cells in tolero- genic cells able to prime regulatory T cells in healthy subjects. Blood 118:3549- 3558.
74. Baatar D, Olkhanud P, Sumitomo K, Taub D, Gress R, and Biragyn A (2007) Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4-Tregs, regulate effector T cells using FasL. J Immunol 178: 4891-4900.
75. Baba M, Imai T, Nishimura M, Kakizaki M, Takagi S, Hieshima K, Nomiyama H, and Yoshie O (1997) Identification of CCR6, the specific receptor for a novel lym- phocyte-directed CC chemokine LARC. J Biol Chem 272:14893-14898.
76. Baba M, Takashima K, Miyake H, Kanzaki N, Teshima K, Wang X, Shiraishi M, and Iizawa Y (2005) TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans. Antimicrob Agents Chemother 49:4584-4591.
77. Babcock GJ, Farzan M, and Sodroski J (2003) Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor. J Biol Chem 278:3378-3385.
78. Bachem A, Güttler S, Hartung E, Ebstein F, Schaefer M, Tannert A, Salama A, Movassaghi K, Opitz C, and Mages HW, et al. (2010) Superior antigen cross-pre- sentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J Exp Med 207:1273-1281.
79. Baekkevold ES, Wurbel MA, Kivisäkk P, Wain CM, Power CA, Haraldsen G, and Campbell JJ (2005) A role for CCR4 in development of mature circulating cutaneous T helper memory cell populations. J Exp Med 201:1045-1051.
80. Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS, Asch AS, Cesarman E, Gershengorn MC, and Mesri EA (1998) G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis ac- tivator. Nature 391:86-89.
81. Balabanian K, Brotin E, Biajoux V, Bouchet-Delbos L, Lainey E, Fenneteau O, Bonnet D, Fiette L, Emilie D, and Bachelerie F (2012) Proper desensitization of CXCR4 is required for lymphocyte development and peripheral compartmentali- zation in mice. Blood 119:5722-5730.
82. Balabanian K, Harriague J, Décrion C, Lagane B, Shorte S, Baleux F, Virelizier JL, Arenzana-Seisdedos F, and Chakrabarti LA (2004) CXCR4-tropic HIV-1 envelope glycoprotein functions as a viral chemokine in unstimulated primary CD4+ T lymphocytes. J Immunol 173:7150-7160.
83. Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B, Arenzana- Seisdedos F, Thelen M, and Bachelerie F (2005a) The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 280:35760-35766.
84. Balabanian K, Lagane B, Pablos JL, Laurent L, Planchenault T, Verola O, Lebbe C, Kerob D, Dupuy A, and Hermine O, et al. (2005b) WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12. Blood 105:2449-2457.
85. Balkwill F (2004) The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14:171-179.
86. Bamberg CE, Mackay CR, Lee H, Zahra D, Jackson J, Lim YS, Whitfeld PL, Craig S, Corsini E, and Lu B, et al. (2010) The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. J Biol Chem 285:7633-7644.
87. Bannert N, Craig S, Farzan M, Sogah D, Santo NV, Choe H, and Sodroski J (2001)
88. Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines. J Exp Med 194:1661-1673.
89. Barlic J, Zhu W, and Murphy PM (2009) Atherogenic lipids induce high-density lipoprotein uptake and cholesterol efflux in human macrophages by up-regulating transmembrane chemokine CXCL16 without engaging CXCL16-dependent cell adhesion. J Immunol 182:7928-7936.
90. Baugher PJ and Richmond A (2008) The carboxyl-terminal PDZ ligand motif of chemokine receptor CXCR2 modulates post-endocytic sorting and cellular chemo- taxis. J Biol Chem 283:30868-30878.
91. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, and Schall TJ (1997) A new class of membrane-bound chemokine with a CX3C motif. Nature 385:640-644.
92. Bazzan E, Saetta M, Turato G, Borroni EM, Cancellieri C, Baraldo S, Savino B, Calabrese F, Ballarin A, and Balestro E, et al. (2013) Expression of the atypical chemokine receptor D6 in human alveolar macrophages in COPD. Chest 143: 98-106.
93. Beaussant Cohen S, Fenneteau O, Plouvier E, Rohrlich PS, Daltroff G, Plantier I, Dupuy A, Kerob D, Beaupain B, and Bordigoni P, et al. (2012) Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry. Orphanet J Rare Dis 7:71.
94. Beck LA, Tancowny B, Brummet ME, Asaki SY, Curry SL, Penno MB, Foster M, Bahl A, and Stellato C (2006) Functional analysis of the chemokine receptor CCR3 on airway epithelial cells. J Immunol 177:3344-3354.
95. Beider K, Begin M, Abraham M, Wald H, Weiss ID, Wald O, Pikarsky E, Zeira E, Eizenberg O, and Galun E, et al. (2011) CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth. Exp Hematol 39:282- 292. Beima KM, Miazgowicz MM, Lewis MD, Yan PS, Huang TH, and Weinmann AS (2006) T-bet binding to newly identified target gene promoters is cell type-in- dependent but results in variable context-dependent functional effects. J Biol Chem 281:11992-12000.
96. Ben-Baruch A, Xu L, Young PR, Bengali K, Oppenheim JJ, and Wang JM (1995) Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte recep- tors.
97. C-C CKR1, a receptor for macrophage inflammatory protein-1 alpha/Rantes, is also a functional receptor for MCP3. J Biol Chem 270:22123-22128.
98. Berahovich RD, Miao Z, Wang Y, Premack B, Howard MC, and Schall TJ (2005) Proteolytic activation of alternative CCR1 ligands in inflammation. J Immunol 174:7341-7351.
99. Berkman N, Ohnona S, Chung FK, and Breuer R (2001) Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge. Am J Respir Cell Mol Biol 24:682-687.
100. Bernardini G, Hedrick J, Sozzani S, Luini W, Spinetti G, Weiss M, Menon S, Zlotnik A, Mantovani A, and Santoni A, et al. (1998) Identification of the CC chemokines TARC and macrophage inflammatory protein-1 beta as novel functional ligands for the CCR8 receptor. Eur J Immunol 28:582-588.
101. Bernardini G, Spinetti G, Ribatti D, Camarda G, Morbidelli L, Ziche M, Santoni A, Capogrossi MC, and Napolitano M (2000) I-309 binds to and activates endothe- lial cell functions and acts as an angiogenic molecule in vivo. Blood 96:4039- 4045.
102. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, Dewor M, Georgiev I, Schober A, and Leng L, et al. (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13:587-596.
103. Berres M-L, Trautwein C, Zaldivar MM, Schmitz P, Pauels K, Lira SA, Tacke F, and Wasmuth HE (2009) The chemokine scavenging receptor D6 limits acute toxic liver injury in vivo. Biol Chem 390:1039-1045.
104. Bhaskar K, Konerth M, Kokiko-Cochran ON, Cardona A, Ransohoff RM, and Lamb BT (2010) Regulation of tau pathology by the microglial fractalkine receptor. Neuron 68:19-31.
105. Bhattacharya B, Carlsten J, Sabo E, Kethu S, Meitner P, Tavares R, Jakate S, Mangray S, Aswad B, and Resnick MB (2007) Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux dis- ease. Hum Pathol 38:1744-1753.
106. Biber K, Zuurman MW, Homan H, and Boddeke HW (2003) Expression of L-CCR in HEK 293 cells reveals functional responses to CCL2, CCL5, CCL7, and CCL8. J Leukoc Biol 74:243-251.
107. Billstrom MA, Johnson GL, Avdi NJ, and Worthen GS (1998) Intracellular signaling by the chemokine receptor US28 during human cytomegalovirus infection. J Virol 72:5535-5544.
108. Binder NB, Niederreiter B, Hoffmann O, Stange R, Pap T, Stulnig TM, Mack M, Erben RG, Smolen JS, and Redlich K (2009) Estrogen-dependent and C-C che- mokine receptor-2-dependent pathways determine osteoclast behavior in osteopo- rosis. Nat Med 15:417-424.
109. Bizzarri C, Beccari AR, Bertini R, Cavicchia MR, Giorgini S, and Allegretti M (2006) ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets. Pharmacol Ther 112: 139-149.
110. Blaak H, Boers PH, Gruters RA, Schuitemaker H, van der Ende ME, and Osterhaus AD (2005) CCR5, GPR15, and CXCR6 are major coreceptors of human immuno- deficiency virus type 2 variants isolated from individuals with and without plasma viremia. J Virol 79:1686-1700.
111. Blackburn PE, Simpson CV, Nibbs RJ, O'Hara M, Booth R, Poulos J, Isaacs NW, and Graham GJ (2004) Purification and biochemical characterization of the D6 chemokine receptor. Biochem J 379:263-272.
112. Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, Jameson SC, Kirby C, Konikoff MR, and Collins MH, et al. (2006) Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 116: 536-547.
113. Blanpain C, Migeotte I, Lee B, Vakili J, Doranz BJ, Govaerts C, Vassart G, Doms RW, and Parmentier M (1999) CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. Blood 94:1899-1905.
114. Blaskovic D, Stanceková M, Svobodová J, and Mistríková J (1980) Isolation of five strains of herpesviruses from two species of free living small rodents. Acta Virol 24: 468. Bleul CC, Wu L, Hoxie JA, Springer TA, and Mackay CR (1997) The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lym- phocytes. Proc Natl Acad Sci USA 94:1925-1930.
115. Bodart V, Anastassov V, Darkes MC, Idzan SR, Labrecque J, Lau G, Mosi RM, Neff KS, Nelson KL, and Ruzek MC, et al. (2009) Pharmacology of AMD3465: a small molecule antagonist of the chemokine receptor CXCR4. Biochem Pharmacol 78: 993-1000. Bogunovic M, Ginhoux F, Helft J, Shang L, Hashimoto D, Greter M, Liu K, Jakubzick C, Ingersoll MA, and Leboeuf M, et al. (2009) Origin of the lamina propria dendritic cell network. Immunity 31:513-525.
116. Boismenu R, Feng L, Xia YY, Chang JC, and Havran WL (1996) Chemokine ex- pression by intraepithelial gamma delta T cells. Implications for the recruitment of inflammatory cells to damaged epithelia. J Immunol 157:985-992.
117. Boldajipour B, Mahabaleshwar H, Kardash E, Reichman-Fried M, Blaser H, Minina S, Wilson D, Xu Q, and Raz E (2008) Control of chemokine-guided cell migration by ligand sequestration. Cell 132:463-473.
118. Bonduelle O, Duffy D, Verrier B, Combadière C, and Combadière B (2012) Cutting edge: Protective effect of CX3CR1+ dendritic cells in a vaccinia virus pulmonary infection model. J Immunol 188:952-956.
119. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, and Mantovani A, et al. (1998) Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187:129-134.
120. Bonecchi R, Borroni EM, Anselmo A, Doni A, Savino B, Mirolo M, Fabbri M, Jala VR, Haribabu B, and Mantovani A, et al. (2008) Regulation of D6 chemokine scav- enging activity by ligand-and Rab11-dependent surface up-regulation. Blood 112: 493-503.
121. Bonecchi R, Locati M, Galliera E, Vulcano M, Sironi M, Fra AM, Gobbi M, Vecchi A, Sozzani S, and Haribabu B, et al. (2004) Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemo- kine/CC chemokine ligand 22) by the D6 decoy receptor. J Immunol 172:4972-4976.
122. Bongers G, Maussang D, Muniz LR, Noriega VM, Fraile-Ramos A, Barker N, Mar- chesi F, Thirunarayanan N, Vischer HF, and Qin L, et al. (2010) The cytomega- lovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice. J Clin Invest 120:3969-3978.
123. Bonini JA, Martin SK, Dralyuk F, Roe MW, Philipson LH, and Steiner DF (1997) Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3. DNA Cell Biol 16:1249-1256.
124. Bordon Y, Hansell CA, Sester DP, Clarke M, Mowat AM, and Nibbs RJ (2009) The atypical chemokine receptor D6 contributes to the development of experimental colitis. J Immunol 182:5032-5040.
125. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr, Broxmeyer HE, and Charo IF (1997) Impaired monocyte migration and reduced type 1 (Th1) cy- tokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 100: 2552-2561.
126. Boring L, Gosling J, Cleary M, and Charo IF (1998) Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394:894-897.
127. Boring L, Gosling J, Monteclaro FS, Lusis AJ, Tsou CL, and Charo IF (1996) Mo- lecular cloning and functional expression of murine JE (monocyte chemoattractant protein 1) and murine macrophage inflammatory protein 1alpha receptors: evi- dence for two closely linked C-C chemokine receptors on chromosome 9. J Biol Chem 271:7551-7558.
128. Borroni EM, Cancellieri C, Vacchini A, Benureau Y, Lagane B, Bachelerie F, Are- nzana-Seisdedos F, Mizuno K, Mantovani A, and Bonecchi R, et al. (2013) b-Arrestin-dependent activation of the cofilin pathway is required for the scav- enging activity of the atypical chemokine receptor D6. Sci Signal 6: S31-33.
129. Bosworth T (2010) New biologics for IBD stalled at investigational stage. Gastro- enterol Endoscopy News 61. Available from http://www.gastroendonews.com/ Archive.aspx. Bottazzi B, Polentarutti N, Acero R, Balsari A, Boraschi D, Ghezzi P, Salmona M, and Mantovani A (1983) Regulation of the macrophage content of neoplasms by chemoattractants. Science 220:210-212.
130. Bourges D, Meurens F, Berri M, Chevaleyre C, Zanello G, Levast B, Melo S, Gerdts V, and Salmon H (2008) New insights into the dual recruitment of IgA+ B cells in the developing mammary gland. Mol Immunol 45:3354-3362.
131. Bradley ME, Bond ME, Manini J, Brown Z, and Charlton SJ (2009) SB265610 is an allosteric, inverse agonist at the human CXCR2 receptor. Br J Pharmacol 158: 328-338.
132. Braunersreuther V, Zernecke A, Arnaud C, Liehn EA, Steffens S, Shagdarsuren E, Bidzhekov K, Burger F, Pelli G, and Luckow B, et al. (2007) Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler Thromb Vasc Biol 27:373-379.
133. Brenner D, Labreuche J, Touboul PJ, Schmidt-Petersen K, Poirier O, Perret C, Schönfelder J, Combadière C, Lathrop M, and Cambien F, et al.; GENIC Inves- tigators (2006) Cytokine polymorphisms associated with carotid intima-media thickness in stroke patients. Stroke 37:1691-1696.
134. Bromley SK, Thomas SY, and Luster AD (2005) Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat Immunol 6:895-901.
135. Brouwer N, Zuurman MW, Wei T, Ransohoff RM, Boddeke HW, and Biber K (2004) Induction of glial L-CCR mRNA expression in spinal cord and brain in experi- mental autoimmune encephalomyelitis. Glia 46:84-94.
136. Brown MF, Bahnck KB, Blumberg LC, Brissette WH, Burrell SA, Driscoll JP, Fedeles F, Fisher MB, Foti RS, and Gladue RP, et al. (2007) Piperazinyl CCR1 antagonists-optimization of human liver microsome stability. Bioorg Med Chem Lett 17:3109-3112.
137. Buanne P, Di Carlo E, Caputi L, Brandolini L, Mosca M, Cattani F, Pellegrini L, Biordi L, Coletti G, and Sorrentino C, et al. (2007) Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice. J Leukoc Biol 82: 1239-1246.
138. Buckland KF, O'connor EC, Coleman EM, Lira SA, Lukacs NW, and Hogaboam CM (2007) Remission of chronic fungal asthma in the absence of CCR8. J Allergy Clin Immunol 119:997-1004.
139. Bullock JZ, Villanueva JM, Blanchard C, Filipovich AH, Putnam PE, Collins MH, Risma KA, Akers RM, Kirby CL, and Buckmeier BK, et al. (2007) Interplay of adaptive Th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 45:22-31.
140. Burger JA, Stewart DJ, Wald O, and Peled A (2011) Potential of CXCR4 antagonists for the treatment of metastatic lung cancer. Expert Rev Anticancer Ther 11: 621-630.
141. Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, Penfold ME, Sunshine MJ, Littman DR, and Kuo CJ, et al. (2006) A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor de- velopment. J Exp Med 203:2201-2213.
142. Busillo JM and Benovic JL (2007) Regulation of CXCR4 signaling. Biochim Biophys Acta 1768:952-963.
143. Cacalano G, Lee J, Kikly K, Ryan AM, Pitts-Meek S, Hultgren B, Wood WI, and Moore MW (1994) Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265:682-684.
144. Cain SA and Monk PN (2002) The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). J Biol Chem 277: 7165-7169.
145. Cairns CM, Gordon JR, Li F, Baca-Estrada ME, Moyana T, and Xiang J (2001) Lymphotactin expression by engineered myeloma cells drives tumor regression: mediation by CD4+ and CD8+ T cells and neutrophils expressing XCR1 receptor. J Immunol 167:57-65.
146. Calatozzolo C, Canazza A, Pollo B, Di Pierro E, Ciusani E, Maderna E, Salce E, Sponza V, Frigerio S, and Di Meco F, et al. (2011) Expression of the new CXCL12 receptor, CXCR7, in gliomas. Cancer Biol Ther 11:242-253.
147. Camarda G, Spinetti G, Bernardini G, Mair C, Davis-Poynter N, Capogrossi MC, and Napolitano M (1999) The equine herpesvirus 2 E1 open reading frame encodes a functional chemokine receptor. J Virol 73:9843-9848.
148. Campanella GS, Colvin RA, and Luster AD (2010) CXCL10 can inhibit endothelial cell proliferation independently of CXCR3. PLoS ONE 5:e12700.
149. Campanella GS, Grimm J, Manice LA, Colvin RA, Medoff BD, Wojtkiewicz GR, Weissleder R, and Luster AD (2006) Oligomerization of CXCL10 is necessary for endothelial cell presentation and in vivo activity. J Immunol 177:6991-6998.
150. Campanella GS, Lee EM, Sun J, and Luster AD (2003) CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10). J Biol Chem 278:17066-17074.
151. Campanella GS, Medoff BD, Manice LA, Colvin RA, and Luster AD (2008a) De- velopment of a novel chemokine-mediated in vivo T cell recruitment assay. J Immunol Methods 331:127-139.
152. Campanella GS, Tager AM, El Khoury JK, Thomas SY, Abrazinski TA, Manice LA, Colvin RA, and Luster AD (2008b) Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc Natl Acad Sci USA 105:4814-4819.
153. Campbell EM, Charo IF, Kunkel SL, Strieter RM, Boring L, Gosling J, and Lukacs NW (1999a) Monocyte chemoattractant protein-1 mediates cockroach allergen-in- duced bronchial hyperreactivity in normal but not CCR2-/-mice: the role of mast cells. J Immunol 163:2160-2167.
154. Campbell JJ, Bowman EP, Murphy K, Youngman KR, Siani MA, Thompson DA, Wu L, Zlotnik A, and Butcher EC (1998) 6-C-kine (SLC), a lymphocyte adhesion-trig- gering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7. J Cell Biol 141:1053-1059.
155. Campbell JJ, Haraldsen G, Pan J, Rottman J, Qin S, Ponath P, Andrew DP, Warnke R, Ruffing N, and Kassam N, et al. (1999b) The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400: 776-780. Campbell JJ, Qin S, Unutmaz D, Soler D, Murphy KE, Hodge MR, Wu L, and Butcher EC (2001) Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 166:6477-6482.
156. Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, Huang D, Kidd G, Dombrowski S, and Dutta R, et al. (2006) Control of microglial neurotox- icity by the fractalkine receptor. Nat Neurosci 9:917-924.
157. Carson KG, Harriman GCB, and Ghosh S (2011), inventors; Millennium Pharma- ceuticals, Inc. (Cambridge, MA), assignee. CCR1 antagonists and methods of use therefore. U.S. patent application 13/151,701. 2 June 2011.
158. Casarosa P, Bakker RA, Verzijl D, Navis M, Timmerman H, Leurs R, and Smit MJ (2001) Constitutive signaling of the human cytomegalovirus-encoded chemokine receptor US28. J Biol Chem 276:1133-1137.
159. Casarosa P, Menge WM, Minisini R, Otto C, van Heteren J, Jongejan A, Timmerman H, Moepps B, Kirchhoff F, and Mertens T, et al. (2003) Identification of the first nonpeptidergic inverse agonist for a constitutively active viral-encoded G protein- coupled receptor. J Biol Chem 278:5172-5178.
160. Casrouge A, Decalf J, Ahloulay M, Lababidi C, Mansour H, Vallet-Pichard A, Mallet V, Mottez E, Mapes J, and Fontanet A, et al. (2011) Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J Clin Invest 121:308-317.
161. Castellino F, Huang AY, Altan-Bonnet G, Stoll S, Scheinecker C, and Germain RN (2006) Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature 440:890-895.
162. Update on Chemokine Receptors 61
163. Castor MG, Rezende B, Resende CB, Alessandri AL, Fagundes CT, Sousa LP, Ara- ntes RM, Souza DG, Silva TA, and Proudfoot AE, et al. (2010) The CCL3/macro- phage inflammatory protein-1alpha-binding protein evasin-1 protects from graft- versus-host disease but does not modify graft-versus-leukemia in mice. J Immunol 184:2646-2654.
164. Catley MC, Coote J, Bari M, and Tomlinson KL (2011) Monoclonal antibodies for the treatment of asthma. Pharmacol Ther 132:333-351.
165. Catusse J, Leick M, Groch M, Clark DJ, Buchner MV, Zirlik K, and Burger M (2010) Role of the atypical chemoattractant receptor CRAM in regulating CCL19 induced CCR7 responses in B-cell chronic lymphocytic leukemia. Mol Cancer 9:297.
166. Catusse J, Spinks J, Mattick C, Dyer A, Laing K, Fitzsimons C, Smit MJ, and Gompels UA (2008) Immunomodulation by herpesvirus U51A chemokine re- ceptor via CCL5 and FOG-2 down-regulation plus XCR1 and CCR7 mimicry in human leukocytes. Eur J Immunol 38:763-777.
167. Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JK, Doherty JM, Mills JC, and Colonna M (2009) A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457:722-725.
168. Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A, and Colonna M (1999) Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 5:919-923.
169. Chakera A, Seeber RM, John AE, Eidne KA, and Greaves DR (2008) The duffy antigen/receptor for chemokines exists in an oligomeric form in living cells and functionally antagonizes CCR5 signaling through hetero-oligomerization. Mol Pharmacol 73:1362-1370.
170. Chang Y, de Nadai P, Azzaoui I, Morales O, Delhem N, Vorng H, Tomavo S, Ait Yahia S, Zhang G, and Wallaert B, et al. (2010) The chemokine CCL18 generates adap- tive regulatory T cells from memory CD4+ T cells of healthy but not allergic sub- jects. FASEB J 24:5063-5072.
171. Charbonnier AS, Kohrgruber N, Kriehuber E, Stingl G, Rot A, and Maurer D (1999) Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells. J Exp Med 190:1755-1768.
172. Charo IF, Myers SJ, Herman A, Franci C, Connolly AJ, and Coughlin SR (1994) Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci USA 91:2752-2756.
173. Charvat TT, Hu C, Jin J, Li Y, Melikian A, Pennell AMK, Punna S, Ungashe S, and Zeng Y (2013), inventors; ChemoCentryx, Inc. (Mountain View, CA), assignee. Triazolyl pyridyl benzenesulfonamides, U.S. patent 8,445,518. 21 May 2013.
174. Chaudhuri A, Nielsen S, Elkjaer ML, Zbrzezna V, Fang F, and Pogo AO (1997) Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs. Blood 89:701-712.
175. Chaudhuri A, Polyakova J, Zbrzezna V, and Pogo AO (1995) The coding sequence of Duffy blood group gene in humans and simians: restriction fragment length poly- morphism, antibody and malarial parasite specificities, and expression in non- erythroid tissues in Duffy-negative individuals. Blood 85:615-621.
176. Chaudhuri A, Polyakova J, Zbrzezna V, Pogo AO, Hesselgesser J, and Horuk R (1994) The major glycoprotein of the Duffy blood-group antigen (Gpd), which is the malarial Plasmodium-vivax erythrocyte receptor is also a novel class of chemokine receptor and is present in brain, kidney, lung, thymus, and spleen. FASEB J 8: A1386-A1386.
177. Chaudhuri A, Polyakova J, Zbrzezna V, Williams K, Gulati S, and Pogo AO (1993) Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite. Proc Natl Acad Sci USA 90:10793-10797.
178. Chen D, Ding Y, Schröppel B, Zhang N, Fu S, Chen D, Zhang H, and Bromberg JS (2003) Differential chemokine and chemokine receptor gene induction by ischemia, alloantigen, and gene transfer in cardiac grafts. Am J Transplant 3:1216-1229.
179. Chen J, Yao Y, Gong C, Yu F, Su S, Chen J, Liu B, Deng H, Wang F, and Lin L, et al. (2011) CCL18 from tumor-associated macrophages promotes breast cancer me- tastasis via PITPNM3. Cancer Cell 19:541-555.
180. Chen NJ, Mirtsos C, Suh D, Lu YC, Lin WJ, McKerlie C, Lee T, Baribault H, Tian H, and Yeh WC (2007) C5L2 is critical for the biological activities of the anaphyla- toxins C5a and C3a. Nature 446:203-207.
181. Chen S, Bacon KB, Li L, Garcia GE, Xia Y, Lo D, Thompson DA, Siani MA, Yama- moto T, and Harrison JK, et al. (1998) In vivo inhibition of CC and CX3C che- mokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J Exp Med 188:193-198.
182. Chenivesse C, Chang Y, Azzaoui I, Ait Yahia S, Morales O, Plé C, Foussat A, Tonnel AB, Delhem N, and Yssel H, et al. (2012) Pulmonary CCL18 recruits human reg- ulatory T cells. J Immunol 189:128-137.
183. Chensue SW, Lukacs NW, Yang TY, Shang X, Frait KA, Kunkel SL, Kung T, Wie- kowski MT, Hedrick JA, and Cook DN, et al. (2001) Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice. J Exp Med 193:573-584.
184. Cho ML, Yoon BY, Ju JH, Jung YO, Jhun JY, Park MK, Park SH, Cho CS, and Kim HY (2007) Expression of CCR2A, an isoform of MCP-1 receptor, is increased by MCP-1, CD40 ligand and TGF-beta in fibroblast like synoviocytes of patients with RA. Exp Mol Med 39:499-507.
185. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, and Newman W, et al. (1996) The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148.
186. Choi YB and Nicholas J (2008) Autocrine and paracrine promotion of cell survival and virus replication by human herpesvirus 8 chemokines. J Virol 82:6501-6513.
187. Chou RC, Kim ND, Sadik CD, Seung E, Lan Y, Byrne MH, Haribabu B, Iwakura Y, and Luster AD (2010) Lipid-cytokine-chemokine cascade drives neutrophil re- cruitment in a murine model of inflammatory arthritis. Immunity 33:266-278.
188. Chow KY, Brotin E, Ben Khalifa Y, Carthagena L, Teissier S, Danckaert A, Galzi JL, Arenzana-Seisdedos F, Thierry F, and Bachelerie F (2010) A pivotal role for CXCL12 signaling in HPV-mediated transformation of keratinocytes: clues to un- derstanding HPV-pathogenesis in WHIM syndrome. Cell Host Microbe 8:523-533.
189. Christmann BS, Moran JM, McGraw JA, Buller RM, and Corbett JA (2011) Ccr5 regulates inflammatory gene expression in response to encephalomyocarditis virus infection. Am J Pathol 179:2941-2951.
190. Chu X, Pan CM, Zhao SX, Liang J, Gao GQ, Zhang XM, Yuan GY, Li CG, Xue LQ, and Shen M, et al.; China Consortium for Genetics of Autoimmune Thyroid Disease (2011) A genome-wide association study identifies two new risk loci for Graves' disease. Nat Genet 43:897-901.
191. Chung CD, Kuo F, Kumer J, Motani AS, Lawrence CE, Henderson WR Jr, and Venkataraman C (2003) CCR8 is not essential for the development of in- flammation in a mouse model of allergic airway disease. J Immunol 170:581-587.
192. Chuntharapai A and Kim KJ (1995) Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. J Immunol 155:2587-2594.
193. Cipollone F, Marini M, Fazia M, Pini B, Iezzi A, Reale M, Paloscia L, Materazzo G, D'Annunzio E, and Conti P, et al. (2001) Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 21:327-334.
194. Cipriani B, Borsellino G, Poccia F, Placido R, Tramonti D, Bach S, Battistini L, and Brosnan CF (2000) Activation of C-C beta-chemokines in human peripheral blood gammadelta T cells by isopentenyl pyrophosphate and regulation by cyto- kines. Blood 95:39-47.
195. Citro A, Cantarelli E, Maffi P, Nano R, Melzi R, Mercalli A, Dugnani E, Sordi V, Magistretti P, and Daffonchio L, et al. (2012) CXCR1/2 inhibition enhances pan- creatic islet survival after transplantation. J Clin Invest 122:3647-3651.
196. Clark-Lewis I, Dewald B, Geiser T, Moser B, and Baggiolini M (1993) Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg. Proc Natl Acad Sci USA 90:3574-3577.
197. Clark-Lewis I, Mattioli I, Gong JH, and Loetscher P (2003) Structure-function re- lationship between the human chemokine receptor CXCR3 and its ligands. J Biol Chem 278:289-295.
198. Clark AK, Staniland AA, and Malcangio M (2011) Fractalkine/CX3CR1 signalling in chronic pain and inflammation. Curr Pharm Biotechnol 12:1707-1714.
199. Clark RA, Chong B, Mirchandani N, Brinster NK, Yamanaka K, Dowgiert RK, and Kupper TS (2006) The vast majority of CLA+ T cells are resident in normal skin. J Immunol 176:4431-4439.
200. Clarke C, Kuboki S, Sakai N, Kasten KR, Tevar AD, Schuster R, Blanchard J, Caldwell CC, Edwards MJ, and Lentsch AB (2011) CXC chemokine receptor-1 is expressed by hepatocytes and regulates liver recovery after hepatic ischemia/ reperfusion injury. Hepatology 53:261-271.
201. Clemetson KJ, Clemetson JM, Proudfoot AE, Power CA, Baggiolini M, and Wells TN (2000) Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. Blood 96:4046-4054.
202. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, and Lusso P (1995) Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-sup- pressive factors produced by CD8+ T cells. Science 270:1811-1815.
203. Cochain C, Auvynet C, Poupel L, Vilar J, Dumeau E, Richart A, Récalde A, Zouggari Y, Yin KYHW, and Bruneval P, et al. (2012) The chemokine decoy receptor D6 prevents excessive inflammation and adverse ventricular remodeling after myo- cardial infarction. Arterioscler Thromb Vasc Biol 32:2206-2213.
204. Codullo V, Baldwin HM, Singh MD, Fraser AR, Wilson C, Gilmour A, Hueber AJ, Bonino C, McInnes IB, and Montecucco C, et al. (2011) An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis. Ann Rheum Dis 70:1115-1121.
205. Cohen C, DeJesus E, Mills A, Pierone G, Kumar P, Ruane P, Elion R, Fusco G, Levy R, and Solomon K (2007) Potent antiretroviral activity of the once daily antagonist INCB009471 over 14 days of monotherapy, in Fourth IAS Conference on HIV Pathogenesis, Treatment, and Prevention; 22-25 July 2007; Sydney, Australia.
206. Cohen-Hillel E, Yron I, Meshel T, Soria G, Attal H, and Ben-Baruch A (2006) CXCL8- induced FAK phosphorylation via CXCR1 and CXCR2: cytoskeleton-and integrin- related mechanisms converge with FAK regulatory pathways in a receptor-specific manner. Cytokine 33:1-16.
207. Cole KE, Strick CA, Paradis TJ, Ogborne KT, Loetscher M, Gladue RP, Lin W, Boyd JG, Moser B, and Wood DE, et al. (1998) Interferon-inducible T cell alpha che- moattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 187: 2009-2021.
208. Colvin RA, Campanella GS, Manice LA, and Luster AD (2006) CXCR3 requires ty- rosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis. Mol Cell Biol 26:5838-5849.
209. Colvin RA, Campanella GS, Sun J, and Luster AD (2004) Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function. J Biol Chem 279: 30219-30227.
210. Combadière B, Faure S, Autran B, Debré P, and Combadière C (2003a) The che- mokine receptor CX3CR1 controls homing and anti-viral potencies of CD8 effector- memory T lymphocytes in HIV-infected patients. AIDS 17:1279-1290.
211. Combadiere C, Ahuja SK, and Murphy PM (1995) Cloning and functional expression of a human eosinophil CC chemokine receptor. J Biol Chem 270:16491-16494.
212. Combadiere C, Ahuja SK, Tiffany HL, and Murphy PM (1996) Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1(alpha), MIP-1(beta), and RANTES. J Leukoc Biol 60:147-152.
213. Combadière C, Feumi C, Raoul W, Keller N, Rodéro M, Pézard A, Lavalette S, Houssier M, Jonet L, and Picard E, et al. (2007) CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest 117:2920-2928.
214. Combadière C, Potteaux S, Gao JL, Esposito B, Casanova S, Lee EJ, Debré P, Tedgui A, Murphy PM, and Mallat Z (2003b) Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 107:1009-1016.
215. Combadière C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B, Merval R, Proudfoot A, Tedgui A, and Mallat Z (2008) Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 117:1649-1657.
216. Combadiere C, Salzwedel K, Smith ED, Tiffany HL, Berger EA, and Murphy PM (1998) Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1. J Biol Chem 273: 23799-23804.
217. Comerford I, Milasta S, Morrow V, Milligan G, and Nibbs R (2006) The chemokine receptor CCX-CKR mediates effective scavenging of CCL19 in vitro. Eur J Immunol 36:1904-1916.
218. Comerford I, Nibbs RJ, Litchfield W, Bunting M, Harata-Lee Y, Haylock-Jacobs S, Forrow S, Korner H, and McColl SR (2010) The atypical chemokine receptor CCX- CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responses. Blood 116:4130-4140.
219. Conductier G, Blondeau N, Guyon A, Nahon JL, and Rovère C (2010) The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J Neuroimmunol 224:93-100.
220. Connolly S, Skrinjar M, and Rosendahl A (2012) Orally bioavailable allosteric CCR8 antagonists inhibit dendritic cell, T cell and eosinophil migration. Biochem Phar- macol 83:778-787.
221. Cook DN, Prosser DM, Forster R, Zhang J, Kuklin NA, Abbondanzo SJ, Niu XD, Chen SC, Manfra DJ, and Wiekowski MT, et al. (2000) CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tis- sue. Immunity 12:495-503.
222. Coombes JL, Siddiqui KR, Arancibia-Cárcamo CV, Hall J, Sun CM, Belkaid Y, and Powrie F (2007) A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 204:1757-1764.
223. Cormier EG, Tran DN, Yukhayeva L, Olson WC, and Dragic T (2001) Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes. J Virol 75: 5541-5549.
224. Cox MA, Jenh CH, Gonsiorek W, Fine J, Narula SK, Zavodny PJ, and Hipkin RW (2001) Human interferon-inducible 10-kDa protein and human interferon-in- ducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: dif- ferential binding to receptor states. Mol Pharmacol 59:707-715.
225. Crozat K, Guiton R, Contreras V, Feuillet V, Dutertre CA, Ventre E, Vu Manh TP, Baranek T, Storset AK, and Marvel J, et al. (2010) The XC chemokine receptor 1 is a conserved selective of mammalian cells homologous to mouse CD8alpha+ dendritic cells. J Exp Med 207:1283-1292.
226. Crozat K, Tamoutounour S, Vu Manh TP, Fossum E, Luche H, Ardouin L, Guilliams M, Azukizawa H, Bogen B, and Malissen B, et al. (2011) Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8a+ type. J Immunol 187:4411-4415.
227. Crump MP, Gong JH, Loetscher P, Rajarathnam K, Amara A, Arenzana-Seisdedos F, Virelizier JL, Baggiolini M, Sykes BD, and Clark-Lewis I (1997) Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J 16:6996-7007.
228. Cruz-Orengo L, Holman DW, Dorsey D, Zhou L, Zhang P, Wright M, McCandless EE, Patel JR, Luker GD, and Littman DR, et al. (2011) CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J Exp Med 208:327-339.
229. Cutbush M and Mollison PL (1950) The Duffy blood group system. Heredity (Edinb) 4:383-389.
230. Cutbush M, Mollison PL, and Parkin DM (1950) A new human blood group. Nature 165:188-189.
231. Cyster JG (1999) Chemokines and cell migration in secondary lymphoid organs. Science 286:2098-2102.
232. D'Ambrosio D, Iellem A, Bonecchi R, Mazzeo D, Sozzani S, Mantovani A, and Sinigaglia F (1998) Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol 161: 5111-5115.
233. D'Amico G, Frascaroli G, Bianchi G, Transidico P, Doni A, Vecchi A, Sozzani S, Allavena P, and Mantovani A (2000) Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat Immunol 1:387-391.
234. D'Haese JG, Demir IE, Friess H, and Ceyhan GO (2010) Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential. Expert Opin Ther Targets 14:207-219.
235. Dairaghi DJ, Fan RA, McMaster BE, Hanley MR, and Schall TJ (1999) HHV8- encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and an- tagonist profiles of viral chemokines. J Biol Chem 274:21569-21574.
236. Dairaghi DJ, Zhang P, Wang Y, Seitz LC, Johnson DA, Miao S, Ertl LS, Zeng Y, Powers JP, and Pennell AM, et al. (2011) Pharmacokinetic and pharmacody- namic evaluation of the novel CCR1 antagonist CCX354 in healthy human subjects: implications for selection of clinical dose. Clin Pharmacol Ther 89: 726-734.
237. Dale DC, Bolyard AA, Kelley ML, Westrup EC, Makaryan V, Aprikyan A, Wood B, and Hsu FJ (2011) The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome. Blood 118:4963-4966.
238. Damaj BB, McColl SR, Neote K, Songqing N, Ogborn KT, Hébert CA, and Naccache PH (1996) Identification of G-protein binding sites of the human interleukin-8 receptors by functional mapping of the intracellular loops. FASEB J 10: 1426-1434.
239. Dambly-Chaudière C, Cubedo N, and Ghysen A (2007) Control of cell migration in the development of the posterior lateral line: antagonistic interactions between the chemokine receptors CXCR4 and CXCR7/RDC1. BMC Dev Biol 7:23.
240. Damon I, Murphy PM, and Moss B (1998) Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog. Proc Natl Acad Sci USA 95: 6403-6407.
241. Daoudi M, Lavergne E, Garin A, Tarantino N, Debré P, Pincet F, Combadière C, and Deterre P (2004) Enhanced adhesive capacities of the naturally occurring Ile249-Met280 variant of the chemokine receptor CX3CR1. J Biol Chem 279: 19649-19657.
242. Darash-Yahana M, Gillespie JW, Hewitt SM, Chen YY, Maeda S, Stein I, Singh SP, Bedolla RB, Peled A, and Troyer DA, et al. (2009) The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers. PLoS ONE 4:e6695.
243. Darbonne WC, Rice GC, Mohler MA, Apple T, Hébert CA, Valente AJ, and Baker JB (1991) Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 88:1362-1369.
244. Daugherty BL, Siciliano SJ, DeMartino JA, Malkowitz L, Sirotina A, and Springer MS (1996) Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med 183:2349-2354.
245. Dawson TC, Beck MA, Kuziel WA, Henderson F, and Maeda N (2000a) Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol 156:1951-1959.
246. Dawson TC, Lentsch AB, Wang Z, Cowhig JE, Rot A, Maeda N, and Peiper SC (2000b) Exaggerated response to endotoxin in mice lacking the Duffy antigen/re- ceptor for chemokines (DARC). Blood 96:1681-1684.
247. De Clercq E (2009) The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil). Biochem Pharmacol 77:1655-1664.
248. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, and Gomperts E, et al. (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. see comments published erratum appears in Science 1996 Nov 15;274 5290: 1069 Science 273:1856-1862.
249. Debes GF, Arnold CN, Young AJ, Krautwald S, Lipp M, Hay JB, and Butcher EC (2005) Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat Immunol 6:889-894.
250. DeBruyne LA, Li K, Bishop DK, and Bromberg JS (2000) Gene transfer of virally encoded chemokine antagonists vMIP-II and MC148 prolongs cardiac allograft survival and inhibits donor-specific immunity. Gene Ther 7:575-582.
251. Décaillot FM, Kazmi MA, Lin Y, Ray-Saha S, Sakmar TP, and Sachdev P (2011) CXCR7/CXCR4 heterodimer constitutively recruits beta-arrestin to enhance cell migration. J Biol Chem 286:32188-32197.
252. DeMarco SJ, Henze H, Lederer A, Moehle K, Mukherjee R, Romagnoli B, Robinson JA, Brianza F, Gombert FO, and Lociuro S, et al. (2006) Discovery of novel, highly potent and selective beta-hairpin mimetic CXCR4 inhibitors with excellent anti- HIV activity and pharmacokinetic profiles. Bioorg Med Chem 14:8396-8404.
253. Dénes A, Ferenczi S, Halász J, Környei Z, and Kovács KJ (2008) Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse. J Cereb Blood Flow Metab 28:1707-1721.
254. Deng HK, Unutmaz D, KewalRamani VN, and Littman DR (1997) Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388:296-300.
255. Denis C, Deiteren K, Mortier A, Tounsi A, Fransen E, Proost P, Renauld JC, and Lambeir AM (2012) C-terminal clipping of chemokine CCL1/I-309 enhances CCR8-mediated intracellular calcium release and anti-apoptotic activity. PLoS ONE 7:e34199.
256. Deruaz M (2008) Ticks produce highly selective chemokine binding proteins with antiinflammatory activity. Ph.D. thesis, Universtiy of Geneva, Geneva, Switzerland. Déruaz M, Frauenschuh A, Alessandri AL, Dias JM, Coelho FM, Russo RC, Ferreira BR, Graham GJ, Shaw JP, and Wells TN, et al. (2008) Ticks produce highly se- lective chemokine binding proteins with antiinflammatory activity. J Exp Med 205: 2019-2031.
257. Desanti GE, Jenkinson WE, Parnell SM, Boudil A, Gautreau-Rolland L, Eksteen B, Ezine S, Lane PJ, Jenkinson EJ, and Anderson G (2011) Clonal analysis reveals uniformity in the molecular profile and lineage potential of CCR9(+) and CCR9(-) thymus-settling progenitors. J Immunol 186:5227-5235.
258. Detheux M, Ständker L, Vakili J, Münch J, Forssmann U, Adermann K, Pöhlmann S, Vassart G, Kirchhoff F, and Parmentier M, et al. (2000) Natural proteolytic pro- cessing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties. J Exp Med 192:1501-1508.
259. Dhawan P and Richmond A (2002) Role of CXCL1 in tumorigenesis of melanoma. J Leukoc Biol 72:9-18.
260. Di Liberto D, Locati M, Caccamo N, Vecchi A, Meraviglia S, Salerno A, Sireci G, Nebuloni M, Caceres N, and Cardona PJ, et al. (2008) Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial re- sistance in Mycobacterium tuberculosis infection. J Exp Med 205:2075-2084.
261. Dias JM, Losberger C, Déruaz M, Power CA, Proudfoot AE, and Shaw JP (2009) Structural basis of chemokine sequestration by a tick chemokine binding protein: the crystal structure of the complex between Evasin-1 and CCL3. PLoS ONE 4: e8514.
262. Diehl GE, Longman RS, Zhang JX, Breart B, Galan C, Cuesta A, Schwab SR, and Littman DR (2013) Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi) cells. Nature 494:116-120.
263. Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, Aït-Yahia S, Brière F, Zlotnik A, Lebecque S, and Caux C (1998) Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188:373-386.
264. Dilloo D, Bacon K, Holden W, Zhong W, Burdach S, Zlotnik A, and Brenner M (1996) Combined chemokine and cytokine gene transfer enhances antitumor immunity. Nat Med 2:1090-1095.
265. Dimitrijevic OB, Stamatovic SM, Keep RF, and Andjelkovic AV (2007) Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke 38:1345-1353.
266. Domachowske JB, Bonville CA, Gao JL, Murphy PM, Easton AJ, and Rosenberg HF (2000) The chemokine macrophage-inflammatory protein-1 alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in para- myxovirus infection. J Immunol 165:2677-2682.
267. Update on Chemokine Receptors Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, and Doms RW (1996) A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149-1158.
268. Dorgham K, Ghadiri A, Hermand P, Rodero M, Poupel L, Iga M, Hartley O, Gorochov G, Combadière C, and Deterre P (2009) An engineered CX3CR1 antagonist endowed with anti-inflammatory activity. J Leukoc Biol 86:903-911.
269. Dorner B, Müller S, Entschladen F, Schröder JM, Franke P, Kraft R, Friedl P, Clark- Lewis I, and Kroczek RA (1997) Purification, structural analysis, and function of natural ATAC, a cytokine secreted by CD8(+) T cells. J Biol Chem 272:8817-8823.
270. Dorner BG, Dorner MB, Zhou X, Opitz C, Mora A, Güttler S, Hutloff A, Mages HW, Ranke K, and Schaefer M, et al. (2009) Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells. Immunity 31:823-833.
271. Dorner BG, Scheffold A, Rolph MS, Huser MB, Kaufmann SH, Radbruch A, Flesch IE, and Kroczek RA (2002) MIP-1alpha, MIP-1beta, RANTES, and ATAC/lym- photactin function together with IFN-gamma as type 1 cytokines. Proc Natl Acad Sci USA 99:6181-6186.
272. Dorr P, Westby M, Dobbs S, Griffin P, Irvine B, Macartney M, Mori J, Rickett G, Smith-Burchnell C, and Napier C, et al. (2005) Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob Agents Chemother 49:4721-4732.
273. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, and Moore JP, et al. (1996) HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. see comments Nature 381:667-673.
274. Drury LJ, Ziarek JJ, Gravel S, Veldkamp CT, Takekoshi T, Hwang ST, Heveker N, Volkman BF, and Dwinell MB (2011) Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways. Proc Natl Acad Sci USA 108:17655-17660.
275. Du J, Luan J, Liu H, Daniel TO, Peiper S, Chen TS, Yu Y, Horton LW, Nanney LB, and Strieter RM, et al. (2002) Potential role for Duffy antigen chemokine-binding protein in angiogenesis and maintenance of homeostasis in response to stress. J Leukoc Biol 71:141-153.
276. Duggal P, An P, Beaty TH, Strathdee SA, Farzadegan H, Markham RB, Johnson L, O'Brien SJ, Vlahov D, and Winkler CA (2003) Genetic influence of CXCR6 che- mokine receptor alleles on PCP-mediated AIDS progression among African Americans. Genes Immun 4:245-250.
277. Dwinell MB, Eckmann L, Leopard JD, Varki NM, and Kagnoff MF (1999) Chemokine receptor expression by human intestinal epithelial cells. Gastroenterology 117: 359-367.
278. Dwyer MP, Yu Y, Chao J, Aki C, Chao J, Biju P, Girijavallabhan V, Rindgen D, Bond R, and Mayer-Ezel R, et al. (2006) Discovery of 2-hydroxy-N,N-dimethyl-3-2-[[(R)-1- (5-methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylaminobenzamide (SCH 527123): a potent, orally bioavailable CXCR2/CXCR1 receptor antagonist. J Med Chem 49:7603-7606.
279. Ebert LM, Meuter S, and Moser B (2006) Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillance. J Immunol 176:4331-4336.
280. Ebisawa M, Hase K, Takahashi D, Kitamura H, Knoop KA, Williams IR, and Ohno H (2011) CCR6hiCD11c(int) B cells promote M-cell differentiation in Peyer's patch. Int Immunol 23:261-269.
281. Edinger AL, Mankowski JL, Doranz BJ, Margulies BJ, Lee B, Rucker J, Sharron M, Hoffman TL, Berson JF, and Zink MC, et al. (1997) CD4-independent, CCR5- dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Proc Natl Acad Sci USA 94:14742-14747.
282. Ehlert JE, Addison CA, Burdick MD, Kunkel SL, and Strieter RM (2004) Identifi- cation and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping. J Immunol 173:6234-6240.
283. Endres MJ, Garlisi CG, Xiao H, Shan L, and Hedrick JA (1999) The Kaposi's sar- coma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8. J Exp Med 189:1993-1998.
284. Eraltan H, Cacina C, Kahraman OT, Kurt O, Aydogan HY, Uyar M, Can A, and Cakmako glu B (2012) MCP-1 and CCR2 gene variants and the risk for oste- oporosis and osteopenia. Genet Test Mol Biomarkers 16:229-233.
285. Esté JA (2002) Sch-351125 and Sch-350634. Schering-Plough. Curr Opin Investig Drugs 3:379-383.
286. Fan P, Kyaw H, Su K, Zeng Z, Augustus M, Carter KC, and Li Y (1998) Cloning and characterization of a novel human chemokine receptor. Biochem Biophys Res Commun 243:264-268.
287. Fan X, Patera AC, Pong-Kennedy A, Deno G, Gonsiorek W, Manfra DJ, Vassileva G, Zeng M, Jackson C, and Sullivan L, et al. (2007) Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8. J Biol Chem 282: 11658-11666.
288. Farber JM (1990) A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines. Proc Natl Acad Sci USA 87:5238-5242.
289. Farzan M, Mirzabekov T, Kolchinsky P, Wyatt R, Cayabyab M, Gerard NP, Gerard C, Sodroski J, and Choe H (1999) Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 96:667-676.
290. Faure S, Meyer L, Costagliola D, Vaneensberghe C, Genin E, Autran B, Delfraissy JF, McDermott DH, Murphy PM, and Debré P, et al. (2000) Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science 287:2274-2277.
291. Feng LY, Ou ZL, Wu FY, Shen ZZ, and Shao ZM (2009) Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and pa- tient survival. Clin Cancer Res 15:2962-2970.
292. Feng Z, Dubyak GR, Lederman MM, and Weinberg A (2006) Cutting edge: human beta defensin 3-a novel antagonist of the HIV-1 coreceptor CXCR4. J Immunol 177:782-786. Ferenczi K, Fuhlbrigge RC, Pinkus J, Pinkus GS, and Kupper TS (2002) Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol 119:1405-1410.
293. Fife BT, Huffnagle GB, Kuziel WA, and Karpus WJ (2000) CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J Exp Med 192:899-905.
294. Fiorina P, Jurewicz M, Vergani A, Petrelli A, Carvello M, D'Addio F, Godwin JG, Law K, Wu E, and Tian Z, et al. (2011) Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via pro- grammed death ligand 1. J Immunol 186:121-131.
295. Fisette A, Munkonda MN, Oikonomopoulou K, Paglialunga S, Lambris JD, and Cianflone K (2013) C5L2 receptor disruption enhances the development of diet-induced insulin resistance in mice. Immunobiology 218:127-133.
296. Fitzsimons CP, Gompels UA, Verzijl D, Vischer HF, Mattick C, Leurs R, and Smit MJ (2006) Chemokine-directed trafficking of receptor stimulus to different g proteins: selective inducible and constitutive signaling by human herpesvirus 6-encoded chemokine receptor U51. Mol Pharmacol 69:888-898.
297. Floto RA, MacAry PA, Boname JM, Mien TS, Kampmann B, Hair JR, Huey OS, Houben EN, Pieters J, and Day C, et al. (2006) Dendritic cell stimulation by my- cobacterial Hsp70 is mediated through CCR5. Science 314:454-458.
298. Fong AM, Robinson LA, Steeber DA, Tedder TF, Yoshie O, Imai T, and Patel DD (1998) Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med 188:1413-1419.
299. Förster R, Davalos-Misslitz AC, and Rot A (2008) CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 8:362-371.
300. Förster R, Emrich T, Kremmer E, and Lipp M (1994) Expression of the G-protein- coupled receptor BLR1 defines mature, recirculating B cells and a subset of T- helper memory cells. Blood 84:830-840.
301. Förster R, Mattis AE, Kremmer E, Wolf E, Brem G, and Lipp M (1996) A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87:1037-1047.
302. Fox JM, Najarro P, Smith GL, Struyf S, Proost P, and Pease JE (2006) Structure/ function relationships of CCR8 agonists and antagonists. Amino-terminal exten- sion of CCL1 by a single amino acid generates a partial agonist. J Biol Chem 281: 36652-36661.
303. Fra AM, Locati M, Otero K, Sironi M, Signorelli P, Massardi ML, Gobbi M, Vecchi A, Sozzani S, and Mantovani A (2003) Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6. J Immunol 170:2279-2282.
304. Francis JN, Jacobson MR, Lloyd CM, Sabroe I, Durham SR, and Till SJ (2004) CXCR1+CD4+ T cells in human allergic disease. J Immunol 172:268-273.
305. Franciszkiewicz K, Le Floc'h A, Jalil A, Vigant F, Robert T, Vergnon I, Mackiewicz A, Benihoud K, Validire P, and Chouaib S, et al. (2009) Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention. Cancer Res 69:6249-6255.
306. Frauenschuh A, Power CA, Déruaz M, Ferreira BR, Silva JS, Teixeira MM, Dias JM, Martin T, Wells TN, and Proudfoot AE (2007) Molecular cloning and character- ization of a highly selective chemokine-binding protein from the tick Rhipicephalus sanguineus. J Biol Chem 282:27250-27258.
307. Fredriksson R, Lagerström MC, Lundin LG, and Schiöth HB (2003) The G-protein- coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63:1256-1272.
308. Freeman CM, Stolberg VR, Chiu BC, Lukacs NW, Kunkel SL, and Chensue SW (2006) CCR4 participation in Th type 1 (mycobacterial) and Th type 2 (schisto- somal) anamnestic pulmonary granulomatous responses. J Immunol 177: 4149-4158.
309. Frendéus B, Godaly G, Hang L, Karpman D, Lundstedt AC, and Svanborg C (2000) Interleukin 8 receptor deficiency confers susceptibility to acute experimental py- elonephritis and may have a human counterpart. J Exp Med 192:881-890.
310. Fridlender ZG and Albelda SM (2012) Tumor-associated neutrophils: friend or foe? Carcinogenesis 33:949-955.
311. Friedman RS, Jacobelli J, and Krummel MF (2006) Surface-bound chemokines cap- ture and prime T cells for synapse formation. Nat Immunol 7:1101-1108.
312. Frigerio S, Junt T, Lu B, Gerard C, Zumsteg U, Holländer GA, and Piali L (2002) Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med 8:1414-1420.
313. Fuhrmann M, Bittner T, Jung CK, Burgold S, Page RM, Mitteregger G, Haass C, LaFerla FM, Kretzschmar H, and Herms J (2010) Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease. Nat Neurosci 13: 411-413.
314. Fujisawa T, Fujisawa R, Kato Y, Nakayama T, Morita A, Katsumata H, Nishimori H, Iguchi K, Kamiya H, and Gray PW, et al. (2002) Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. J Allergy Clin Immunol 110: 139-146.
315. Fukuma N, Akimitsu N, Hamamoto H, Kusuhara H, Sugiyama Y, and Sekimizu K (2003) A role of the Duffy antigen for the maintenance of plasma chemokine con- centrations. Biochem Biophys Res Commun 303:137-139.
316. Fulkerson PC, Zimmermann N, Brandt EB, Muntel EE, Doepker MP, Kavanaugh JL, Mishra A, Witte DP, Zhang H, and Farber JM, et al. (2004) Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by IFN- gamma (Mig, CXCL9). Proc Natl Acad Sci USA 101:1987-1992.
317. Furuichi K, Gao JL, and Murphy PM (2006) Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemia-reperfusion injury. Am J Pathol 169: 372-387.
318. Gabrilovich DI and Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9:162-174.
319. Galasso JM, Harrison JK, and Silverstein FS (1998) Excitotoxic brain injury stim- ulates expression of the chemokine receptor CCR5 in neonatal rats. Am J Pathol 153:1631-1640.
320. Galkina E, Harry BL, Ludwig A, Liehn EA, Sanders JM, Bruce A, Weber C, and Ley K (2007) CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon- gamma production, and macrophage accumulation in the aortic wall. Circulation 116:1801-1811.
321. Galliera E, Jala VR, Trent JO, Bonecchi R, Signorelli P, Lefkowitz RJ, Mantovani A, Locati M, and Haribabu B (2004) b-Arrestin-dependent constitutive internalization of the human chemokine decoy receptor D6. J Biol Chem 279:25590-25597.
322. Galligan CL, Matsuyama W, Matsukawa A, Mizuta H, Hodge DR, Howard OM, and Yoshimura T (2004) Up-regulated expression and activation of the orphan chemokine receptor, CCRL2, in rheumatoid arthritis. Arthritis Rheum 50: 1806-1814.
323. Galvani AP and Slatkin M (2003) Evaluating plague and smallpox as historical se- lective pressures for the CCR5-Delta 32 HIV-resistance allele. Proc Natl Acad Sci USA 100:15276-15279.
324. Gangavarapu P, Rajagopalan L, Kolli D, Guerrero-Plata A, Garofalo RP, and Rajarathnam K (2012) The monomer-dimer equilibrium and glycosaminogly- can interactions of chemokine CXCL8 regulate tissue-specific neutrophil re- cruitment. J Leukoc Biol 91:259-265.
325. Gao H, Neff TA, Guo RF, Speyer CL, Sarma JV, Tomlins S, Man Y, Riedemann NC, Hoesel LM, and Younkin E, et al. (2005a) Evidence for a functional role of the second C5a receptor C5L2. FASEB J 19:1003-1005.
326. Gao JL and Murphy PM (1994) Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. J Biol Chem 269: 28539-28542.
327. Gao JQ, Sugita T, Kanagawa N, Iida K, Okada N, Mizuguchi H, Nakayama T, Hayakawa T, Yoshie O, and Tsutsumi Y, et al. (2005b) Anti-tumor responses in- duced by chemokine CCL19 transfected into an ovarian carcinoma model via fiber- mutant adenovirus vector. Biol Pharm Bull 28:1066-1070.
328. Gao Q, Zhao YJ, Wang XY, Qiu SJ, Shi YH, Sun J, Yi Y, Shi JY, Shi GM, and Ding ZB, et al. (2012) CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepato- cellular carcinoma. Cancer Res 72:3546-3556.
329. Garcia-Perez J, Rueda P, Alcami J, Rognan D, Arenzana-Seisdedos F, Lagane B, and Kellenberger E (2011) Allosteric model of maraviroc binding to CC chemokine receptor 5 (CCR5). J Biol Chem 286:33409-33421.
330. Garcia-Zepeda EA, Combadiere C, Rothenberg ME, Sarafi MN, Lavigne F, Hamid Q, Murphy PM, and Luster AD (1996) Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J Immunol 157:5613-5626.
331. Gardner L, Patterson AM, Ashton BA, Stone MA, and Middleton J (2004) The human Duffy antigen binds selected inflammatory but not homeostatic chemokines. Bio- chem Biophys Res Commun 321:306-312.
332. Gatto D, Wood K, and Brink R (2011) EBI2 operates independently of but in co- operation with CXCR5 and CCR7 to direct B cell migration and organization in follicles and the germinal center. J Immunol 187:4621-4628.
333. Gaudin F, Nasreddine S, Donnadieu AC, Emilie D, Combadière C, Prévot S, Machelon V, and Balabanian K (2011) Identification of the chemokine CX3CL1 as a new regulator of malignant cell proliferation in epithelial ovarian cancer. PLoS ONE 6:e21546.
334. Gauvreau GM, Boulet LP, Cockcroft DW, Baatjes A, Cote J, Deschesnes F, Davis B, Strinich T, Howie K, and Duong M, et al. (2008) Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses. Am J Respir Crit Care Med 177:952-958.
335. Geherin SA, Fintushel SR, Lee MH, Wilson RP, Patel RT, Alt C, Young AJ, Hay JB, and Debes GF (2012) The skin, a novel niche for recirculating B cells. J Immunol 188:6027-6035.
336. Geissmann F, Cameron TO, Sidobre S, Manlongat N, Kronenberg M, Briskin MJ, Dustin ML, and Littman DR (2005) Intravascular immune surveillance by CXCR6 + NKT cells patrolling liver sinusoids. PLoS Biol 3:e113.
337. Geissmann F, Jung S, and Littman DR (2003) Blood monocytes consist of two prin- cipal subsets with distinct migratory properties. Immunity 19:71-82.
338. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, and Ley K (2010) De- velopment of monocytes, macrophages, and dendritic cells. Science 327:656- 661.
339. Gerard NP, Lu B, Liu P, Craig S, Fujiwara Y, Okinaga S, and Gerard C (2005) An anti-inflammatory function for the complement anaphylatoxin C5a-binding pro- tein, C5L2. J Biol Chem 280:39677-39680.
340. Geras-Raaka E, Varma A, Clark-Lewis I, and Gershengorn MC (1998) Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF- 1alpha inhibit signaling by KSHV G protein-coupled receptor. Biochem Biophys Res Commun 253:725-727.
341. Gerlag DM, Hollis S, Layton M, Vencovský J, Szekanecz Z, Braddock M, and Tak PP; ESCAPE Study Group (2010) Preclinical and clinical investigation of a CCR5 an- tagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate. Arthritis Rheum 62:3154-3160.
342. Germanov E, Veinotte L, Cullen R, Chamberlain E, Butcher EC, and Johnston B (2008) Critical role for the chemokine receptor CXCR6 in homeostasis and acti- vation of CD1d-restricted NKT cells. J Immunol 181:81-91.
343. Gerrits H, van Ingen Schenau DS, Bakker NE, van Disseldorp AJ, Strik A, Hermens LS, Koenen TB, Krajnc-Franken MA, and Gossen JA (2008) Early postnatal lethality and cardiovascular defects in CXCR7-deficient mice. Gen- esis 46:235-245.
344. Gershengorn MC, Geras-Raaka E, Varma A, and Clark-Lewis I (1998) Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture. J Clin Invest 102:1469-1472.
345. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA Jr, Luster AD, Luscinskas FW, and Rosenzweig A (1999) MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398: 718-723.
346. Giagulli C, Magiera AK, Bugatti A, Caccuri F, Marsico S, Rusnati M, Vermi W, Fiorentini S, and Caruso A (2012) HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation. Blood 119:2274-2283.
347. Gilbert J, Lekstrom-Himes J, Donaldson D, Lee Y, Hu M, Xu J, Wyant T, and Davidson M; MLN1202 Study Group (2011) Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant pro- tein-1 promoter region. Am J Cardiol 107:906-911.
348. Ginestier C, Liu S, Diebel ME, Korkaya H, Luo M, Brown M, Wicinski J, Cabaud O, Charafe-Jauffret E, and Birnbaum D, et al. (2010) CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest 120:485-497.
349. Gladue RP, Cole SH, Roach ML, Tylaska LA, Nelson RT, Shepard RM, McNeish JD, Ogborne KT, and Neote KS (2006) The human specific CCR1 antagonist CP- 481,715 inhibits cell infiltration and inflammatory responses in human CCR1 transgenic mice. J Immunol 176:3141-3148.
350. Gladue RP, Tylaska LA, Brissette WH, Lira PD, Kath JC, Poss CS, Brown MF, Paradis TJ, Conklyn MJ, and Ogborne KT, et al. (2003) CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for in- flammatory diseases. J Biol Chem 278:40473-40480.
351. Glass WG, Lim JK, Cholera R, Pletnev AG, Gao JL, and Murphy PM (2005) Che- mokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med 202:1087-1098.
352. Glass WG, Liu MT, Kuziel WA, and Lane TE (2001) Reduced macrophage infiltration and demyelination in mice lacking the chemokine receptor CCR5 following in- fection with a neurotropic coronavirus. Virology 288:8-17.
353. Glass WG, McDermott DH, Lim JK, Lekhong S, Yu SF, Frank WA, Pape J, Cheshier RC, and Murphy PM (2006) CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med 203:35-40.
354. Glatzel A, Wesch D, Schiemann F, Brandt E, Janssen O, and Kabelitz D (2002) Patterns of chemokine receptor expression on peripheral blood gamma delta T lymphocytes: strong expression of CCR5 is a selective feature of V delta 2/V gamma 9 gamma delta T cells. J Immunol 168:4920-4929.
355. Godfrey DI, Kennedy J, Mombaerts P, Tonegawa S, and Zlotnik A (1994) Onset of TCR-beta gene rearrangement and role of TCR-beta expression during CD3-CD4- CD8-thymocyte differentiation. J Immunol 152:4783-4792.
356. Godfrey DI, Kennedy J, Suda T, and Zlotnik A (1993) A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J Immunol 150:4244-4252.
357. Godiska R, Chantry D, Raport CJ, Sozzani S, Allavena P, Leviten D, Mantovani A, and Gray PW (1997) Human macrophage-derived chemokine (MDC), a novel che- moattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J Exp Med 185:1595-1604.
358. Golding H, Aliberti J, King LR, Manischewitz J, Andersen J, Valenzuela J, Landau NR, and Sher A (2003) Inhibition of HIV-1 infection by a CCR5-binding cyclophilin from Toxoplasma gondii. Blood 102:3280-3286.
359. Gombert M, Dieu-Nosjean MC, Winterberg F, Bünemann E, Kubitza RC, Da Cunha L, Haahtela A, Lehtimäki S, Müller A, and Rieker J, et al. (2005) CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans- type dendritic cells to sites of atopic skin inflammation. J Immunol 174:5082- 5091.
360. Gompels UA, Nicholas J, Lawrence G, Jones M, Thomson BJ, Martin ME, Efstathiou S, Craxton M, and Macaulay HA (1995) The DNA sequence of human herpesvirus- 6: structure, coding content, and genome evolution. Virology 209:29-51.
361. Gong W, Howard OM, Turpin JA, Grimm MC, Ueda H, Gray PW, Raport CJ, Oppenheim JJ, and Wang JM (1998) Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication. J Biol Chem 273: 4289-4292.
362. Gong X, Gong W, Kuhns DB, Ben-Baruch A, Howard OM, and Wang JM (1997) Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors. J Biol Chem 272:11682-11685.
363. Gonzalo JA, Pan Y, Lloyd CM, Jia GQ, Yu G, Dussault B, Powers CA, Proudfoot AE, Coyle AJ, and Gearing D, et al. (1999) Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. J Immunol 163: 403-411.
364. Gonzalo JA, Qiu Y, Lora JM, Al-Garawi A, Villeval JL, Boyce JA, Martinez-A C, Marquez G, Goya I, and Hamid Q, et al. (2007) Coordinated involvement of mast cells and T cells in allergic mucosal inflammation: critical role of the CC chemokine ligand 1:CCR8 axis. J Immunol 179:1740-1750.
365. Gosling J, Dairaghi DJ, Wang Y, Hanley M, Talbot D, Miao Z, and Schall TJ (2000) Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK. J Immunol 164: 2851-2856.
366. Goulding C, McManus R, Murphy A, MacDonald G, Barrett S, Crowe J, Hegarty J, McKiernan S, and Kelleher D (2005) The CCR5-D32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source. Gut 54: 1157-1161. Gouwy M, Schiraldi M, Struyf S, Van Damme J, and Uguccioni M (2012) Possible mechanisms involved in chemokine synergy fine tuning the inflammatory re- sponse. Immunol Lett 145:10-14.
367. Goya I, Gutiérrez J, Varona R, Kremer L, Zaballos A, and Márquez G (1998) Iden- tification of CCR8 as the specific receptor for the human beta-chemokine I-309: cloning and molecular characterization of murine CCR8 as the receptor for TCA-3.
368. J Immunol 160:1975-1981.
369. Goya I, Villares R, Zaballos A, Gutiérrez J, Kremer L, Gonzalo JA, Varona R, Car- ramolino L, Serrano A, and Pallarés P, et al. (2003) Absence of CCR8 does not impair the response to ovalbumin-induced allergic airway disease. J Immunol 170: 2138-2146. Update on Chemokine Receptors Graham GJ (2009) D6 and the atypical chemokine receptor family: novel regulators of immune and inflammatory processes. Eur J Immunol 39:342-351.
370. Graham GJ, Locati M, Mantovani A, Rot A, and Thelen M (2012) The biochemistry and biology of the atypical chemokine receptors. Immunol Lett 145:30-38.
371. Granelli-Piperno A, Moser B, Pope M, Chen D, Wei Y, Isdell F, O'Doherty U, Paxton W, Koup R, and Mojsov S, et al. (1996) Efficient interaction of HIV-1 with puri- fied dendritic cells via multiple chemokine coreceptors. J Exp Med 184:2433- 2438.
372. Gravel S, Malouf C, Boulais PE, Berchiche YA, Oishi S, Fujii N, Leduc R, Sinnett D, and Heveker N (2010) The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains. J Biol Chem 285:37939-37943.
373. Gray EE, Suzuki K, and Cyster JG (2011) Cutting edge: Identification of a motile IL- 17-producing gammadelta T cell population in the dermis. J Immunol 186: 6091-6095.
374. Greaves DR, Wang W, Dairaghi DJ, Dieu MC, Saint-Vis B, Franz-Bacon K, Rossi D, Caux C, McClanahan T, and Gordon S, et al. (1997) CCR6, a CC chemokine re- ceptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med 186:837-844.
375. Greiff L, Ahlström-Emanuelsson C, Bahl A, Bengtsson T, Dahlström K, Erjefält J, Widegren H, and Andersson M (2010) Effects of a dual CCR3 and H1-antagonist on symptoms and eosinophilic inflammation in allergic rhinitis. Respir Res 11:17.
376. Groom JR and Luster AD (2011) CXCR3 ligands: redundant, collaborative and an- tagonistic functions. Immunol Cell Biol 89:207-215.
377. Groom JR, Richmond J, Murooka TT, Sorensen EW, Sung JH, Bankert K, von Andrian UH, Moon JJ, Mempel TR, and Luster AD (2012) CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell dif- ferentiation. Immunity 37:1091-1103.
378. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, and Rollins BJ (1998) Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2:275-281.
379. Gu L, Tseng S, Horner RM, Tam C, Loda M, and Rollins BJ (2000) Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404: 407-411.
380. Guan E, Wang J, and Norcross MA (2004) Amino-terminal processing of MIP-1beta/ CCL4 by CD26/dipeptidyl-peptidase IV. J Cell Biochem 92:53-64.
381. Guarda G, Hons M, Soriano SF, Huang AY, Polley R, Martín-Fontecha A, Stein JV, Germain RN, Lanzavecchia A, and Sallusto F (2007) L-selectin-negative CCR7- effector and memory CD8+ T cells enter reactive lymph nodes and kill dendritic cells. Nat Immunol 8:743-752.
382. Gulino AV, Moratto D, Sozzani S, Cavadini P, Otero K, Tassone L, Imberti L, Pir- ovano S, Notarangelo LD, and Soresina R, et al. (2004) Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myeloka- thexis (WHIM) syndrome. Blood 104:444-452.
383. Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, and Williams LT (1998) A B- cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391:799-803.
384. Guo HG, Sadowska M, Reid W, Tschachler E, Hayward G, and Reitz M (2003) Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse. J Virol 77:2631-2639.
385. Gupta SK, Lysko PG, Pillarisetti K, Ohlstein E, and Stadel JM (1998) Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J Biol Chem 273:4282-4287.
386. Gutwein P, Schramme A, Sinke N, Abdel-Bakky MS, Voss B, Obermüller N, Doberstein K, Koziolek M, Fritzsche F, and Johannsen M, et al. (2009) Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients. Eur J Cancer 45:478-489.
387. Ha HK, Lee W, Park HJ, Lee SD, Lee JZ, and Chung MK (2011) Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer. Mol Med Rep 4: 419-424.
388. Hachet-Haas M, Balabanian K, Rohmer F, Pons F, Franchet C, Lecat S, Chow KY, Dagher R, Gizzi P, and Didier B, et al. (2008) Small neutralizing molecules to inhibit actions of the chemokine CXCL12. J Biol Chem 283:23189-23199.
389. Hajnická V, Kocáková P, Sláviková M, Slovák M, Gasperík J, Fuchsberger N, and Nuttall PA (2001) Anti-interleukin-8 activity of tick salivary gland extracts. Parasite Immunol 23:483-489.
390. Hancock WW, Gao W, Csizmadia V, Faia KL, Shemmeri N, and Luster AD (2001) Donor-derived IP-10 initiates development of acute allograft rejection. J Exp Med 193:975-980.
391. Handel TM, Johnson Z, Crown SE, Lau EK, and Proudfoot AE (2005) Regulation of protein function by glycosaminoglycans-as exemplified by chemokines. Annu Rev Biochem 74:385-410.
392. Hanefeld M, Schell E, Gouni-Berthold I, Melichar M, Vesela I, Sullivan T, Miao S, Johnson D, Jaen J, and Bekker P, et al. (2011) Oral chemokine receptor 2 antag- onist CCX140-B shows safety and efficacy in type 2 diabetes mellitus. Diabetes 60: A310.
393. Hannedouche S, Zhang J, Yi T, Shen W, Nguyen D, Pereira JP, Guerini D, Baum- garten BU, Roggo S, and Wen B, et al. (2011) Oxysterols direct immune cell mi- gration via EBI2. Nature 475:524-527.
394. Hansell CAH, Schiering C, Kinstrie R, Ford L, Bordon Y, McInnes IB, Goodyear CS, and Nibbs RJB (2011) Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice. Blood 117:5413-5424.
395. Hapfelmeier S, Müller AJ, Stecher B, Kaiser P, Barthel M, Endt K, Eberhard M, Robbiani R, Jacobi CA, and Heikenwalder M, et al. (2008) Microbe sampling by mucosal dendritic cells is a discrete, MyD88-independent step in DeltainvG S. Typhimurium colitis. J Exp Med 205:437-450.
396. Haque NS, Fallon JT, Pan JJ, Taubman MB, and Harpel PC (2004) Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion. Blood 103:1296-1304.
397. Haque NS, Fallon JT, Taubman MB, and Harpel PC (2001) The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium. Blood 97:39-45.
398. Haque NS, Zhang X, French DL, Li J, Poon M, Fallon JT, Gabel BR, Taubman MB, Koschinsky M, and Harpel PC (2000) CC chemokine I-309 is the principal mono- cyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells. Circulation 102:786-792.
399. Harcourt J, Alvarez R, Jones LP, Henderson C, Anderson LJ, and Tripp RA (2006) Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses. J Immunol 176:1600-1608.
400. Haringman JJ, Gerlag DM, Smeets TJ, Baeten D, van den Bosch F, Bresnihan B, Breedveld FC, Dinant HJ, Legay F, and Gram H, et al. (2006) A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) mono- clonal antibody in patients with rheumatoid arthritis. Arthritis Rheum 54: 2387-2392.
401. Harris TH, Banigan EJ, Christian DA, Konradt C, Tait Wojno ED, Norose K, Wilson EH, John B, Weninger W, and Luster AD, et al. (2012) Generalized Lévy walks and the role of chemokines in migration of effector CD8+ T cells. Nature 486: 545-548.
402. Harrison JK, Barber CM, and Lynch KR (1994) cDNA cloning of a G-protein-coupled receptor expressed in rat spinal cord and brain related to chemokine receptors. Neurosci Lett 169:85-89.
403. Hartl D, Griese M, Nicolai T, Zissel G, Prell C, Konstantopoulos N, Gruber R, Reinhardt D, Schendel DJ, and Krauss-Etschmann S (2005) Pulmonary chemo- kines and their receptors differentiate children with asthma and chronic cough. J Allergy Clin Immunol 115:728-736.
404. Hartmann TN, Leick M, Ewers S, Diefenbacher A, Schraufstatter I, Honczarenko M, and Burger M (2008) Human B cells express the orphan chemokine receptor CRAM-A/B in a maturation-stage-dependent and CCL5-modulated manner. Im- munology 125:252-262.
405. Haskell CA, Hancock WW, Salant DJ, Gao W, Csizmadia V, Peters W, Faia K, Fituri O, Rottman JB, and Charo IF (2001) Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection. J Clin Invest 108:679-688.
406. Haskell CA, Horuk R, Liang M, Rosser M, Dunning L, Islam I, Kremer L, Gutiérrez J, Marquez G, and Martinez-A C, et al. (2006) Identification and characterization of a potent, selective nonpeptide agonist of the CC chemokine receptor CCR8. Mol Pharmacol 69:309-316.
407. Hatabu T, Kawazu S, Aikawa M, and Kano S (2003) Binding of Plasmodium falci- parum-infected erythrocytes to the membrane-bound form of Fractalkine/CX3CL1. Proc Natl Acad Sci USA 100:15942-15946.
408. He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, Busciglio J, Yang X, Hof- mann W, and Newman W, et al. (1997) CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385:645-649.
409. Hedrick JA, Saylor V, Figueroa D, Mizoue L, Xu Y, Menon S, Abrams J, Handel T, and Zlotnik A (1997) Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo. J Immunol 158:1533-1540.
410. Hedrick MN, Lonsdorf AS, Shirakawa AK, Richard Lee CC, Liao F, Singh SP, Zhang HH, Grinberg A, Love PE, and Hwang ST, et al. (2009) CCR6 is required for IL-23- induced psoriasis-like inflammation in mice. J Clin Invest 119:2317-2329.
411. Heiman AS, Abonyo BO, Darling-Reed SF, and Alexander MS (2005) Cytokine- stimulated human lung alveolar epithelial cells release eotaxin-2 (CCL24) and eotaxin-3 (CCL26). J Interferon Cytokine Res 25:82-91.
412. Heinemann A, Hartnell A, Stubbs VE, Murakami K, Soler D, LaRosa G, Askenase PW, Williams TJ, and Sabroe I (2000) Basophil responses to chemokines are reg- ulated by both sequential and cooperative receptor signaling. J Immunol 165: 7224-7233.
413. Heinzel K, Benz C, and Bleul CC (2007) A silent chemokine receptor regulates steady-state leukocyte homing in vivo. Proc Natl Acad Sci USA 104:8421-8426.
414. Hellier S, Frodsham AJ, Hennig BJ, Klenerman P, Knapp S, Ramaley P, Satsangi J, Wright M, Zhang L, and Thomas HC, et al. (2003) Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection. Hepatology 38:1468-1476.
415. Hernandez PA, Gorlin RJ, Lukens JN, Taniuchi S, Bohinjec J, Francois F, Klotman ME, and Diaz GA (2003) Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 34:70-74.
416. Heveker N, Tissot M, Thuret A, Schneider-Mergener J, Alizon M, Roch M, and Marullo S (2001) Pharmacological properties of peptides derived from stromal cell-derived factor 1: study on human polymorphonuclear cells. Mol Pharmacol 59:1418-1425.
417. Heydtmann M, Lalor PF, Eksteen JA, Hübscher SG, Briskin M, and Adams DH (2005) CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver- infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver. J Immunol 174:1055-1062.
418. Hickey MJ, Held KS, Baum E, Gao JL, Murphy PM, and Lane TE (2007) CCR1 deficiency increases susceptibility to fatal coronavirus infection of the central nervous system. Viral Immunol 20:599-608.
419. Hieshima K, Imai T, Baba M, Shoudai K, Ishizuka K, Nakagawa T, Tsuruta J, Takeya M, Sakaki Y, and Takatsuki K, et al. (1997) A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. J Immunol 159: 1140-1149.
420. Hikono H, Kohlmeier JE, Takamura S, Wittmer ST, Roberts AD, and Woodland DL (2007) Activation phenotype, rather than central-or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells. J Exp Med 204:1625-1636.
421. Hirahara K, Liu L, Clark RA, Yamanaka K, Fuhlbrigge RC, and Kupper TS (2006) The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors. J Immunol 177:4488-4494.
422. Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N, Yama- guchi T, Nomura T, Ito H, and Nakamura T, et al. (2007) Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid ar- thritis and its animal model. J Exp Med 204:2803-2812.
423. Hojo S, Koizumi K, Tsuneyama K, Arita Y, Cui Z, Shinohara K, Minami T, Hashi- moto I, Nakayama T, and Sakurai H, et al. (2007) High-level expression of che- mokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer. Cancer Res 67:4725-4731.
424. Holmes FE, Arnott N, Vanderplank P, Kerr NC, Longbrake EE, Popovich PG, Imai T, Combadière C, Murphy PM, and Wynick D (2008) Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviour. J Neurochem 106: 640-649.
425. Holmes WE, Lee J, Kuang WJ, Rice GC, and Wood WI (1991) Structure and func- tional expression of a human interleukin-8 receptor. Science 253:1278-1280.
426. Holst PJ, Rosenkilde MM, Manfra D, Chen SC, Wiekowski MT, Holst B, Cifire F, Lipp M, Schwartz TW, and Lira SA (2001) Tumorigenesis induced by the HHV8- encoded chemokine receptor requires ligand modulation of high constitutive ac- tivity. J Clin Invest 108:1789-1796.
427. Holz O, Khalilieh S, Ludwig-Sengpiel A, Watz H, Stryszak P, Soni P, Tsai M, Sadeh J, and Magnussen H (2010) SCH527123, a novel CXCR2 antagonist, inhibits ozone- induced neutrophilia in healthy subjects. Eur Respir J 35:564-570.
428. Homey B (2005) Chemokines and inflammatory skin diseases. Adv Dermatol 21: 251-277.
429. Homey B, Steinhoff M, Ruzicka T, and Leung DY (2006) Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 118:178-189.
430. Homey B, Wang W, Soto H, Buchanan ME, Wiesenborn A, Catron D, Müller A, McClanahan TK, Dieu-Nosjean MC, and Orozco R, et al. (2000) Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol 164:3465- 3470.
431. Horikawa T, Nakayama T, Hikita I, Yamada H, Fujisawa R, Bito T, Harada S, Fukunaga A, Chantry D, and Gray PW, et al. (2002) IFN-gamma-inducible ex- pression of thymus and activation-regulated chemokine/CCL17 and macrophage- derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis. Int Immunol 14:767-773.
432. Horton LW, Yu Y, Zaja-Milatovic S, Strieter RM, and Richmond A (2007) Opposing roles of murine Duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth. Cancer Res 67:9791-9799.
433. Horuk R (2001) Chemokine receptors. Cytokine Growth Factor Rev 12:313-335.
434. Horuk R (2009) Chemokine receptor antagonists: overcoming developmental hurdles. Nat Rev Drug Discov 8:23-33.
435. Horuk R, Chitnis CE, Darbonne WC, Colby TJ, Rybicki A, Hadley TJ, and Miller LH (1993a) A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 261:1182-1184.
436. Horuk R, Colby TJ, Darbonne WC, Schall TJ, and Neote K (1993b) The human erythrocyte inflammatory peptide (chemokine) receptor. Biochemical character- ization, solubilization, and development of a binding assay for the soluble receptor. Biochemistry 32:5733-5738.
437. Horuk R, Hesselgesser J, Zhou Y, Faulds D, Halks-Miller M, Harvey S, Taub D, Samson M, Parmentier M, and Rucker J, et al. (1998) The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains. J Biol Chem 273: 386-391.
438. Horuk R, Martin AW, Wang Z, Schweitzer L, Gerassimides A, Guo H, Lu Z, Hes- selgesser J, Perez HD, and Kim J, et al. (1997) Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol 158:2882-2890.
439. Horuk R, Wang ZX, Peiper SC, and Hesselgesser J (1994) Identification and char- acterization of a promiscuous chemokine-binding protein in a human eryth- roleukemic cell line. J Biol Chem 269:17730-17733.
440. Hoshino A, Kawamura YI, Yasuhara M, Toyama-Sorimachi N, Yamamoto K, Mat- sukawa A, Lira SA, and Dohi T (2007) Inhibition of CCL1-CCR8 interaction pre- vents aggregation of macrophages and development of peritoneal adhesions. J Immunol 178:5296-5304.
441. Hou C, Singer M, and Matheis M (2008) JNJ-17166864, a selective CCR2 antagonist with potential therapeutic implications for inflammatory diseases, in 104th In- ternational Conference American Thoracic Society; 16-21 May 2008; Toronto, ON, Canada. Howard OM, Dong HF, Shirakawa AK, and Oppenheim JJ (2000) LEC induces chemotaxis and adhesion by interacting with CCR1 and CCR8. Blood 96:840-845.
442. Hu JK, Kagari T, Clingan JM, and Matloubian M (2011) Expression of chemokine receptor CXCR3 on T cells affects the balance between effector and memory CD8 T- cell generation. Proc Natl Acad Sci USA 108:E118-E127.
443. Huang H, Li F, Cairns CM, Gordon JR, and Xiang J (2001) Neutrophils and B cells express XCR1 receptor and chemotactically respond to lymphotactin. Biochem Biophys Res Commun 281:378-382.
444. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, Kang S, Ceradini D, Jin Z, and Yazdanbakhsh K, et al. (1996) The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. see comments Nat Med 2:1240-1243.
445. Hub E and Rot A (1998) Binding of RANTES, MCP-1, MCP-3, and MIP-1alpha to cells in human skin. Am J Pathol 152:749-757.
446. Huber-Lang M, Sarma JV, Rittirsch D, Schreiber H, Weiss M, Flierl M, Younkin E, Schneider M, Suger-Wiedeck H, and Gebhard F, et al. (2005) Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans. J Immunol 174:1104-1110.
447. Huber AR, Kunkel SL, Todd RF 3rd, and Weiss SJ (1991) Regulation of trans- endothelial neutrophil migration by endogenous interleukin-8. Science 254:99-102.
448. Hudak S, Hagen M, Liu Y, Catron D, Oldham E, McEvoy LM, and Bowman EP (2002) Immune surveillance and effector functions of CCR10(+) skin homing T cells. J Immunol 169:1189-1196.
449. Hughes PM, Allegrini PR, Rudin M, Perry VH, Mir AK, and Wiessner C (2002) Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J Cereb Blood Flow Metab 22:308-317.
450. Hughes RO, Rogier DJ, Devraj R, Zheng C, Cao G, Feng H, Xia M, Anand R, Xing L, and Glenn J, et al. (2011) Discovery of ((1S,3R)-1-isopropyl-3-((3S,4S)-3-methoxy- tetrahydro-2H-pyran-4-ylamino)cyclopentyl)(4-(5-(trifluoromethyl)pyridazin-3-yl) piperazin-1-yl)methanone, PF-4254196, a CCR2 antagonist with an improved cardiovascular profile. Bioorg Med Chem Lett 21:2626-2630.
451. Hugues S, Scholer A, Boissonnas A, Nussbaum A, Combadière C, Amigorena S, and Fetler L (2007) Dynamic imaging of chemokine-dependent CD8+ T cell help for CD8+ T cell responses. Nat Immunol 8:921-930.
452. Huising MO, Stet RJ, Kruiswijk CP, Savelkoul HF, and Lidy Verburg-van Kemenade BM (2003) Molecular evolution of CXC chemokines: extant CXC chemokines originate from the CNS. Trends Immunol 24:307-313.
453. Hulshof JW, Casarosa P, Menge WM, Kuusisto LM, van der Goot H, Smit MJ, de Esch IJ, and Leurs R (2005) Synthesis and structure-activity relationship of the first nonpeptidergic inverse agonists for the human cytomegalovirus encoded chemokine receptor US28. J Med Chem 48:6461-6471.
454. Hulshof JW, Vischer HF, Verheij MH, Fratantoni SA, Smit MJ, de Esch IJ, and Leurs R (2006) Synthesis and pharmacological characterization of novel inverse agonists acting on the viral-encoded chemokine receptor US28. Bioorg Med Chem 14:7213-7230.
455. Hulshof S, van Haastert ES, Kuipers HF, van den Elsen PJ, De Groot CJ, van der Valk P, Ravid R, and Biber K (2003) CX3CL1 and CX3CR1 expression in human brain tissue: noninflammatory control versus multiple sclerosis. J Neuropathol Exp Neurol 62:899-907.
456. Humpert ML, Tzouros M, Thelen S, Bignon A, Levoye A, Arenzana-Seisdedos F, Balabanian K, Bachelerie F, Langen H, and Thelen M (2012) Complementary methods provide evidence for the expression of CXCR7 on human B cells. Proteo- mics 12:1938-1948.
457. Hütter G, Nowak D, Mossner M, Ganepola S, Müssig A, Allers K, Schneider T, Hofmann J, Kücherer C, and Blau O, et al. (2009) Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 360:692-698.
458. Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, and D'Ambrosio D (2001) Unique chemotactic response profile and specific ex- pression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 194:847-853.
459. Ikin EW, Mourant AE, Pettenkofer HJ, and Blumenthal G (1951) Discovery of the expected haemagglutinin, anti-Fyb. Nature 168:1077-1078.
460. Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, and Yoshie O (1997a) The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 272:15036-15042.
461. Imai T, Chantry D, Raport CJ, Wood CL, Nishimura M, Godiska R, Yoshie O, and Gray PW (1998) Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J Biol Chem 273:1764-1768.
462. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, Kakizaki M, Takagi S, Nomiyama H, and Schall TJ, et al. (1997b) Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91:521-530.
463. Imai T, Nagira M, Takagi S, Kakizaki M, Nishimura M, Wang J, Gray PW, Matsushima K, and Yoshie O (1999) Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activa- tion-regulated chemokine and macrophage-derived chemokine. Int Immunol 11: 81-88.
464. Imai T, Yoshida T, Baba M, Nishimura M, Kakizaki M, and Yoshie O (1996) Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem 271:21514-21521.
465. Imaoka H, Campbell H, Babirad I, Watson RM, Mistry M, Sehmi R, and Gauvreau GM (2011) TPI ASM8 reduces eosinophil progenitors in sputum after allergen challenge. Clin Exp Allergy 41:1740-1746.
466. Inoue A, Hasegawa H, Kohno M, Ito MR, Terada M, Imai T, Yoshie O, Nose M, and Fujita S (2005) Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice. Arthritis Rheum 52:1522-1533.
467. Isaacman-Beck J, Hermann EA, Yi Y, Ratcliffe SJ, Mulenga J, Allen S, Hunter E, Derdeyn CA, and Collman RG (2009) Heterosexual transmission of human im- munodeficiency virus type 1 subtype C: Macrophage tropism, alternative cor- eceptor use, and the molecular anatomy of CCR5 utilization. J Virol 83:8208-8220.
468. Isegawa Y, Ping Z, Nakano K, Sugimoto N, and Yamanishi K (1998) Human her- pesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor. J Virol 72:6104-6112.
469. Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, Yoshida S, Saburi Y, Miya- moto T, Takemoto S, and Suzushima H, et al. (2012a) Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol 30:837-842.
470. Ishida T, Utsunomiya A, Iida S, Inagaki H, Takatsuka Y, Kusumoto S, Takeuchi G, Shimizu S, Ito M, and Komatsu H, et al. (2003) Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin in- volvement and unfavorable outcome. Clin Cancer Res 9:3625-3634.
471. Ishida Y, Gao JL, and Murphy PM (2008) Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J Immunol 180:569-579.
472. Ishida Y, Kimura A, Kuninaka Y, Inui M, Matsushima K, Mukaida N, and Kondo T (2012b) Pivotal role of the CCL5/CCR5 interaction for recruitment of endothelial progenitor cells in mouse wound healing. J Clin Invest 122:711-721.
473. Islam SA, Chang DS, Colvin RA, Byrne MH, McCully ML, Moser B, Lira SA, Charo IF, and Luster AD (2011) Mouse CCL8, a CCR8 agonist, promotes atopic derma- titis by recruiting IL-5+ T(H)2 cells. Nat Immunol 12:167-177.
474. Islam SA, Ling MF, Leung J, and Luster AD (2013) Identification of human CCR8 as a CCL18 receptor. J Exp Med 210:1889-1898.
475. Iwamoto S, Omi T, Kajii E, and Ikemoto S (1995) Genomic organization of the gly- coprotein D gene: Duffy blood group Fya/Fyb alloantigen system is associated with a polymorphism at the 44-amino acid residue. Blood 85:622-626.
476. Izikson L, Klein RS, Charo IF, Weiner HL, and Luster AD (2000) Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med 192:1075-1080.
477. Jacobson J, Thompson M, and Fischl M (2009) Phase 2a study of PRO 140 in HIV- infected adults, in 49th Interscience Conference on Antimicrobial Agents and Update on Chemokine Receptors Chemotherapy (ICAAC 2009), Abstract H-1229; 12-15 September 2009; San Francisco, CA Jähnichen S, Blanchetot C, Maussang D, Gonzalez-Pajuelo M, Chow KY, Bosch L, De Vrieze S, Serruys B, Ulrichts H, and Vandevelde W, et al. (2010) CXCR4 nano- bodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells. Proc Natl Acad Sci USA 107:20565-20570.
478. Jakubzick C, Tacke F, Llodra J, van Rooijen N, and Randolph GJ (2006) Modulation of dendritic cell trafficking to and from the airways. J Immunol 176:3578-3584.
479. Jamieson T, Cook DN, Nibbs RJ, Rot A, Nixon C, McLean P, Alcami A, Lira SA, Wiekowski M, and Graham GJ (2005) The chemokine receptor D6 limits the in- flammatory response in vivo. Nat Immunol 6:403-411.
480. Jenh CH, Cox MA, Cui L, Reich EP, Sullivan L, Chen SC, Kinsley D, Qian S, Kim SH, and Rosenblum S, et al. (2012) A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft re- jection. BMC Immunol 13:2.
481. Jensen AS, Sparre-Ulrich AH, Davis-Poynter N, and Rosenkilde MM (2012) Struc- tural diversity in conserved regions like the DRY-motif among viral 7TM receptors -a consequence of evolutionary pressure? Adv Virol 2012:231813.
482. Jenkins TJ, Guan B, Dai M, Li G, Lightburn TE, Huang S, Freeze BS, Burdi DF, Jacutin-Porte S, and Bennett R, et al. (2007) Design, synthesis, and evaluation of naphthalene-sulfonamide antagonists of human CCR8. J Med Chem 50:566-584.
483. Jensen KK, Manfra DJ, Grisotto MG, Martin AP, Vassileva G, Kelley K, Schwartz TW, and Lira SA (2005) The human herpes virus 8-encoded chemokine receptor is required for angioproliferation in a murine model of Kaposi's sarcoma. J Immunol 174:3686-3694.
484. Jensen PC, Nygaard R, Thiele S, Elder A, Zhu G, Kolbeck R, Ghosh S, Schwartz TW, and Rosenkilde MM (2007) Molecular interaction of a potent nonpeptide agonist with the chemokine receptor CCR8. Mol Pharmacol 72:327-340.
485. Jensen PC and Rosenkilde MM (2009) Chapter 8. Activation mechanisms of che- mokine receptors. Methods Enzymol 461:171-190.
486. Jia T, Serbina NV, Brandl K, Zhong MX, Leiner IM, Charo IF, and Pamer EG (2008) Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of in- flammatory monocytes during Listeria monocytogenes infection. J Immunol 180: 6846-6853.
487. Jiang D, Liang J, Campanella GS, Guo R, Yu S, Xie T, Liu N, Jung Y, Homer R, and Meltzer EB, et al. (2010) Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4. J Clin Invest 120:2049-2057.
488. Jilma-Stohlawetz P, Homoncik M, Drucker C, Marsik C, Rot A, Mayr WR, Seibold B, and Jilma B (2001) Fy phenotype and gender determine plasma levels of monocyte chemotactic protein. Transfusion 41:378-381.
489. Johnson CH, Miao C, Blanchard EG, Caidi H, Radu GU, Harcourt JL, and Haynes LM (2012) Effect of chemokine receptor CX3CR1 deficiency in a murine model of respiratory syncytial virus infection. Comp Med 62:14-20.
490. Johnson M, Li AR, Liu J, Fu Z, Zhu L, Miao S, Wang X, Xu Q, Huang A, and Marcus A, et al. (2007) Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3. Bioorg Med Chem Lett 17:3339-3343.
491. Johnson Z, Kosco-Vilbois MH, Herren S, Cirillo R, Muzio V, Zaratin P, Carbonatto M, Mack M, Smailbegovic A, and Rose M, et al. (2004) Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. J Immunol 173:5776-5785.
492. Johnston B, Kim CH, Soler D, Emoto M, and Butcher EC (2003) Differential che- mokine responses and homing patterns of murine TCR alpha beta NKT cell sub- sets. J Immunol 171:2960-2969.
493. Johswich K, Martin M, Thalmann J, Rheinheimer C, Monk PN, and Klos A (2006) Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on mye- loid and epithelial cell lines. J Biol Chem 281:39088-39095.
494. Jones CP, Pitchford SC, Lloyd CM, and Rankin SM (2009) CXCR2 mediates the recruitment of endothelial progenitor cells during allergic airways remodeling. Stem Cells 27:3074-3081.
495. Jones SA, Wolf M, Qin S, Mackay CR, and Baggiolini M (1996) Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxi- dase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc Natl Acad Sci USA 93:6682-6686.
496. Joseph PR, Sarmiento JM, Mishra AK, Das ST, Garofalo RP, Navarro J, and Rajarathnam K (2010) Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors. J Biol Chem 285:29262-29269.
497. Joubert P, Lajoie-Kadoch S, Labonté I, Gounni AS, Maghni K, Wellemans V, Chakir J, Laviolette M, Hamid Q, and Lamkhioued B (2005) CCR3 expression and function in asthmatic airway smooth muscle cells. J Immunol 175:2702-2708.
498. Ju DW, Tao Q, Cheng DS, Zhang W, Zhang M, Hamada H, and Cao X (2000) Ade- novirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cy- tosine deaminase suicide gene therapy in established murine colon carcinoma. Gene Ther 7:329-338.
499. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, and Littman DR (2000) Analysis of fractalkine receptor CX(3)CR1 function by targeted de- letion and green fluorescent protein reporter gene insertion. Mol Cell Biol 20: 4106-4114.
500. Kaiser E, Förster R, Wolf I, Ebensperger C, Kuehl WM, and Lipp M (1993) The G protein-coupled receptor BLR1 is involved in murine B cell differentiation and is also expressed in neuronal tissues. Eur J Immunol 23:2532-2539.
501. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Asahina A, Onai N, and Matsushima K, et al. (2001) Thymus and activation- regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 107:535-541.
502. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Komine M, Asahina A, and Tamaki K (2002) Serum macrophage-derived chemo- kine (MDC) levels are closely related with the disease activity of atopic dermatitis. Clin Exp Immunol 127:270-273.
503. Kalant D, Cain SA, Maslowska M, Sniderman AD, Cianflone K, and Monk PN (2003) The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acyla- tion-stimulating protein. J Biol Chem 278:11123-11129.
504. Kanagawa N, Niwa M, Hatanaka Y, Tani Y, Nakagawa S, Fujita T, Yamamoto A, and Okada N (2007) CC-chemokine ligand 17 gene therapy induces tumor re- gression through augmentation of tumor-infiltrating immune cells in a murine model of preexisting CT26 colon carcinoma. Int J Cancer 121:2013-2022.
505. Kang YS, Cha JJ, Hyun YY, and Cha DR (2011) Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments. Expert Opin Investig Drugs 20:745-756.
506. Karim S, Singh P, and Ribeiro JM (2011) A deep insight into the sialotranscriptome of the gulf coast tick, Amblyomma maculatum. PLoS ONE 6:e28525.
507. Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, and Miller SD (1995) An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental auto- immune encephalomyelitis. J Immunol 155:5003-5010.
508. Kastenmüller W, Brandes M, Wang Z, Herz J, Egen JG, and Germain RN (2013) Peripheral prepositioning and local CXCL9 chemokine-mediated guidance or- chestrate rapid memory CD8+ T cell responses in the lymph node. Immunity 38: 502-513.
509. Kawai T, Choi U, Cardwell L, DeRavin SS, Naumann N, Whiting-Theobald NL, Linton GF, Moon J, Murphy PM, and Malech HL (2007) WHIM syndrome myelo- kathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4. Blood 109:78-84.
510. Kawasaki S, Takizawa H, Yoneyama H, Nakayama T, Fujisawa R, Izumizaki M, Imai T, Yoshie O, Homma I, and Yamamoto K, et al. (2001) Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. J Immunol 166:2055-2062.
511. Kayama H, Ueda Y, Sawa Y, Jeon SG, Ma JS, Okumura R, Kubo A, Ishii M, Okazaki T, and Murakami M, et al. (2012) Intestinal CX3C chemokine receptor 1(high) (CX3CR1(high)) myeloid cells prevent T-cell-dependent colitis. Proc Natl Acad Sci USA 109:5010-5015.
512. Keeley EC, Mehrad B, and Strieter RM (2010) CXC chemokines in cancer angio- genesis and metastases. Adv Cancer Res 106:91-111.
513. Kehrl JH (2006) Chemoattractant receptor signaling and the control of lymphocyte migration. Immunol Res 34:211-227.
514. Kellermann SA, Hudak S, Oldham ER, Liu YJ, and McEvoy LM (1999) The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro-and in vivo-derived dendritic cells. J Immunol 162:3859-3864.
515. Kelner GS, Kennedy J, Bacon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, Copeland NG, Bazan JF, Moore KW, and Schall TJ, et al. (1994) Lymphotactin: a cytokine that represents a new class of chemokine. Science 266:1395-1399.
516. Kennedy J, Kelner GS, Kleyensteuber S, Schall TJ, Weiss MC, Yssel H, Schneider PV, Cocks BG, Bacon KB, and Zlotnik A (1995) Molecular cloning and functional characterization of human lymphotactin. J Immunol 155:203-209.
517. Kerstjens HA, Bjermer L, Eriksson L, Dahlström K, and Vestbo J (2010) Tolerability and efficacy of inhaled AZD4818, a CCR1 antagonist, in moderate to severe COPD patients. Respir Med 104:1297-1303.
518. Keshav S (2006) CCX282-B, an orally active inhibitor of chemokine receptor CCR9, in a randomized, double-blind, placebo-controlled phase 2 study in moderate to severe Crohn's disease, in 14th United European Gastroenterology Week (UEGW 2006);
519. Khan IA, MacLean JA, Lee FS, Casciotti L, DeHaan E, Schwartzman JD, and Luster AD (2000) IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 12:483-494.
520. Khandaker MH, Mitchell G, Xu L, Andrews JD, Singh R, Leung H, Madrenas J, Ferguson SS, Feldman RD, and Kelvin DJ (1999) Metalloproteinases are involved in lipopolysaccharide-and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression. Blood 93:2173-2185.
521. Kim BS, Uhm TG, Lee SK, Lee SH, Kang JH, Park CS, and Chung IY (2010) The crucial role of GATA-1 in CCR3 gene transcription: modulated balance by multiple GATA elements in the CCR3 regulatory region. J Immunol 185:6866-6875.
522. Kim CH, Johnston B, and Butcher EC (2002) Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity. Blood 100: 11-16.
523. Kim CH, Kunkel EJ, Boisvert J, Johnston B, Campbell JJ, Genovese MC, Greenberg HB, and Butcher EC (2001a) Bonzo/CXCR6 expression defines type 1-polarized T- cell subsets with extralymphoid tissue homing potential. J Clin Invest 107: 595-601.
524. Kim CH, Nagata K, and Butcher EC (2003) Dendritic cells support sequential reprogramming of chemoattractant receptor profiles during naive to effector T cell differentiation. J Immunol 171:152-158.
525. Kim CH, Rott L, Kunkel EJ, Genovese MC, Andrew DP, Wu L, and Butcher EC (2001b) Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest 108:1331-1339.
526. Kim IS, Jang SW, Sung HJ, Lee JS, and Ko J (2005) Differential CCR1-mediated chemotaxis signaling induced by human CC chemokine HCC-4/CCL16 in HOS cells. FEBS Lett 579:6044-6048.
527. Kim KW, Vallon-Eberhard A, Zigmond E, Farache J, Shezen E, Shakhar G, Ludwig A, Lira SA, and Jung S (2011) In vivo structure/function and expression analysis of the CX3C chemokine fractalkine. Blood 118:e156-e167.
528. Kim Y, Sung Ss, Kuziel WA, Feldman S, Fu SM, and Rose CE Jr (2001c) Enhanced airway Th2 response after allergen challenge in mice deficient in CC chemokine receptor-2 (CCR2). J Immunol 166:5183-5192.
529. Kitade H, Sawamoto K, Nagashimada M, Inoue H, Yamamoto Y, Sai Y, Takamura T, Yamamoto H, Miyamoto KI, and Ginsberg HN, et al. (2012) CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status. Diabetes 61: 1680-1690.
530. Kitamura K, Farber JM, and Kelsall BL (2010) CCR6 marks regulatory T cells as a colon-tropic, IL-10-producing phenotype. J Immunol 185:3295-3304.
531. Kitaura M, Nakajima T, Imai T, Harada S, Combadiere C, Tiffany HL, Murphy PM, and Yoshie O (1996) Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J Biol Chem 271:7725-7730.
532. Kledal TN, Rosenkilde MM, Coulin F, Simmons G, Johnsen AH, Alouani S, Power CA, Lüttichau HR, Gerstoft J, and Clapham PR, et al. (1997) A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Sci- ence 277: 1656-1659.
533. Kledal TN, Rosenkilde MM, and Schwartz TW (1998) Selective recognition of the membrane-bound CX3C chemokine, fractalkine, by the human cytomegalovirus- encoded broad-spectrum receptor US28. FEBS Lett 441:209-214.
534. Kleinewietfeld M, Puentes F, Borsellino G, Battistini L, Rötzschke O, and Falk K (2005) CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset. Blood 105:2877-2886.
535. Knight JC, Novembre FJ, Brown DR, Goldsmith CS, and Esposito JJ (1989) Studies on Tanapox virus. Virology 172:116-124.
536. Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, and Campbell DJ (2009) The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 10:595-602.
537. Kochi Y, Okada Y, Suzuki A, Ikari K, Terao C, Takahashi A, Yamazaki K, Hosono N, Myouzen K, and Tsunoda T, et al. (2010) A regulatory variant in CCR6 is associ- ated with rheumatoid arthritis susceptibility. Nat Genet 42:515-519.
538. Koelink PJ, Overbeek SA, Braber S, de Kruijf P, Folkerts G, Smit MJ, and Kraneveld AD (2012) Targeting chemokine receptors in chronic inflammatory diseases: an extensive review. Pharmacol Ther 133:1-18.
539. Koenecke C and Förster R (2009) CCR9 and inflammatory bowel disease. Expert Opin Ther Targets 13:297-306.
540. Köhler A, De Filippo K, Hasenberg M, van den Brandt C, Nye E, Hosking MP, Lane TE, Männ L, Ransohoff RM, and Hauser AE, et al. (2011) G-CSF-mediated thrombopoietin release triggers neutrophil motility and mobilization from bone marrow via induction of Cxcr2 ligands. Blood 117:4349-4357.
541. Kohlmeier JE, Miller SC, Smith J, Lu B, Gerard C, Cookenham T, Roberts AD, and Woodland DL (2008) The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. Immunity 29: 101-113.
542. Kondo K, Kondo T, Okuno T, Takahashi M, and Yamanishi K (1991) Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol 72: 1401-1408.
543. Korniejewska A, McKnight AJ, Johnson Z, Watson ML, and Ward SG (2011) Ex- pression and agonist responsiveness of CXCR3 variants in human T lymphocytes. Immunology 132:503-515.
544. Kowalska MA, Ratajczak MZ, Majka M, Jin J, Kunapuli S, Brass L, and Poncz M (2000) Stromal cell-derived factor-1 and macrophage-derived chemokine: 2 che- mokines that activate platelets. Blood 96:50-57.
545. Kralj A, Wetzel A, Mahmoudian S, Stamminger T, Tschammer N, and Heinrich MR (2011) Identification of novel allosteric modulators for the G-protein coupled US28 receptor of human cytomegalovirus. Bioorg Med Chem Lett 21:5446-5450.
546. Krasinski A, Punna S, Ungashe S, Wang Q, and Zeng Y (2011), inventors; Chemo- centryx, assignee. Fused heteroaryl pyridyl and phenyl benzenesulfonamides as CCR2 modulators for the treatment of inflammation. US patent 7,884,110. 2008 Jul 11.
547. Kremer L, Carramolino L, Goya I, Zaballos A, Gutiérrez J, Moreno-Ortiz M del C, Martínez-A C, and Márquez G (2001) The transient expression of C-C chemokine receptor 8 in thymus identifies a thymocyte subset committed to become CD4+ single-positive T cells. J Immunol 166:218-225.
548. Kriegova E, Tsyrulnyk A, Arakelyan A, Mrazek F, Ordeltova M, Petzmann S, Zat- loukal J, Kolek V, du Bois RM, and Popper H, et al. (2006) Expression of CCX CKR in pulmonary sarcoidosis. Inflamm Res 55:441-445.
549. Kristensen NN, Gad M, Thomsen AR, Lu B, Gerard C, and Claesson MH (2006) CXC chemokine receptor 3 expression increases the disease-inducing potential of CD4+ CD25-T cells in adoptive transfer colitis. Inflamm Bowel Dis 12:374-381.
550. Kroczek RA and Henn V (2012) The role of XCR1 and its ligand XCL1 in antigen cross-presentation by murine and human dendritic cells. Front Immunol 3:14.
551. Krueger A, Willenzon S, Lyszkiewicz M, Kremmer E, and Förster R (2010) CC che- mokine receptor 7 and 9 double-deficient hematopoietic progenitors are severely impaired in seeding the adult thymus. Blood 115:1906-1912.
552. Kucharzik T, Hudson JT 3rd, Waikel RL, Martin WD, and Williams IR (2002) CCR6 expression distinguishes mouse myeloid and lymphoid dendritic cell subsets: demonstration using a CCR6 EGFP knock-in mouse. Eur J Immunol 32:104- 112.
553. Kuhn DE, Beall CJ, and Kolattukudy PE (1995) The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity. Biochem Biophys Res Commun 211:325-330.
554. Kuhne MR, Mulvey T, Belanger B, Chen S, Pan C, Chong C, Cao F, Niekro W, Kempe T, and Henning KA, et al. (2013) BMS-936564/MDX-1338: a fully human anti- CXCR4 antibody induces apoptosis in vitro and shows antitumor activity in vivo in hematologic malignancies. Clin Cancer Res 19:357-366.
555. Kunkel EJ, Boisvert J, Murphy K, Vierra MA, Genovese MC, Wardlaw AJ, Greenberg HB, Hodge MR, Wu L, and Butcher EC, et al. (2002) Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am J Pathol 160:347-355.
556. Kunkel EJ, Campbell DJ, and Butcher EC (2003) Chemokines in lymphocyte traf- ficking and intestinal immunity. Microcirculation 10:313-323.
557. Kurachi M, Kurachi J, Suenaga F, Tsukui T, Abe J, Ueha S, Tomura M, Sugihara K, Takamura S, and Kakimi K, et al. (2011) Chemokine receptor CXCR3 facilitates CD8(+) T cell differentiation into short-lived effector cells leading to memory de- generation. J Exp Med 208:1605-1620.
558. Kurihara T and Bravo R (1996) Cloning and functional expression of mCCR2, a murine receptor for the C-C chemokines JE and FIC. J Biol Chem 271: 11603-11607.
559. Kurobe H, Liu C, Ueno T, Saito F, Ohigashi I, Seach N, Arakaki R, Hayashi Y, Kitagawa T, and Lipp M, et al. (2006) CCR7-dependent cortex-to-medulla migra- tion of positively selected thymocytes is essential for establishing central tolerance. Immunity 24:165-177.
560. Kurts C, Robinson BW, and Knolle PA (2010) Cross-priming in health and disease. Nat Rev Immunol 10:403-414.
561. Kuschert GS, Hoogewerf AJ, Proudfoot AE, Chung CW, Cooke RM, Hubbard RE, Wells TN, and Sanderson PN (1998) Identification of a glycosaminoglycan binding surface on human interleukin-8. Biochemistry 37:11193-11201.
562. Lagane B, Chow KY, Balabanian K, Levoye A, Harriague J, Planchenault T, Baleux F, Gunera-Saad N, Arenzana-Seisdedos F, and Bachelerie F (2008) CXCR4 di- merization and beta-arrestin-mediated signaling account for the enhanced che- motaxis to CXCL12 in WHIM syndrome. Blood 112:34-44.
563. Lagu B, Gerchak C, Pan M, Hou C, Singer M, Malaviya R, Matheis M, Olini G, Cavender D, and Wachter M (2007) Potent and selective CC-chemokine receptor-2 (CCR2) antagonists as a potential treatment for asthma. Bioorg Med Chem Lett 17: 4382-4386.
564. Lalani AS, Masters J, Zeng W, Barrett J, Pannu R, Everett H, Arendt CW, and McFadden G (1999) Use of chemokine receptors by poxviruses. Science 286: 1968-1971.
565. Lalani AS and McFadden G (1997) Secreted poxvirus chemokine binding proteins. J Leukoc Biol 62:570-576.
566. Lalezari J, Gathe J, Brinson C, Thompson M, Cohen C, Dejesus E, Galindez J, Ernst JA, Martin DE, and Palleja SM (2011) Safety, efficacy, and pharmaco- kinetics of TBR-652, a CCR5/CCR2 antagonist, in HIV-1-infected, treatment- experienced, CCR5 antagonist-naive subjects. J Acquir Immune Defic Syndr 57: 118-125.
567. Lalezari J, Yadavalli GK, Para M, Richmond G, Dejesus E, Brown SJ, Cai W, Chen C, Zhong J, and Novello LA, et al. (2008) Safety, pharmacokinetics, and antiviral activity of HGS004, a novel fully human IgG4 monoclonal antibody against CCR5, in HIV-1-infected patients. J Infect Dis 197:721-727.
568. Lamkhioued B, Abdelilah SG, Hamid Q, Mansour N, Delespesse G, and Renzi PM (2003) The CCR3 receptor is involved in eosinophil differentiation and is up- regulated by Th2 cytokines in CD34+ progenitor cells. J Immunol 170:537- 547.
569. Landsman L, Bar-On L, Zernecke A, Kim KW, Krauthgamer R, Shagdarsuren E, Lira SA, Weissman IL, Weber C, and Jung S (2009) CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 113: 963-972.
570. Laprise C, Sladek R, Ponton A, Bernier MC, Hudson TJ, and Laviolette M (2004) Functional classes of bronchial mucosa genes that are differentially expressed in asthma. BMC Genomics 5:21.
571. Lasagni L, Francalanci M, Annunziato F, Lazzeri E, Giannini S, Cosmi L, Sagrinati C, Mazzinghi B, Orlando C, and Maggi E, et al. (2003) An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP- 10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J Exp Med 197:1537-1549.
572. Latchney LR, Fallon MA, Culp DJ, Gelbard HA, and Dewhurst S (2004) Immuno- histochemical assessment of fractalkine, inflammatory cells, and human herpes- virus 7 in human salivary glands. J Histochem Cytochem 52:671-681.
573. Lazaar AL, Sweeney LE, MacDonald AJ, Alexis NE, Chen C, and Tal-Singer R (2011) SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil acti- vation and ozone-induced airway inflammation in humans. Br J Clin Pharmacol 72:282-293.
574. Lazennec G and Richmond A (2010) Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 16:133-144.
575. Le Borgne M, Etchart N, Goubier A, Lira SA, Sirard JC, van Rooijen N, Caux C, Aït- Yahia S, Vicari A, and Kaiserlian D, et al. (2006) Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell cross- priming in vivo. Immunity 24:191-201.
576. Lebre MC, Vergunst CE, Choi IY, Aarrass S, Oliveira AS, Wyant T, Horuk R, Reedquist KA, and Tak PP (2011) Why CCR2 and CCR5 blockade failed and why CCR1 blockade might still be effective in the treatment of rheumatoid arthritis. PLoS ONE 6:e21772.
577. Lee BJ, Koszinowski UH, Sarawar SR, and Adler H (2003) A gammaherpesvirus G protein-coupled receptor homologue is required for increased viral replication in response to chemokines and efficient reactivation from latency. J Immunol 170: 243-251.
578. Lee I, Wang L, Wells AD, Dorf ME, Ozkaynak E, and Hancock WW (2005) Re- cruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med 201:1037-1044.
579. Lee JS, Wurfel MM, Matute-Bello G, Frevert CW, Rosengart MR, Ranganathan M, Wong VW, Holden T, Sutlief S, and Richmond A, et al. (2006) The Duffy antigen modifies systemic and local tissue chemokine responses following lipopolysaccha- ride stimulation. J Immunol 177:8086-8094.
580. Lee KM, McKimmie CS, Gilchrist DS, Pallas KJ, Nibbs RJ, Garside P, McDonald V, Jenkins C, Ransohoff R, and Liu L, et al. (2011) D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion. Blood 118: 6220-6229.
581. Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, and Moser B (1998) B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tis- sues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med 187: 655-660.
582. Lei Y, Ripen AM, Ishimaru N, Ohigashi I, Nagasawa T, Jeker LT, Bösl MR, Hol- länder GA, Hayashi Y, and Malefyt RdeW, et al. (2011) Aire-dependent production of XCL1 mediates medullary accumulation of thymic dendritic cells and contrib- utes to regulatory T cell development. J Exp Med 208:383-394.
583. Update on Chemokine Receptors Leick M, Catusse J, Follo M, Nibbs RJ, Hartmann TN, Veelken H, and Burger M (2010) CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B. Immunology 129:536-546.
584. Lesnik P, Haskell CA, and Charo IF (2003) Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J Clin Invest 111:333-340.
585. Letsch A, Keilholz U, Schadendorf D, Assfalg G, Asemissen AM, Thiel E, and Scheibenbogen C (2004) Functional CCR9 expression is associated with small intestinal metastasis. J Invest Dermatol 122:685-690.
586. Levoye A, Balabanian K, Baleux F, Bachelerie F, and Lagane B (2009) CXCR7 het- erodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 113:6085-6093.
587. L'Heureux GP, Bourgoin S, Jean N, McColl SR, and Naccache PH (1995) Diverging signal transduction pathways activated by interleukin-8 and related chemokines in human neutrophils: interleukin-8, but not NAP-2 or GRO alpha, stimulates phospholipase D activity. Blood 85:522-531.
588. Li A, Varney ML, Valasek J, Godfrey M, Dave BJ, and Singh RK (2005) Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migra- tion and MMP-2 production and angiogenesis. Angiogenesis 8:63-71.
589. Li F and Gordon JR (2001) Il-8((3-73))K11R is a high affinity agonist of the neutrophil CXCR1 and CXCR2. Biochem Biophys Res Commun 286:595-600.
590. Li H and d'Anjou M (2009) Pharmacological significance of glycosylation in thera- peutic proteins. Curr Opin Biotechnol 20:678-684.
591. Li Y, Huang D, Xia X, Wang Z, Luo L, and Wen R (2011) CCR3 and choroidal neovascularization. PLoS ONE 6:e17106.
592. Liang M, Mallari C, Rosser M, Ng HP, May K, Monahan S, Bauman JG, Islam I, Ghannam A, and Buckman B, et al. (2000) Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1. J Biol Chem 275:19000-19008.
593. Liang X (2008) CXCR4, inhibitors and mechanisms of action. Chem Biol Drug Des 72: 97-110.
594. Liao F, Alderson R, Su J, Ullrich SJ, Kreider BL, and Farber JM (1997a) STRL22 is a receptor for the CC chemokine MIP-3alpha. Biochem Biophys Res Commun 236: 212-217.
595. Liao F, Alkhatib G, Peden KW, Sharma G, Berger EA, and Farber JM (1997b) STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J Exp Med 185:2015-2023.
596. Liao F, Lee HH, and Farber JM (1997c) Cloning of STRL22, a new human gene encoding a G-protein-coupled receptor related to chemokine receptors and located on chromosome 6q27. Genomics 40:175-180.
597. Liao F, Rabin RL, Smith CS, Sharma G, Nutman TB, and Farber JM (1999) CC- chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J Immunol 162:186-194.
598. Liao F, Shirakawa AK, Foley JF, Rabin RL, and Farber JM (2002) Human B cells become highly responsive to macrophage-inflammatory protein-3 alpha/CC che- mokine ligand-20 after cellular activation without changes in CCR6 expression or ligand binding. J Immunol 168:4871-4880.
599. Libert F, Parmentier M, Lefort A, Dumont JE, and Vassart G (1990) Complete nucleotide sequence of a putative G protein coupled receptor: RDC1. Nucleic Acids Res 18:1917.
600. Liehn EA, Merx MW, Postea O, Becher S, Djalali-Talab Y, Shagdarsuren E, Kelm M, Zernecke A, and Weber C (2008) Ccr1 deficiency reduces inflammatory remodelling and preserves left ventricular function after myocardial infarction. J Cell Mol Med 12:496-506.
601. Lim JK, Louie CY, Glaser C, Jean C, Johnson B, Johnson H, McDermott DH, and Murphy PM (2008) Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic. J Infect Dis 197:262-265.
602. Limou S, Coulonges C, Herbeck JT, van Manen D, An P, Le Clerc S, Delaneau O, Diop G, Taing L, and Montes M, et al. (2010) Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term non- progression to AIDS. J Infect Dis 202:908-915.
603. Liò P and Vannucci M (2003) Investigating the evolution and structure of chemokine receptors. Gene 317:29-37.
604. Liu C, Yang XV, Wu J, Kuei C, Mani NS, Zhang L, Yu J, Sutton SW, Qin N, and Banie H, et al. (2011) Oxysterols direct B-cell migration through EBI2. Nature 475:519-523.
605. Liu J, Fu Z, Li AR, Johnson M, Zhu L, Marcus A, Danao J, Sullivan T, Tonn G, and Collins T, et al. (2009) Optimization of a series of quinazolinone-derived antagonists of CXCR3. Bioorg Med Chem Lett 19:5114-5118.
606. Liu L, Darnall L, Hu T, Choi K, Lane TE, and Ransohoff RM (2010) Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells. J Neurosci 30: 9074-9083.
607. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, and Landau NR (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-377.
608. Lloyd CM, Delaney T, Nguyen T, Tian J, Martinez-A C, Coyle AJ, and Gutierrez- Ramos JC (2000) CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/ monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J Exp Med 191:265-274.
609. Loetscher M, Amara A, Oberlin E, Brass N, Legler D, Loetscher P, D'Apuzzo M, Meese E, Rousset D, and Virelizier JL, et al. (1997) TYMSTR, a putative chemo- kine receptor selectively expressed in activated T cells, exhibits HIV-1 coreceptor function. Curr Biol 7:652-660.
610. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, and Moser B (1996a) Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 184:963-969.
611. Loetscher M, Loetscher P, Brass N, Meese E, and Moser B (1998a) Lymphocyte- specific chemokine receptor CXCR3: regulation, chemokine binding and gene lo- calization. Eur J Immunol 28:3696-3705.
612. Loetscher P, Gong JH, Dewald B, Baggiolini M, and Clark-Lewis I (1998b) N-ter- minal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities. J Biol Chem 273:22279-22283.
613. Loetscher P, Seitz M, Baggiolini M, and Moser B (1996b) Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J Exp Med 184:569-577.
614. Lord GM, Rao RM, Choe H, Sullivan BM, Lichtman AH, Luscinskas FW, and Glimcher LH (2005) T-bet is required for optimal proinflammatory CD4+ T-cell trafficking. Blood 106:3432-3439.
615. Louahed J, Struyf S, Demoulin JB, Parmentier M, Van Snick J, Van Damme J, and Renauld JC (2003) CCR8-dependent activation of the RAS/MAPK pathway mediates anti-apoptotic activity of I-309/ CCL1 and vMIP-I. Eur J Immunol 33: 494-501.
616. Lu B, Humbles A, Bota D, Gerard C, Moser B, Soler D, Luster AD, and Gerard NP (1999) Structure and function of the murine chemokine receptor CXCR3. Eur J Immunol 29:3804-3812.
617. Lu P, Li L, Liu G, van Rooijen N, Mukaida N, and Zhang X (2009) Opposite roles of CCR2 and CX3CR1 macrophages in alkali-induced corneal neovascularization. Cornea 28:562-569.
618. Lu Y, Wang J, Xu Y, Koch AE, Cai Z, Chen X, Galson DL, Taichman RS, and Zhang J (2008) CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro. Mol Cancer Res 6:546-554.
619. Lucendo AJ, De Rezende L, Comas C, Caballero T, and Bellón T (2008) Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis. Am J Gastroenterol 103:2184-2193.
620. Lucotte G and Mercier G (1998) Distribution of the CCR5 gene 32-bp deletion in Europe. J Acquir Immune Defic Syndr Hum Retrovirol 19:174-177.
621. Lukacs NW, Prosser DM, Wiekowski M, Lira SA, and Cook DN (2001) Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation. J Exp Med 194:551-555.
622. Luker KE, Gupta M, and Luker GD (2009) Imaging chemokine receptor dimerization with firefly luciferase complementation. FASEB J 23:823-834.
623. Luker KE, Lewin SA, Mihalko LA, Schmidt BT, Winkler JS, Coggins NL, Thomas DG, and Luker GD (2012) Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells. Oncogene 31:4750-4758.
624. Luker KE, Steele JM, Mihalko LA, Ray P, and Luker GD (2010) Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands. Oncogene 29:4599-4610.
625. Lundy SK, Lira SA, Smit JJ, Cook DN, Berlin AA, and Lukacs NW (2005) Attenu- ation of allergen-induced responses in CCR6-/-mice is dependent upon altered pulmonary T lymphocyte activation. J Immunol 174:2054-2060.
626. Luster AD, Cardiff RD, MacLean JA, Crowe K, and Granstein RD (1998) Delayed wound healing and disorganized neovascularization in transgenic mice expressing the IP-10 chemokine. Proc Assoc Am Physicians 110:183-196.
627. Luster AD, Greenberg SM, and Leder P (1995) The IP-10 chemokine binds to a spe- cific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 182:219-231.
628. Luster AD, Unkeless JC, and Ravetch JV (1985) Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315:672-676.
629. Luther SA, Tang HL, Hyman PL, Farr AG, and Cyster JG (2000) Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc Natl Acad Sci USA 97:12694-12699.
630. Lüttichau HR (2010) The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist. J Biol Chem 285:9137-9146.
631. Lüttichau HR, Clark-Lewis I, Jensen PO, Moser C, Gerstoft J, and Schwartz TW (2003) A highly selective CCR2 chemokine agonist encoded by human herpesvirus
632. J Biol Chem 278:10928-10933.
633. Lüttichau HR, Gerstoft J, and Schwartz TW (2001) MC148 encoded by human mol- luscum contagiosum poxvirus is an antagonist for human but not murine CCR8. J Leukoc Biol 70:277-282.
634. Lüttichau HR, Johnsen AH, Jurlander J, Rosenkilde MM, and Schwartz TW (2007) Kaposi sarcoma-associated herpes virus targets the lymphotactin receptor with both a broad spectrum antagonist vCCL2 and a highly selective and potent agonist vCCL3. J Biol Chem 282:17794-17805.
635. Lüttichau HR, Stine J, Boesen TP, Johnsen AH, Chantry D, Gerstoft J, and Schwartz TW (2000) A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus molluscum contagiosum. J Exp Med 191:171-180.
636. Luzina IG, Papadimitriou JC, Anderson R, Pochetuhen K, and Atamas SP (2006) Induction of prolonged infiltration of T lymphocytes and transient T lymphocyte- dependent collagen deposition in mouse lungs following adenoviral gene transfer of CCL18. Arthritis Rheum 54:2643-2655.
637. Madigan J, Freeman DJ, Menzies F, Forrow S, Nelson SM, Young A, Sharkey A, Moffett A, Graham GJ, and Greer IA, et al. (2010) Chemokine scavenger D6 is expressed by trophoblasts and aids the survival of mouse embryos transferred into allogeneic recipients. J Immunol 184:3202-3212.
638. Maeda K, Nakata H, Koh Y, Miyakawa T, Ogata H, Takaoka Y, Shibayama S, Sagawa K, Fukushima D, and Moravek J, et al. (2004) Spirodiketopiperazine- based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro. J Virol 78:8654-8662.
639. Maghazachi AA, Skalhegg BS, Rolstad B, and Al-Aoukaty A (1997) Interferon-in- ducible protein-10 and lymphotactin induce the chemotaxis and mobilization of intracellular calcium in natural killer cells through pertussis toxin-sensitive and -insensitive heterotrimeric G-proteins. FASEB J 11:765-774.
640. Mantovani A, Bonecchi R, and Locati M (2006) Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol 6:907-918.
641. Mariani M, Lang R, Binda E, Panina-Bordignon P, and D'Ambrosio D (2004) Domi- nance of CCL22 over CCL17 in induction of chemokine receptor CCR4 de- sensitization and internalization on human Th2 cells. Eur J Immunol 34:231-240.
642. Martin MP, Dean M, Smith MW, Winkler C, Gerrard B, Michael NL, Lee B, Doms RW, Margolick J, and Buchbinder S, et al. (1998) Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 282:1907-1911.
643. Martinez CO, McHale MJ, Wells JT, Ochoa O, Michalek JE, McManus LM, and Shireman PK (2010) Regulation of skeletal muscle regeneration by CCR2- activating chemokines is directly related to macrophage recruitment. Am J Physiol Regul Integr Comp Physiol 299:R832-R842.
644. Martinez FO, Sica A, Mantovani A, and Locati M (2008) Macrophage activation and polarization. Front Biosci 13:453-461.
645. Martínez MA, Gutiérrez A, Armand-Ugón M, Blanco J, Parera M, Gómez J, Clotet B, and Esté JA (2002) Suppression of chemokine receptor expression by RNA in- terference allows for inhibition of HIV-1 replication. AIDS 16:2385-2390.
646. Martinez de la Torre Y, Buracchi C, Borroni EM, Dupor J, Bonecchi R, Nebuloni M, Pasqualini F, Doni A, Lauri E, and Agostinis C, et al. (2007) Protection against inflammation-and autoantibody-caused fetal loss by the chemokine decoy receptor D6. Proc Natl Acad Sci USA 104:2319-2324.
647. Martinez de la Torre Y, Locati M, Buracchi C, Dupor J, Cook DN, Bonecchi R, Nebuloni M, Rukavina D, Vago L, and Vecchi A, et al. (2005) Increased in- flammation in mice deficient for the chemokine decoy receptor D6. Eur J Immunol 35:1342-1346.
648. Martínez Muñoz L, Lucas P, Navarro G, Checa AI, Franco R, Martínez-A C, Rodrí- guez-Frade JM, and Mellado M (2009) Dynamic regulation of CXCR1 and CXCR2 homo-and heterodimers. J Immunol 183:7337-7346.
649. Matejuk A, Adlard K, Zamora A, Silverman M, Vandenbark AA, and Offner H (2001) 17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental auto- immune encephalomyelitis. J Neurosci Res 65:529-542.
650. Matloubian M, David A, Engel S, Ryan JE, and Cyster JG (2000) A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 1:298-304.
651. Matsumura S, Wang B, Kawashima N, Braunstein S, Badura M, Cameron TO, Babb JS, Schneider RJ, Formenti SC, and Dustin ML, et al. (2008) Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. J Immunol 181: 3099-3107.
652. Maussang D, Langemeijer E, Fitzsimons CP, Stigter-van Walsum M, Dijkman R, Borg MK, Slinger E, Schreiber A, Michel D, and Tensen CP, et al. (2009) The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2. Cancer Res 69:2861-2869.
653. Maussang D, Verzijl D, van Walsum M, Leurs R, Holl J, Pleskoff O, Michel D, van Dongen GA, and Smit MJ (2006) Human cytomegalovirus-encoded chemokine re- ceptor US28 promotes tumorigenesis. Proc Natl Acad Sci USA 103:13068-13073.
654. Mayr FB, Spiel AO, Leitner JM, Firbas C, Kliegel T, Jilma-Stohlawetz P, Derendorf H, and Jilma B (2008) Duffy antigen modifies the chemokine response in human endotoxemia. Crit Care Med 36:159-165.
655. McCulloch CV, Morrow V, Milasta S, Comerford I, Milligan G, Graham GJ, Isaacs NW, and Nibbs RJ (2008) Multiple roles for the C-terminal tail of the chemokine scavenger D6. J Biol Chem 283:7972-7982.
656. McDermott DH, Fong AM, Yang Q, Sechler JM, Cupples LA, Merrell MN, Wilson PW, D'Agostino RB, O'Donnell CJ, and Patel DD, et al. (2003) Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with pro- tection from cardiovascular disease in humans. J Clin Invest 111:1241-1250.
657. McDermott DH, Halcox JP, Schenke WH, Waclawiw MA, Merrell MN, Epstein N, Quyyumi AA, and Murphy PM (2001) Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ Res 89:401-407.
658. McDermott DH, Liu Q, Ulrick J, Kwatemaa N, Anaya-O'Brien S, Penzak SR, Filho JO, Priel DA, Kelly C, and Garofalo M, et al. (2011) The CXCR4 antagonist pler- ixafor corrects panleukopenia in patients with WHIM syndrome. Blood 118: 4957-4962.
659. McDermott DH, Yang Q, Kathiresan S, Cupples LA, Massaro JM, Keaney JF Jr, Larson MG, Vasan RS, Hirschhorn JN, and O'Donnell CJ, et al. (2005) CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study. Circulation 112: 1113-1120.
660. McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, Waterhouse CC, Beck PL, Muruve DA, and Kubes P (2010) Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330:362-366.
661. McDonald KG, McDonough JS, Wang C, Kucharzik T, Williams IR, and Newberry RD (2007) CC chemokine receptor 6 expression by B lympho- cytes is essential for the development of isolated lymphoid follicles. Am J Pathol 170:1229-1240.
662. McKimmie CS, Fraser AR, Hansell C, Gutiérrez L, Philipsen S, Connell L, Rot A, Kurowska-Stolarska M, Carreno P, and Pruenster M, et al. (2008) Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J Immunol 181:3353-3363.
663. McLean KA, Holst PJ, Martini L, Schwartz TW, and Rosenkilde MM (2004) Similar activation of signal transduction pathways by the herpesvirus-encoded chemokine receptors US28 and ORF74. Virology 325:241-251.
664. McMorran BJ, Wieczorski L, Drysdale KE, Chan JA, Huang HM, Smith C, Mitiku C, Beeson JG, Burgio G, and Foote SJ (2012) Platelet factor 4 and Duffy antigen required for platelet killing of Plasmodium falciparum. Science 338:1348-1351.
665. Medina-Contreras O, Geem D, Laur O, Williams IR, Lira SA, Nusrat A, Parkos CA, and Denning TL (2011) CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice. J Clin Invest 121: 4787-4795.
666. Medoff BD, Wain JC, Seung E, Jackobek R, Means TK, Ginns LC, Farber JM, and Luster AD (2006) CXCR3 and its ligands in a murine model of obliterative bronchiolitis: regulation and function. J Immunol 176:7087-7095.
667. Mei J, Liu Y, Dai N, Favara M, Greene T, Jeyaseelan S, Poncz M, Lee JS, and Worthen GS (2010) CXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infection. Immunity 33:106-117.
668. Melar M, Ott DE, and Hope TJ (2007) Physiological levels of virion-associated human immunodeficiency virus type 1 envelope induce coreceptor-dependent calcium flux. J Virol 81:1773-1785.
669. Mellado M, Martín de Ana A, Gómez L, Martínez C, and Rodríguez-Frade JM (2008) Chemokine receptor 2 blockade prevents asthma in a cynomolgus monkey model. J Pharmacol Exp Ther 324:769-775.
670. Mellado M, Rodríguez-Frade JM, Vila-Coro AJ, de Ana AM, and Martínez-A C (1999) Chemokine control of HIV-1 infection. Nature 400:723-724.
671. Mellado M, Rodríguez-Frade JM, Vila-Coro AJ, Fernández S, Martín de Ana A, Jones DR, Torán JL, and Martínez-A C (2001) Chemokine receptor homo-or hetero- dimerization activates distinct signaling pathways. EMBO J 20:2497-2507.
672. Melnychuk RM, Streblow DN, Smith PP, Hirsch AJ, Pancheva D, and Nelson JA (2004) Human cytomegalovirus-encoded G protein-coupled receptor US28 mediates smooth muscle cell migration through Galpha12. J Virol 78:8382-8391.
673. Ménard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, Ratsimbasoa A, Thonier V, Carod JF, Domarle O, and Colin Y, et al. (2010) Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci USA 107:5967-5971.
674. Menke J, Zeller GC, Kikawada E, Means TK, Huang XR, Lan HY, Lu B, Farber J, Luster AD, and Kelley VR (2008) CXCL9, but not CXCL10, promotes CXCR3- dependent immune-mediated kidney disease. J Am Soc Nephrol 19:1177-1189.
675. Menten P, Struyf S, Schutyser E, Wuyts A, De Clercq E, Schols D, Proost P, and Van Damme J (1999) The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine. J Clin Invest 104:R1-R5.
676. Meucci O, Fatatis A, Simen AA, and Miller RJ (2000) Expression of CX3CR1 che- mokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci USA 97:8075-8080.
677. Meyer A, Coyle AJ, Proudfoot AE, Wells TN, and Power CA (1996) Cloning and characterization of a novel murine macrophage inflammatory protein-1 alpha re- ceptor. J Biol Chem 271:14445-14451.
678. Meyer M, Hensbergen PJ, van der Raaij-Helmer EM, Brandacher G, Margreiter R, Heufler C, Koch F, Narumi S, Werner ER, and Colvin R, et al. (2001) Cross- reactivity of three T cell attracting murine chemokines stimulating the CXC che- mokine receptor CXCR3 and their induction in cultured cells and during allograft rejection. Eur J Immunol 31:2521-2527.
679. Middleton J, Neil S, Wintle J, Clark-Lewis I, Moore H, Lam C, Auer M, Hub E, and Rot A (1997) Transcytosis and surface presentation of IL-8 by venular endo- thelial cells. Cell 91:385-395.
680. Migeotte I, Franssen JD, Goriely S, Willems F, and Parmentier M (2002) Distribution and regulation of expression of the putative human chemokine receptor HCR in leukocyte populations. Eur J Immunol 32:494-501.
681. Mikhak Z, Fukui M, Farsidjani A, Medoff BD, Tager AM, and Luster AD (2009) Contribution of CCR4 and CCR8 to antigen-specific T(H)2 cell trafficking in al- lergic pulmonary inflammation. J Allergy Clin Immunol 123:67-73, e3.
682. Miller LH, Mason SJ, Clyde DF, and McGinniss MH (1976) The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 295:302-304.
683. Miller LH, Mason SJ, Dvorak JA, McGinniss MH, and Rothman IK (1975) Eryth- rocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determi- nants. Science 189:561-563.
684. Miller MD, Hata S, De Waal Malefyt R, and Krangel MS (1989) A novel polypeptide secreted by activated human T lymphocytes. J Immunol 143:2907-2916.
685. Miller MD, Wilson SD, Dorf ME, Seuanez HN, O'Brien SJ, and Krangel MS (1990) Sequence and chromosomal location of the I-309 gene. Relationship to genes encoding a family of inflammatory cytokines. J Immunol 145:2737-2744.
686. Milligan ED, Zapata V, Chacur M, Schoeniger D, Biedenkapp J, O'Connor KA, Verge GM, Chapman G, Green P, and Foster AC, et al. (2004) Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. Eur J Neurosci 20:2294-2302.
687. Milne RS, Mattick C, Nicholson L, Devaraj P, Alcami A, and Gompels UA (2000) RANTES binding and down-regulation by a novel human herpesvirus-6 beta che- mokine receptor. J Immunol 164:2396-2404.
688. Miltz W, Loetscher P, Janser P, Hersperger R, Hiestand P, and Meingassner J (2008) Dual CCR2/CCR5 antagonists: a new approach for the treatment of autoimmune diseases, in ACS Meeting; 6-10 April 2008; New Orleans, LA. Available from http:// oasys2.confex.com/acs/235nm/techprogram/.
689. Mionnet C, Buatois V, Kanda A, Milcent V, Fleury S, Lair D, Langelot M, Lacoeuille Y, Hessel E, and Coffman R, et al. (2010) CX3CR1 is required for airway in- flammation by promoting T helper cell survival and maintenance in inflamed lung. Nat Med 16:1305-1312.
690. Mirzadegan T, Benkö G, Filipek S, and Palczewski K (2003) Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin. Biochemistry 42: 2759-2767.
691. Mishra A and Rothenberg ME (2003) Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroen- terology 125:1419-1427.
692. Miu J, Mitchell AJ, Müller M, Carter SL, Manders PM, McQuillan JA, Saunders BM, Ball HJ, Lu B, and Campbell IL, et al. (2008) Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency. J Immunol 180:1217-1230.
693. Moatti D, Faure S, Fumeron F, Amara Mel-W, Seknadji P, McDermott DH, Debré P, Aumont MC, Murphy PM, and de Prost D, et al. (2001) Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97:1925-1928.
694. Mohan K and Issekutz TB (2007) Blockade of chemokine receptor CXCR3 inhibits T cell recruitment to inflamed joints and decreases the severity of adjuvant arthritis. J Immunol 179:8463-8469.
695. Molon B, Gri G, Bettella M, Gómez-Moutón C, Lanzavecchia A, Martínez-A C, Mañes S, and Viola A (2005) T cell costimulation by chemokine receptors. Nat Immunol 6: 465-471. Update on Chemokine Receptors Molteni R, Crespo CL, Feigelson S, Moser C, Fabbri M, Grabovsky V, Krombach F, Laudanna C, Alon R, and Pardi R (2009) Beta-arrestin 2 is required for the in- duction and strengthening of integrin-mediated leukocyte adhesion during CXCR2- driven extravasation. Blood 114:1073-1082.
696. Monnier J, Lewén S, O'Hara E, Huang K, Tu H, Butcher EC, and Zabel BA (2012) Expression, regulation, and function of atypical chemerin receptor CCRL2 on en- dothelial cells. J Immunol 189:956-967.
697. Montaner S, Sodhi A, Molinolo A, Bugge TH, Sawai ET, He Y, Li Y, Ray PE, and Gutkind JS (2003) Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic po- tential of viral latent genes. Cancer Cell 3:23-36.
698. Montaner S, Sodhi A, Pece S, Mesri EA, and Gutkind JS (2001) The Kaposi's sar- coma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Cancer Res 61:2641-2648.
699. Montecucco F, Lenglet S, Braunersreuther V, Pelli G, Pellieux C, Montessuit C, Lerch R, Deruaz M, Proudfoot AE, and Mach F (2010) Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice. Arterioscler Thromb Vasc Biol 30:1371-1377.
700. Moorman NJ, Virgin HW 4th, and Speck SH (2003) Disruption of the gene encoding the gammaHV68 v-GPCR leads to decreased efficiency of reactivation from latency. Virology 307:179-190.
701. Morales J, Homey B, Vicari AP, Hudak S, Oldham E, Hedrick J, Orozco R, Copeland NG, Jenkins NA, and McEvoy LM, et al. (1999) CTACK, a skin-associated che- mokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci USA 96:14470-14475.
702. Morimoto Y, Bian Y, Gao P, Yashiro-Ohtani Y, Zhou XY, Ono S, Nakahara H, Kogo M, Hamaoka T, and Fujiwara H (2005) Induction of surface CCR4 and its func- tionality in mouse Th2 cells is regulated differently during Th2 development. J Leukoc Biol 78:753-761.
703. Morteau O, Gerard C, Lu B, Ghiran S, Rits M, Fujiwara Y, Law Y, Distelhorst K, Nielsen EM, and Hill ED, et al. (2008) An indispensable role for the chemokine receptor CCR10 in IgA antibody-secreting cell accumulation. J Immunol 181: 6309-6315.
704. Moyle G (2006) The last word on aplaviroc: a CCR5 antagonist with poor efficacy. The Body http://www.thebody.com/content/confs/hiv8/art39205.html.
705. Moyle G, DeJesus E, Boffito M, Wong RS, Gibney C, Badel K, MacFarland R, Cal- andra G, Bridger G, and Becker S; X4 Antagonist Concept Trial Study Team (2009) Proof of activity with AMD11070, an orally bioavailable inhibitor of CXCR4-tropic HIV type 1. Clin Infect Dis 48:798-805.
706. Mueller A, Meiser A, McDonagh EM, Fox JM, Petit SJ, Xanthou G, Williams TJ, and Pease JE (2008) CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3. J Leukoc Biol 83:875-882.
707. Mukaida N (2003) Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol 284:L566-L577.
708. Müller S, Dorner B, Korthaüer U, Mages HW, D'Apuzzo M, Senger G, and Kroczek RA (1995) Cloning of ATAC, an activation-induced, chemokine-related molecule exclusively expressed in CD8+ T lymphocytes. Eur J Immunol 25:1744-1748.
709. Murai M, Yoneyama H, Harada A, Yi Z, Vestergaard C, Guo B, Suzuki K, Asakura H, and Matsushima K (1999) Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. J Clin Invest 104: 49-57.
710. Murphy PM, Baggiolini M, Charo IF, Hébert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, and Power CA (2000) International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52:145-176.
711. Murphy PM and Tiffany HL (1991) Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 253:1280-1283.
712. Mutalithas K, Guillen C, Raport C, Kolbeck R, Soler D, Brightling CE, Pavord ID, and Wardlaw AJ (2010) Expression of CCR8 is increased in asthma. Clin Exp Allergy 40:1175-1185.
713. Najarro P, Gubser C, Hollinshead M, Fox J, Pease J, and Smith GL (2006) Yaba-like disease virus chemokine receptor 7L, a CCR8 orthologue. J Gen Virol 87:809-816.
714. Najarro P, Lee HJ, Fox J, Pease J, and Smith GL (2003) Yaba-like disease virus protein 7L is a cell-surface receptor for chemokine CCL1. J Gen Virol 84:3325- 3336.
715. Nakanishi Y, Lu B, Gerard C, and Iwasaki A (2009) CD8(+) T lymphocyte mobili- zation to virus-infected tissue requires CD4(+) T-cell help. Nature 462:510-513.
716. Nakano H and Gunn MD (2001) Gene duplications at the chemokine locus on mouse chromosome 4: multiple strain-specific haplotypes and the deletion of secondary lymphoid-organ chemokine and EBI-1 ligand chemokine genes in the plt mutation. J Immunol 166:361-369.
717. Nakano K, Tadagaki K, Isegawa Y, Aye MM, Zou P, and Yamanishi K (2003) Human herpesvirus 7 open reading frame U12 encodes a functional beta-chemokine re- ceptor. J Virol 77:8108-8115.
718. Nakatani T, Kaburagi Y, Shimada Y, Inaoki M, Takehara K, Mukaida N, and Sato S (2001) CCR4 memory CD4+ T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis. J Allergy Clin Immunol 107: 353-358.
719. Nakayama T, Hieshima K, Arao T, Jin Z, Nagakubo D, Shirakawa AK, Yamada Y, Fujii M, Oiso N, and Kawada A, et al. (2008) Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia. Oncogene 27: 3221-3232.
720. Nakayama T, Hieshima K, Izawa D, Tatsumi Y, Kanamaru A, and Yoshie O (2003) Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues. J Immunol 170:1136- 1140.
721. Nakayama T, Watanabe Y, Oiso N, Higuchi T, Shigeta A, Mizuguchi N, Katou F, Hashimoto K, Kawada A, and Yoshie O (2010) Eotaxin-3/CC chemokine ligand 26 is a functional ligand for CX3CR1. J Immunol 185:6472-6479.
722. Nanki T, Takada K, Komano Y, Morio T, Kanegane H, Nakajima A, Lipsky PE, and Miyasaka N (2009) Chemokine receptor expression and functional effects of chemokines on B cells: implication in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther 11:R149.
723. Nansen A, Marker O, Bartholdy C, and Thomsen AR (2000) CCR2+ and CCR5+ CD8
724. + T cells increase during viral infection and migrate to sites of infection. Eur J Immunol 30:1797-1806.
725. Napolitano M, Zingoni A, Bernardini G, Spinetti G, Nista A, Storlazzi CT, Rocchi M, and Santoni A (1996) Molecular cloning of TER1, a chemokine receptor-like gene expressed by lymphoid tissues. J Immunol 157:2759-2763.
726. Nardelli B, Tiffany HL, Bong GW, Yourey PA, Morahan DK, Li Y, Murphy PM, and Alderson RF (1999) Characterization of the signal transduction pathway ac- tivated in human monocytes and dendritic cells by MPIF-1, a specific ligand for CC chemokine receptor 1. J Immunol 162:435-444.
727. Nasser MW, Marjoram RJ, Brown SL, and Richardson RM (2005) Cross-de- sensitization among CXCR1, CXCR2, and CCR5: role of protein kinase C-epsilon. J Immunol 174:6927-6933.
728. Naumann U, Cameroni E, Pruenster M, Mahabaleshwar H, Raz E, Zerwes HG, Rot A, and Thelen M (2010) CXCR7 functions as a scavenger for CXCL12 and CXCL11. PLoS ONE 5:e9175.
729. Naya A, Ishikawa M, Matsuda K, Ohwaki K, Saeki T, Noguchi K, and Ohtake N (2003) Structure-activity relationships of xanthene carboxamides, novel CCR1 re- ceptor antagonists. Bioorg Med Chem 11:875-884.
730. Neote K, Darbonne W, Ogez J, Horuk R, and Schall TJ (1993) Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 268:12247-12249.
731. Neote K, Mak JY, Kolakowski LF Jr, and Schall TJ (1994) Functional and bio- chemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor. Blood 84:44-52.
732. Neptune ER, Iiri T, and Bourne HR (1999) Galphai is not required for chemotaxis mediated by Gi-coupled receptors. J Biol Chem 274:2824-2828.
733. Nibbs R, Graham G, and Rot A (2003) Chemokines on the move: control by the chemokine "interceptors" Duffy blood group antigen and D6. Semin Immunol 15: 287-294.
734. Nibbs RJ, Gilchrist DS, King V, Ferra A, Forrow S, Hunter KD, and Graham GJ (2007) The atypical chemokine receptor D6 suppresses the development of chem- ically induced skin tumors. J Clin Invest 117:1884-1892.
735. Nibbs RJ, Kriehuber E, Ponath PD, Parent D, Qin S, Campbell JD, Henderson A, Kerjaschki D, Maurer D, and Graham GJ, et al. (2001) The beta-chemokine re- ceptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol 158:867-877.
736. Nibbs RJ, Wylie SM, Pragnell IB, and Graham GJ (1997) Cloning and character- ization of a novel murine beta chemokine receptor, D6. Comparison to three other related macrophage inflammatory protein-1alpha receptors, CCR-1, CCR-3, and CCR-5. J Biol Chem 272:12495-12504.
737. Nibbs RJ, Yang J, Landau NR, Mao JH, and Graham GJ (1999) LD78beta, a non- allelic variant of human MIP-1alpha (LD78alpha), has enhanced receptor inter- actions and potent HIV suppressive activity. J Biol Chem 274:17478-17483.
738. Nicholas J (1996) Determination and analysis of the complete nucleotide sequence of human herpesvirus. J Virol 70:5975-5989.
739. Nicholas J, Cameron KR, and Honess RW (1992) Herpesvirus saimiri encodes homologues of G protein-coupled receptors and cyclins. Nature 355:362-365.
740. Nichols WG, Steel HM, Bonny T, Adkison K, Curtis L, Millard J, Kabeya K, and Clumeck N (2008) Hepatotoxicity observed in clinical trials of aplaviroc (GW873140). Antimicrob Agents Chemother 52:858-865.
741. Niess JH, Brand S, Gu X, Landsman L, Jung S, McCormick BA, Vyas JM, Boes M, Ploegh HL, and Fox JG, et al. (2005) CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307:254-258.
742. Nishimura M, Umehara H, Nakayama T, Yoneda O, Hieshima K, Kakizaki M, Dohmae N, Yoshie O, and Imai T (2002) Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol 168:6173-6180.
743. Nishiyori A, Minami M, Ohtani Y, Takami S, Yamamoto J, Kawaguchi N, Kume T, Akaike A, and Satoh M (1998) Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? FEBS Lett 429:167-172.
744. Nomiyama H, Hieshima K, Nakayama T, Sakaguchi T, Fujisawa R, Tanase S, Nishiura H, Matsuno K, Takamori H, and Tabira Y, et al. (2001) Human CC chemokine liver-expressed chemokine/CCL16 is a functional ligand for CCR1, CCR2 and CCR5, and constitutively expressed by hepatocytes. Int Immunol 13: 1021-1029.
745. Nomiyama H, Imai T, Kusuda J, Miura R, Callen DF, and Yoshie O (1998) Human chemokines fractalkine (SCYD1), MDC (SCYA22) and TARC (SCYA17) are clus- tered on chromosome 16q13. Cytogenet Cell Genet 81:10-11.
746. Nomiyama H, Osada N, and Yoshie O (2010) The evolution of mammalian chemokine genes. Cytokine Growth Factor Rev 21:253-262.
747. Nomiyama H, Osada N, and Yoshie O (2011) A family tree of vertebrate chemokine receptors for a unified nomenclature. Dev Comp Immunol 35:705-715.
748. Norment AM, Bogatzki LY, Gantner BN, and Bevan MJ (2000) Murine CCR9, a chemokine receptor for thymus-expressed chemokine that is up-regulated fol- lowing pre-TCR signaling. J Immunol 164:639-648.
749. Notohamiprodjo M, Segerer S, Huss R, Hildebrandt B, Soler D, Djafarzadeh R, Buck W, Nelson PJ, and von Luettichau I (2005) CCR10 is expressed in cutaneous T-cell lymphoma. Int J Cancer 115:641-647.
750. Nouri-Aria KT, Wilson D, Francis JN, Jopling LA, Jacobson MR, Hodge MR, Andrew DP, Till SJ, Varga EM, and Williams TJ, et al. (2002) CCR4 in human allergen-induced late responses in the skin and lung. Eur J Immunol 32: 1933-1938.
751. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, and Legler DF, et al. (1996) The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell- line-adapted HIV-1. Nature 382:833-835.
752. Obmolova G, Teplyakov A, Malia TJ, Grygiel TL, Sweet R, Snyder LA, and Gilliland GL (2012) Structural basis for high selectivity of anti-CCL2 neutralizing antibody CNTO 888. Mol Immunol 51:227-233.
753. Ockinger J, Stridh P, Beyeen AD, Lundmark F, Seddighzadeh M, Oturai A, Sørensen PS, Lorentzen AR, Celius EG, and Leppä V, et al. (2010) Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple scle- rosis and rheumatoid arthritis. Genes Immun 11:142-154.
754. Ogilvie P, Thelen S, Moepps B, Gierschik P, da Silva Campos AC, Baggiolini M, and Thelen M (2004) Unusual chemokine receptor antagonism involving a mito- gen-activated protein kinase pathway. J Immunol 172:6715-6722.
755. Ohno M, Hirata T, Enomoto M, Araki T, Ishimaru H, and Takahashi TA (2000) A putative chemoattractant receptor, C5L2, is expressed in granulocyte and imma- ture dendritic cells, but not in mature dendritic cells. Mol Immunol 37:407-412.
756. Okada N, Sasaki A, Niwa M, Okada Y, Hatanaka Y, Tani Y, Mizuguchi H, Nakagawa S, Fujita T, and Yamamoto A (2006) Tumor suppressive efficacy through aug- mentation of tumor-infiltrating immune cells by intratumoral injection of chemo- kine-expressing adenoviral vector. Cancer Gene Ther 13:393-405.
757. Okada T, Miller MJ, Parker I, Krummel MF, Neighbors M, Hartley SB, O'Garra A, Cahalan MD, and Cyster JG (2005) Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells. PLoS Biol 3:e150.
758. Okada T, Ngo VN, Ekland EH, Förster R, Lipp M, Littman DR, and Cyster JG (2002) Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J Exp Med 196:65-75.
759. Okinaga S, Slattery D, Humbles A, Zsengeller Z, Morteau O, Kinrade MB, Brodbeck RM, Krause JE, Choe HR, and Gerard NP, et al. (2003) C5L2, a nonsignaling C5A binding protein. Biochemistry 42:9406-9415.
760. Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, Glickman JN, Siebert R, Baron RM, and Kasper DL, et al. (2012) Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336:489-493.
761. Olszyna DP, Florquin S, Sewnath M, Branger J, Speelman P, van Deventer SJ, Strieter RM, and van der Poll T (2001) CXC chemokine receptor 2 contributes to host defense in murine urinary tract infection. J Infect Dis 184:301-307.
762. Oostendorp J, Hylkema MN, Luinge M, Geerlings M, Meurs H, Timens W, Zaagsma J, Postma DS, Boddeke HW, and Biber K (2004) Localization and enhanced mRNA expression of the orphan chemokine receptor L-CCR in the lung in a murine model of ovalbumin-induced airway inflammation. J Histochem Cytochem 52:401-410.
763. Otero K, Vecchi A, Hirsch E, Kearley J, Vermi W, Del Prete A, Gonzalvo-Feo S, Garlanda C, Azzolino O, and Salogni L, et al. (2010) Nonredundant role of CCRL2 in lung dendritic cell trafficking. Blood 116:2942-2949.
764. Pan Y, Lloyd C, Zhou H, Dolich S, Deeds J, Gonzalo JA, Vath J, Gosselin M, Ma J, and Dussault B, et al. (1997) Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387:611-617.
765. Panina-Bordignon P, Papi A, Mariani M, Di Lucia P, Casoni G, Bellettato C, Buon- santi C, Miotto D, Mapp C, and Villa A, et al. (2001) The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest 107:1357-1364.
766. Papadakis KA, Prehn J, Nelson V, Cheng L, Binder SW, Ponath PD, Andrew DP, and Targan SR (2000) The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune sys- tem. J Immunol 165:5069-5076.
767. Park SH, Casagrande F, Cho L, Albrecht L, and Opella SJ (2011) Interactions of interleukin-8 with the human chemokine receptor CXCR1 in phospholipid bilayers by NMR spectroscopy. J Mol Biol 414:194-203.
768. Park SH, Das BB, Casagrande F, Tian Y, Nothnagel HJ, Chu M, Kiefer H, Maier K, De Angelis AA, and Marassi FM, et al. (2012) Structure of the chemokine receptor CXCR1 in phospholipid bilayers. Nature 491:779-783.
769. Pathi SP, Kowalczewski C, Tadipatri R, and Fischbach C (2010) A novel 3-D min- eralized tumor model to study breast cancer bone metastasis. PLoS ONE 5:e8849.
770. Pati S, Cavrois M, Guo HG, Foulke JS Jr, Kim J, Feldman RA, and Reitz M (2001) Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis. J Virol 75: 8660-8673.
771. Paust S, Gill HS, Wang BZ, Flynn MP, Moseman EA, Senman B, Szczepanik M, Telenti A, Askenase PW, and Compans RW, et al. (2010) Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol 11:1127-1135.
772. Pease J and Horuk R (2012) Chemokine receptor antagonists. J Med Chem 55: 9363-9392.
773. Pease JE (2006) Asthma, allergy and chemokines. Curr Drug Targets 7:3-12.
774. Pease JE (2011) Targeting chemokine receptors in allergic disease. Biochem J 434: 11-24.
775. Pease JE and Horuk R (2009) Chemokine receptor antagonists: Part 1. Expert Opin Ther Pat 19:39-58.
776. Peiper SC, Wang ZX, Neote K, Martin AW, Showell HJ, Conklyn MJ, Ogborne K, Hadley TJ, Lu ZH, and Hesselgesser J, et al. (1995) The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 181:1311-1317.
777. Penfold ME, Dairaghi DJ, Duke GM, Saederup N, Mocarski ES, Kemble GW, and Schall TJ (1999) Cytomegalovirus encodes a potent alpha chemokine. Proc Natl Acad Sci USA 96:9839-9844.
778. Penton-Rol G, Cota M, Polentarutti N, Luini W, Bernasconi S, Borsatti A, Sica A, LaRosa GJ, Sozzani S, and Poli G, et al. (1999) Up-regulation of CCR2 chemokine receptor expression and increased susceptibility to the multitropic HIV strain 89.6 in monocytes exposed to glucocorticoid hormones. J Immunol 163:3524-3529.
779. Penton-Rol G, Polentarutti N, Luini W, Borsatti A, Mancinelli R, Sica A, Sozzani S, and Mantovani A (1998) Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-gamma. J Immunol 160: 3869-3873.
780. Pere H, Montier Y, Bayry J, Quintin-Colonna F, Merillon N, Dransart E, Badoual C, Gey A, Ravel P, and Marcheteau E, et al. (2011) A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens. Blood 118:4853-4862.
781. Pereira JP, Kelly LM, Xu Y, and Cyster JG (2009) EBI2 mediates B cell segregation between the outer and centre follicle. Nature 460:1122-1126.
782. Peters W, Cyster JG, Mack M, Schlöndorff D, Wolf AJ, Ernst JD, and Charo IF (2004) CCR2-dependent trafficking of F4/80dim macrophages and CD11cdim/in- termediate dendritic cells is crucial for T cell recruitment to lungs infected with Mycobacterium tuberculosis. J Immunol 172:7647-7653.
783. Peters W, Scott HM, Chambers HF, Flynn JL, Charo IF, and Ernst JD (2001) Che- mokine receptor 2 serves an early and essential role in resistance to Mycobacte- rium tuberculosis. Proc Natl Acad Sci USA 98:7958-7963.
784. Piali L, Weber C, LaRosa G, Mackay CR, Springer TA, Clark-Lewis I, and Moser B (1998) The chemokine receptor CXCR3 mediates rapid and shear-resistant adhe- sion-induction of effector T lymphocytes by the chemokines IP10 and Mig. Eur J Immunol 28:961-972.
785. Pleskoff O, Tréboute C, Brelot A, Heveker N, Seman M, and Alizon M (1997) Iden- tification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science 276:1874-1878.
786. Polentarutti N, Allavena P, Bianchi G, Giardina G, Basile A, Sozzani S, Mantovani A, and Introna M (1997) IL-2-regulated expression of the monocyte chemotactic protein- 1 receptor (CCR2) in human NK cells: characterization of a predominant 3.4-kilobase transcript containing CCR2B and CCR2A sequences. J Immunol 158:2689-2694.
787. Ponath PD, Qin S, Post TW, Wang J, Wu L, Gerard NP, Newman W, Gerard C, and Mackay CR (1996) Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med 183:2437-2448.
788. Pope SM, Fulkerson PC, Blanchard C, Akei HS, Nikolaidis NM, Zimmermann N, Molkentin JD, and Rothenberg ME (2005a) Identification of a cooperative mech- anism involving interleukin-13 and eotaxin-2 in experimental allergic lung in- flammation. J Biol Chem 280:13952-13961.
789. Pope SM, Zimmermann N, Stringer KF, Karow ML, and Rothenberg ME (2005b) The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia. J Immunol 175:5341-5350.
790. Postea O, Vasina EM, Cauwenberghs S, Projahn D, Liehn EA, Lievens D, Theelen W, Kramp BK, Butoi ED, and Soehnlein O, et al. (2012) Contribution of platelet CX(3) CR1 to platelet-monocyte complex formation and vascular recruitment during hyperlipidemia. Arterioscler Thromb Vasc Biol 32:1186-1193.
791. Potteaux S, Combadière C, Esposito B, Lecureuil C, Ait-Oufella H, Merval R, Ardouin P, Tedgui A, and Mallat Z (2006) Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 26:1858-1863.
792. Power CA, Church DJ, Meyer A, Alouani S, Proudfoot AE, Clark-Lewis I, Sozzani S, Mantovani A, and Wells TN (1997) Cloning and characterization of a specific re- ceptor for the novel CC chemokine MIP-3alpha from lung dendritic cells. J Exp Med 186:825-835.
793. Power CA, Meyer A, Nemeth K, Bacon KB, Hoogewerf AJ, Proudfoot AE, and Wells TN (1995) Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J Biol Chem 270:19495-19500.
794. Procopiou PA, Ford AJ, Graves RH, Hall DA, Hodgson ST, Lacroix YM, Needham D, and Slack RJ (2012) Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation. Bioorg Med Chem Lett 22:2730-2733.
795. Proost P, Loos T, Mortier A, Schutyser E, Gouwy M, Noppen S, Dillen C, Ronsse I, Conings R, and Struyf S, et al. (2008) Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue in- flammation. J Exp Med 205:2085-2097.
796. Proost P, Schutyser E, Menten P, Struyf S, Wuyts A, Opdenakker G, Detheux M, Parmentier M, Durinx C, and Lambeir AM, et al. (2001) Amino-terminal trunca- tion of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 98:3554-3561.
797. Proudfoot AE, Power CA, Hoogewerf AJ, Montjovent MO, Borlat F, Offord RE, and Wells TN (1996) Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. J Biol Chem 271: 2599-2603.
798. Pruenster M, Mudde L, Bombosi P, Dimitrova S, Zsak M, Middleton J, Richmond A, Graham GJ, Segerer S, and Nibbs RJ, et al. (2009) The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat Immunol 10:101-108.
799. Pusic I and DiPersio JF (2010) Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and pro- genitor cells. Curr Opin Hematol 17:319-326.
800. Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, Kaiser EA, Snyder LA, and Pollard JW (2011) CCL2 recruits inflammatory monocytes to facilitate breast- tumour metastasis. Nature 475:222-225.
801. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, Koch AE, Moser B, and Mackay CR (1998) The chemokine receptors CXCR3 and CCR5 mark sub- sets of T cells associated with certain inflammatory reactions. J Clin Invest 101: 746-754.
802. Qu C, Edwards EW, Tacke F, Angeli V, Llodrá J, Sanchez-Schmitz G, Garin A, Haque NS, Peters W, and van Rooijen N, et al. (2004) Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J Exp Med 200:1231-1241.
803. Quan C, Ren YQ, Xiang LH, Sun LD, Xu AE, Gao XH, Chen HD, Pu XM, Wu RN, and Liang CZ, et al. (2010) Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. Nat Genet 42:614-618.
804. Quinones MP, Estrada CA, Kalkonde Y, Ahuja SK, Kuziel WA, Mack M, and Ahuja SS (2005) The complex role of the chemokine receptor CCR2 in collagen-induced arthritis: implications for therapeutic targeting of CCR2 in rheumatoid arthritis. J Mol Med (Berl) 83:672-681.
805. Raby AC, Holst B, Davies J, Colmont C, Laumonnier Y, Coles B, Shah S, Hall J, Topley N, and Köhl J, et al. (2011) TLR activation enhances C5a-induced pro- Update on Chemokine Receptors inflammatory responses by negatively modulating the second C5a receptor, C5L2. Eur J Immunol 41:2741-2752.
806. Ragin AB, Wu Y, Storey P, Cohen BA, Edelman RR, and Epstein LG (2006) Monocyte chemoattractant protein-1 correlates with subcortical brain injury in HIV infection. Neurology 66:1255-1257.
807. Rahbar R, Murooka TT, and Fish EN (2009) Role for CCR5 in dissemination of vaccinia virus in vivo. J Virol 83:2226-2236.
808. Rajagopal S, Kim J, Ahn S, Craig S, Lam CM, Gerard NP, Gerard C, and Lefkowitz RJ (2010) Beta-arrestin-but not G protein-mediated signaling by the "decoy" re- ceptor CXCR7. Proc Natl Acad Sci USA 107:628-632.
809. Raman D, Neel NF, Sai J, Mernaugh RL, Ham AJ, and Richmond AJ (2009) Char- acterization of chemokine receptor CXCR2 interacting proteins using a proteomics approach to define the CXCR2 "chemosynapse". Methods Enzymol 460:315-330.
810. Raoul W, Auvynet C, Camelo S, Guillonneau X, Feumi C, Combadière C, and Sennlaub F (2010) CCL2/CCR2 and CX3CL1/CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration. J Neuro- inflammation 7:87.
811. Raport CJ, Gosling J, Schweickart VL, Gray PW, and Charo IF (1996) Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha. J Biol Chem 271:17161-17166.
812. Raport CJ, Schweickart VL, Eddy RL Jr, Shows TB, and Gray PW (1995) The orphan G-protein-coupled receptor-encoding gene V28 is closely related to genes for che- mokine receptors and is expressed in lymphoid and neural tissues. Gene 163: 295-299.
813. Rasmussen SG, Choi HJ, Fung JJ, Pardon E, Casarosa P, Chae PS, Devree BT, Rosenbaum DM, Thian FS, and Kobilka TS, et al. (2011) Structure of a nanobody- stabilized active state of the b(2) adrenoceptor. Nature 469:175-180.
814. Ravensberg AJ, Ricciardolo FL, van Schadewijk A, Rabe KF, Sterk PJ, Hiemstra PS, and Mauad T (2005) Eotaxin-2 and eotaxin-3 expression is associated with per- sistent eosinophilic bronchial inflammation in patients with asthma after allergen challenge. J Allergy Clin Immunol 115:779-785.
815. Ravindran R, Rusch L, Itano A, Jenkins MK, and McSorley SJ (2007) CCR6-de- pendent recruitment of blood phagocytes is necessary for rapid CD4 T cell responses to local bacterial infection. Proc Natl Acad Sci USA 104:12075-12080.
816. Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, Lira S, Uccelli A, Lanzavecchia A, Engelhardt B, and Sallusto F (2009) C-C chemokine receptor 6- regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 10:514-523.
817. Reeves JD, McKnight A, Potempa S, Simmons G, Gray PW, Power CA, Wells T, Weiss RA, and Talbot SJ (1997) CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry. Virology 231:130-134.
818. Reif K, Ekland EH, Ohl L, Nakano H, Lipp M, Förster R, and Cyster JG (2002) Balanced responsiveness to chemoattractants from adjacent zones determines B- cell position. Nature 416:94-99.
819. Reutershan J, Harry B, Chang D, Bagby GJ, and Ley K (2009) DARC on RBC limits lung injury by balancing compartmental distribution of CXC chemokines. Eur J Immunol 39:1597-1607.
820. Richmond A (2008) CCR9 homes metastatic melanoma cells to the small bowel. Clin Cancer Res 14:621-623.
821. Rittirsch D, Flierl MA, Nadeau BA, Day DE, Huber-Lang M, Mackay CR, Zetoune FS, Gerard NP, Cianflone K, and Köhl J, et al. (2008) Functional roles for C5a receptors in sepsis. Nat Med 14:551-557.
822. Rittner HL, Brack A, and Stein C (2008) Pain and the immune system. Br J Anaesth 101:40-44.
823. Rivino L, Messi M, Jarrossay D, Lanzavecchia A, Sallusto F, and Geginat J (2004) Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and non- polarized cells among human CD4+ central memory T cells. J Exp Med 200:725-735.
824. Rivollier A, He J, Kole A, Valatas V, and Kelsall BL (2012) Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macro- phages to inflammatory dendritic cells in the colon. J Exp Med 209:139-155.
825. Robbins SH, Walzer T, Dembélé D, Thibault C, Defays A, Bessou G, Xu H, Vivier E, Sellars M, and Pierre P, et al. (2008) Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol 9:R17.
826. Robertson MJ (2002) Role of chemokines in the biology of natural killer cells. J Leukoc Biol 71:173-183.
827. Robinson LA, Nataraj C, Thomas DW, Cosby JM, Griffiths R, Bautch VL, Patel DD, and Coffman TM (2003) The chemokine CX3CL1 regulates NK cell activity in vivo. Cell Immunol 225:122-130.
828. Robinson LA, Nataraj C, Thomas DW, Howell DN, Griffiths R, Bautch V, Patel DD, Feng L, and Coffman TM (2000) A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. J Immunol 165:6067-6072.
829. Rodero M, Marie Y, Coudert M, Blondet E, Mokhtari K, Rousseau A, Raoul W, Carpentier C, Sennlaub F, and Deterre P, et al. (2008) Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma. J Clin Oncol 26:5957-5964.
830. Rodríguez-Frade JM, Vila-Coro AJ, de Ana AM, Albar JP, Martínez-A C, and Mellado M (1999) The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. Proc Natl Acad Sci USA 96: 3628-3633.
831. Roos RS, Loetscher M, Legler DF, Clark-Lewis I, Baggiolini M, and Moser B (1997) Identification of CCR8, the receptor for the human CC chemokine I-309. J Biol Chem 272:17251-17254.
832. Rosenblum JM, Zhang QW, Siu G, Collins TL, Sullivan T, Dairaghi DJ, Medina JC, and Fairchild RL (2009) CXCR3 antagonism impairs the development of donor- reactive, IFN-gamma-producing effectors and prolongs allograft survival. Trans- plantation 87:360-369.
833. Rosenkilde MM, Andersen MB, Nygaard R, Frimurer TM, and Schwartz TW (2007) Activation of the CXCR3 chemokine receptor through anchoring of a small molecule chelator ligand between TM-III, -IV, and -VI. Mol Pharmacol 71:930-941.
834. Rosenkilde MM, Kledal TN, Bräuner-Osborne H, and Schwartz TW (1999) Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven- transmembrane oncogene product, ORF-74. J Biol Chem 274:956-961.
835. Rosenkilde MM, Kledal TN, Holst PJ, and Schwartz TW (2000) Selective elimination of high constitutive activity or chemokine binding in the human herpesvirus 8 encoded seven transmembrane oncogene ORF74. J Biol Chem 275:26309-26315.
836. Rosenkilde MM, Kledal TN, and Schwartz TW (2005) High constitutive activity of a virus-encoded 7TM receptor in the absence of the conserved DRY-motif (Asp-Arg- Tyr) in transmembrane helix 3. Mol Pharmacol 66:11-19.
837. Rosenkilde MM, McLean KA, Holst PJ, and Schwartz TW (2004) The CXC chemokine receptor encoded by herpesvirus saimiri, ECRF3, shows ligand-regulated signaling through Gi, Gq, and G12/13 proteins but constitutive signaling only through Gi and G12/13 proteins. J Biol Chem 279:32524-32533.
838. Rosenkilde MM and Schwartz TW (2004) The chemokine system -a major regulator of angiogenesis in health and disease. APMIS 112:481-495.
839. Rosenkilde MM, Waldhoer M, Lüttichau HR, and Schwartz TW (2001) Virally encoded 7TM receptors. Oncogene 20:1582-1593.
840. Rot A (1992) Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol Today 13:291-294.
841. Rot A (2005) Contribution of Duffy antigen to chemokine function. Cytokine Growth Factor Rev 16:687-694.
842. Rothenberg ME and Hogan SP (2006) The eosinophil. Annu Rev Immunol 24: 147-174.
843. Rothenberg ME, MacLean JA, Pearlman E, Luster AD, and Leder P (1997) Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eo- sinophilia. J Exp Med 185:785-790.
844. Rottman JB, Slavin AJ, Silva R, Weiner HL, Gerard CG, and Hancock WW (2000) Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent. Eur J Immunol 30:2372-2377.
845. Rubbert A, Combadiere C, Ostrowski M, Arthos J, Dybul M, Machado E, Cohn MA, Hoxie JA, Murphy PM, and Fauci AS, et al. (1998) Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry. J Immunol 160:3933-3941.
846. Rucker J, Edinger AL, Sharron M, Samson M, Lee B, Berson JF, Yi Y, Margulies B, Collman RG, and Doranz BJ, et al. (1997) Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. J Virol 71:8999-9007.
847. Rucker J, Samson M, Doranz BJ, Libert F, Berson JF, Yi Y, Smyth RJ, Collman RG, Broder CC, and Vassart G, et al. (1996) Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 87:437-446.
848. Ruckes T, Saul D, Van Snick J, Hermine O, and Grassmann R (2001) Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309. Blood 98:1150-1159.
849. Rueda P, Balabanian K, Lagane B, Staropoli I, Chow K, Levoye A, Laguri C, Sadir R, Delaunay T, and Izquierdo E, et al. (2008) The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins. PLoS ONE 3:e2543.
850. Rueda P, Richart A, Récalde A, Gasse P, Vilar J, Guérin C, Lortat-Jacob H, Vieira P, Baleux F, and Chretien F, et al. (2012) Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan inter- actions. Circulation 126:1882-1895.
851. Ruiz ME, Cicala C, Arthos J, Kinter A, Catanzaro AT, Adelsberger J, Holmes KL, Cohen OJ, and Fauci AS (1998) Peripheral blood-derived CD34+ progenitor cells: CXC chemokine receptor 4 and CC chemokine receptor 5 expression and infection by HIV. J Immunol 161:4169-4176.
852. Ruiz-Argüello MB, Smith VP, Campanella GS, Baleux F, Arenzana-Seisdedos F, Luster AD, and Alcami A (2008) An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain. J Virol 82:917-926.
853. Rummel PC, Arfelt KN, Baumann L, Jenkins TJ, Thiele S, Lüttichau HR, Johnsen A, Pease J, Ghosh S, and Kolbeck R, et al. (2012) Molecular requirements for in- hibition of the chemokine receptor CCR8-probe-dependent allosteric interactions. Br J Pharmacol 167:1206-1217.
854. Russo RC, Alessandri AL, Garcia CC, Cordeiro BF, Pinho V, Cassali GD, Proudfoot AE, and Teixeira MM (2011) Therapeutic effects of evasin-1, a chemokine binding protein, in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 45: 72-80.
855. Saccani A, Saccani S, Orlando S, Sironi M, Bernasconi S, Ghezzi P, Mantovani A, and Sica A (2000) Redox regulation of chemokine receptor expression. Proc Natl Acad Sci USA 97:2761-2766.
856. Sadik CD, Kim ND, Iwakura Y, and Luster AD (2012) Neutrophils orchestrate their own recruitment in murine arthritis through C5aR and FcgR signaling. Proc Natl Acad Sci USA 109:E3177-E3185.
857. Saeki H, Moore AM, Brown MJ, and Hwang ST (1999) Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol 162:2472-2475.
858. Sai J, Walker G, Wikswo J, and Richmond A (2006) The IL sequence in the LLKIL motif in CXCR2 is required for full ligand-induced activation of Erk, Akt, and chemotaxis in HL60 cells. J Biol Chem 281:35931-35941.
859. Saini V, Staren DM, Ziarek JJ, Nashaat ZN, Campbell EM, Volkman BF, Marchese A, and Majetschak M (2011) The CXC chemokine receptor 4 ligands ubiquitin and stromal cell-derived factor-1a function through distinct receptor interactions. J Biol Chem 286:33466-33477.
860. Sakai N, Kuboki S, Van Sweringen HL, Tevar AD, Schuster R, Blanchard J, Edwards MJ, and Lentsch AB (2011) CXCR1 deficiency does not alter liver regeneration after partial hepatectomy in mice. Transplant Proc 43:1967-1970.
861. Salazar-Gonzalez RM, Niess JH, Zammit DJ, Ravindran R, Srinivasan A, Maxwell JR, Stoklasek T, Yadav R, Williams IR, and Gu X, et al. (2006) CCR6-mediated dendritic cell activation of pathogen-specific T cells in Peyer's patches. Immunity 24:623-632.
862. Salcedo R, Young HA, Ponce ML, Ward JM, Kleinman HK, Murphy WJ, and Oppenheim JJ (2001) Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells. J Immunol 166:7571-7578.
863. Salchow K, Bond ME, Evans SC, Press NJ, Charlton SJ, Hunt PA, and Bradley ME (2010) A common intracellular allosteric binding site for antagonists of the CXCR2 receptor. Br J Pharmacol 159:1429-1439.
864. Sallusto F and Lanzavecchia A (2000) Understanding dendritic cell and T-lympho- cyte traffic through the analysis of chemokine receptor expression. Immunol Rev 177:134-140.
865. Sallusto F, Lanzavecchia A, and Mackay CR (1998a) Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 19: 568-574.
866. Sallusto F, Lenig D, Förster R, Lipp M, and Lanzavecchia A (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708-712.
867. Sallusto F, Lenig D, Mackay CR, and Lanzavecchia A (1998b) Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187:875-883.
868. Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay CR, Qin S, and Lanzavecchia A (1998c) Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 28:2760-2769.
869. Salomon I, Netzer N, Wildbaum G, Schif-Zuck S, Maor G, and Karin N (2002) Tar- geting the function of IFN-gamma-inducible protein 10 suppresses ongoing adju- vant arthritis. J Immunol 169:2685-2693.
870. Samson M, Labbe O, Mollereau C, Vassart G, and Parmentier M (1996a) Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 35:3362-3367.
871. Samson M, LaRosa G, Libert F, Paindavoine P, Detheux M, Vassart G, and Parmentier M (1997) The second extracellular loop of CCR5 is the major determinant of ligand specificity. J Biol Chem 272:24934-24941.
872. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, and Forceille C, et al. (1996b) Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. see comments Nature 382:722-725.
873. Samson M, Stordeur P, Labbé O, Soularue P, Vassart G, and Parmentier M (1996c) Molecular cloning and chromosomal mapping of a novel human gene, ChemR1, expressed in T lymphocytes and polymorphonuclear cells and encoding a putative chemokine receptor. Eur J Immunol 26:3021-3028.
874. Sánchez-Alcañiz JA, Haege S, Mueller W, Pla R, Mackay F, Schulz S, López-Bendito G, Stumm R, and Marín O (2011) Cxcr7 controls neuronal migration by regulating chemokine responsiveness. Neuron 69:77-90.
875. Sanders SK, Crean SM, Boxer PA, Kellner D, LaRosa GJ, and Hunt SW 3rd (2000) Functional differences between monocyte chemotactic protein-1 receptor A and monocyte chemotactic protein-1 receptor B expressed in a Jurkat T cell. J Immunol 165:4877-4883.
876. Santella JB 3rd, Gardner DS, Yao W, Shi C, Reddy P, Tebben AJ, DeLucca GV, Wacker DA, Watson PS, and Welch PK, et al. (2008) From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part I: the discovery of CCR3 antag- onist development candidate BMS-639623 with picomolar inhibition potency against eosinophil chemotaxis. Bioorg Med Chem Lett 18:576-585.
877. Sarafi MN, Garcia-Zepeda EA, MacLean JA, Charo IF, and Luster AD (1997) Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1. J Exp Med 185:99-109.
878. Sather BD, Treuting P, Perdue N, Miazgowicz M, Fontenot JD, Rudensky AY, and Campbell DJ (2007) Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease. J Exp Med 204:1335-1347.
879. Sato N, Ahuja SK, Quinones M, Kostecki V, Reddick RL, Melby PC, Kuziel WA, and Ahuja SS (2000) CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation. J Exp Med 192:205-218.
880. Sato W, Aranami T, and Yamamura T (2007) Cutting edge: Human Th17 cells are identified as bearing CCR2+CCR5-phenotype. J Immunol 178:7525-7529.
881. Savino B, Borroni EM, Torres NM, Proost P, Struyf S, Mortier A, Mantovani A, Locati M, and Bonecchi R (2009) Recognition versus adaptive up-regulation and degradation of CC chemokines by the chemokine decoy receptor D6 are determined by their N-terminal sequence. J Biol Chem 284:26207-26215.
882. Schaerli P, Ebert L, Willimann K, Blaser A, Roos RS, Loetscher P, and Moser B (2004) A skin-selective homing mechanism for human immune surveillance T cells. J Exp Med 199:1265-1275.
883. Schall TJ and Proudfoot AE (2011) Overcoming hurdles in developing successful drugs targeting chemokine receptors. Nat Rev Immunol 11:355-363.
884. Schecter AD, Calderon TM, Berman AB, McManus CM, Fallon JT, Rossikhina M, Zhao W, Christ G, Berman JW, and Taubman MB (2000) Human vascular smooth muscle cells possess functional CCR5. J Biol Chem 275:5466-5471.
885. Schiraldi M, Raucci A, Muñoz LM, Livoti E, Celona B, Venereau E, Apuzzo T, De Marchis F, Pedotti M, and Bachi A, et al. (2012) HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J Exp Med 209:551-563.
886. Schnabel RB, Baumert J, Barbalic M, Dupuis J, Ellinor PT, Durda P, Dehghan A, Bis JC, Illig T, and Morrison AC, et al. (2010) Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemo- attractant protein-1 and other inflammatory mediators. Blood 115:5289-5299.
887. Schneider MA, Meingassner JG, Lipp M, Moore HD, and Rot A (2007) CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J Exp Med 204: 735-745.
888. Scholten DJ, Canals M, Maussang D, Roumen L, Smit MJ, Wijtmans M, de Graaf C, Vischer HF, and Leurs R (2012) Pharmacological modulation of chemokine re- ceptor function. Br J Pharmacol 165:1617-1643.
889. Schönemeier B, Kolodziej A, Schulz S, Jacobs S, Hoellt V, and Stumm R (2008) Regional and cellular localization of the CXCl12/SDF-1 chemokine receptor CXCR7 in the developing and adult rat brain. J Comp Neurol 510:207-220.
890. Schraufstatter IU, Zhao M, Khaldoyanidi SK, and Discipio RG (2012) The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spec- trum. Immunology 135:287-298.
891. Schuh JM, Blease K, and Hogaboam CM (2002) The role of CC chemokine receptor 5 (CCR5) and RANTES/CCL5 during chronic fungal asthma in mice. FASEB J 16: 228-230.
892. Schulz O, Jaensson E, Persson EK, Liu X, Worbs T, Agace WW, and Pabst O (2009) Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J Exp Med 206:3101-3114.
893. Schumann K, Lämmermann T, Bruckner M, Legler DF, Polleux J, Spatz JP, Schuler G, Förster R, Lutz MB, and Sorokin L, et al. (2010) Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of den- dritic cells. Immunity 32:703-713.
894. Schutyser E, Struyf S, and Van Damme J (2003) The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 14:409-426.
895. Schwarz M and Murphy PM (2001) Kaposi's sarcoma-associated herpesvirus G pro- tein-coupled receptor constitutively activates NF-kappa B and induces proin- flammatory cytokine and chemokine production via a C-terminal signaling determinant. J Immunol 167:505-513.
896. Schweickart VL, Epp A, Raport CJ, and Gray PW (2000) CCR11 is a functional re- ceptor for the monocyte chemoattractant protein family of chemokines. J Biol Chem 275:9550-9556.
897. Sciumè G, De Angelis G, Benigni G, Ponzetta A, Morrone S, Santoni A, and Bernardini G (2011) CX3CR1 expression defines 2 KLRG1+ mouse NK-cell subsets with distinct functional properties and positioning in the bone marrow. Blood 117:4467-4475.
898. Scola AM, Johswich KO, Morgan BP, Klos A, and Monk PN (2009) The human complement fragment receptor, C5L2, is a recycling decoy receptor. Mol Immunol 46:1149-1162.
899. Segura E, Wong J, and Villadangos JA (2009) Cutting edge: B220+CCR9-dendritic cells are not plasmacytoid dendritic cells but are precursors of conventional den- dritic cells. J Immunol 183:1514-1517.
900. Seibert C, Veldkamp CT, Peterson FC, Chait BT, Volkman BF, and Sakmar TP (2008) Sequential tyrosine sulfation of CXCR4 by tyrosylprotein sulfotransferases. Biochemistry 47:11251-11262.
901. Semple BD, Kossmann T, and Morganti-Kossmann MC (2010) Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 net- works. J Cereb Blood Flow Metab 30:459-473.
902. Serbina NV and Pamer EG (2006) Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 7:311-317.
903. Severin IC, Gaudry JP, Johnson Z, Kungl A, Jansma A, Gesslbauer B, Mulloy B, Power C, Proudfoot AE, and Handel T (2010) Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glyco- saminoglycans. J Biol Chem 285:17713-17724.
904. Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A, Giltnane JM, Yang L, Zhao H, and Calame K, et al. (2002) Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17:51-62.
905. Sharma B, Singh S, Varney ML, and Singh RK (2010) Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma. Expert Opin Ther Targets 14: 435-442.
906. Sharrack B, Leach T, Jacobson E, Donaldson DD, Xu X, and Hu M (2007) Frequent MRI study of a novel CCR2 antagonist in relapsing-remitting multiple sclerosis. Ann Neurol 62 (Suppl. 11):S74.
907. Sharron M, Pöhlmann S, Price K, Lolis E, Tsang M, Kirchhoff F, Doms RW, and Lee B (2000) Expression and coreceptor activity of STRL33/Bonzo on primary periph- eral blood lymphocytes. Blood 96:41-49.
908. Shea-Donohue T, Thomas K, Cody MJ, Aiping Zhao, Detolla LJ, Kopydlowski KM, Fukata M, Lira SA, and Vogel SN (2008) Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-alpha), exhibit increased susceptibility to dextran sodium sulfate (DSS)-induced colitis. Innate Immun 14:117-124.
909. Shepard LW, Yang M, Xie P, Browning DD, Voyno-Yasenetskaya T, Kozasa T, and Ye RD (2001) Constitutive activation of NF-kappa B and secretion of interleukin-8 induced by the G protein-coupled receptor of Kaposi's sarcoma-associated herpes- virus involve G alpha(13) and RhoA. J Biol Chem 276:45979-45987.
910. Shields PL, Morland CM, Salmon M, Qin S, Hubscher SG, and Adams DH (1999) Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol 163:6236-6243.
911. Shimada T, Matsumoto M, Tatsumi Y, Kanamaru A, and Akira S (1998) A novel lipopolysaccharide inducible C-C chemokine receptor related gene in murine macrophages. FEBS Lett 425:490-494.
912. Shimaoka T, Kume N, Minami M, Hayashida K, Kataoka H, Kita T, and Yonehara S (2000) Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J Biol Chem 275:40663-40666.
913. Shimaoka T, Nakayama T, Fukumoto N, Kume N, Takahashi S, Yamaguchi J, Minami M, Hayashida K, Kita T, and Ohsumi J, et al. (2004) Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells. J Leukoc Biol 75:267-274.
914. Shin N, Solomon K, Zhou N, Wang KH, Garlapati V, Thomas B, Li Y, Covington M, Baribaud F, Erickson-Viitanen S, et al. (2011) Identification and characterization of INCB9471, an allosteric noncompetitive small-molecule antagonist of C-C che- mokine receptor 5 with potent inhibitory activity against monocyte migration and HIV-1 infection. J Pharmacol Exp Ther 338:228-239.
915. Sica A, Saccani A, Borsatti A, Power CA, Wells TN, Luini W, Polentarutti N, Sozzani S, and Mantovani A (1997) Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J Exp Med 185:969-974.
916. Update on Chemokine Receptors Sierro F, Biben C, Martínez-Muñoz L, Mellado M, Ransohoff RM, Li M, Woehl B, Leung H, Groom J, and Batten M, et al. (2007) Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci USA 104:14759-14764.
917. Simmons G, Clapham PR, Picard L, Offord RE, Rosenkilde MM, Schwartz TW, Buser R, Wells TN, and Proudfoot AE (1997) Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 276:276-279.
918. Singh MD, King V, Baldwin H, Burden D, Thorrat A, Holmes S, McInnes IB, Nicoll R, Shams K, and Pallas K, et al. (2012) Elevated expression of the chemokine-scav- enging receptor D6 is associated with impaired lesion development in psoriasis. Am J Pathol 181:1158-1164.
919. Singh SP, Zhang HH, Foley JF, Hedrick MN, and Farber JM (2008a) Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J Immunol 180:214-221.
920. Singh UP, Singh S, Singh R, Cong Y, Taub DD, and Lillard JW Jr (2008b) CXCL10- producing mucosal CD4+ T cells, NK cells, and NKT cells are associated with chronic colitis in IL-10(-/-) mice, which can be abrogated by anti-CXCL10 antibody inhibition. J Interferon Cytokine Res 28:31-43.
921. Slinger E, Maussang D, Schreiber A, Siderius M, Rahbar A, Fraile-Ramos A, Lira SA, Söderberg-Nauclér C, and Smit MJ (2010) HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis. Sci Signal 3: ra58.
922. Smit MJ, Verdijk P, van der Raaij-Helmer EM, Navis M, Hensbergen PJ, Leurs R, and Tensen CP (2003) CXCR3-mediated chemotaxis of human T cells is regulated by a Gi-and phospholipase C-dependent pathway and not via activation of MEK/ p44/p42 MAPK nor Akt/PI-3 kinase. Blood 102:1959-1965.
923. Smit MJ, Verzijl D, Casarosa P, Navis M, Timmerman H, and Leurs R (2002) Kaposi's sarcoma-associated herpesvirus-encoded G protein-coupled receptor ORF74 constitutively activates p44/p42 MAPK and Akt via G(i) and phospholipase C-dependent signaling pathways. J Virol 76:1744-1752.
924. Smith MW, Carrington M, Winkler C, Lomb D, Dean M, Huttley G, and O'Brien SJ (1997) CCR2 chemokine receptor and AIDS progression. Nat Med 3:1052-1053.
925. Smith P, Fallon RE, Mangan NE, Walsh CM, Saraiva M, Sayers JR, McKenzie AN, Alcami A, and Fallon PG (2005) Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity. J Exp Med 202:1319-1325.
926. Snelgrove RJ (2011) Targeting of a common receptor shared by CXCL8 and N-Ac- PGP as a therapeutic strategy to alleviate chronic neutrophilic lung diseases. Eur J Pharmacol 667:1-5.
927. Sogawa Y, Ohyama T, Maeda H, and Hirahara K (2011) Inhibition of neutrophil migration in mice by mouse formyl peptide receptors 1 and 2 dual agonist: in- dication of cross-desensitization in vivo. Immunology 132:441-450.
928. Sohy D, Parmentier M, and Springael JY (2007) Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers. J Biol Chem 282:30062-30069.
929. Sohy D, Yano H, de Nadai P, Urizar E, Guillabert A, Javitch JA, Parmentier M, and Springael JY (2009) Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonists. J Biol Chem 284:31270-31279.
930. Sokolowska-Wojdylo M, Wenzel J, Gaffal E, Lenz J, Speuser P, Erdmann S, Abu- zahra F, Bowman E, Roszkiewicz J, and Bieber T, et al. (2005) Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7. Br J Dermatol 152:258-264.
931. Soldan SS, Alvarez Retuerto AI, Sicotte NL, and Voskuhl RR (2003) Immune mod- ulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J Immunol 171:6267-6274.
932. Soler D, Chapman TR, Poisson LR, Wang L, Cote-Sierra J, Ryan M, McDonald A, Badola S, Fedyk E, and Coyle AJ, et al. (2006) CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes. J Immunol 177:6940-6951.
933. Soler D, Humphreys TL, Spinola SM, and Campbell JJ (2003) CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking. Blood 101:1677-1682.
934. Soroceanu L, Matlaf L, Bezrookove V, Harkins L, Martinez R, Greene M, Soter- opoulos P, and Cobbs CS (2011) Human cytomegalovirus US28 found in glioblas- toma promotes an invasive and angiogenic phenotype. Cancer Res 71:6643-6653.
935. Soruri A, Grigat J, Forssmann U, Riggert J, and Zwirner J (2007) beta-Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved. Eur J Immunol 37:2474-2486.
936. Soto H, Wang W, Strieter RM, Copeland NG, Gilbert DJ, Jenkins NA, Hedrick J, and Zlotnik A (1998) The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc Natl Acad Sci USA 95:8205-8210.
937. Sozzani S, Allavena P, Vecchi A, and Mantovani A (1999) The role of chemokines in the regulation of dendritic cell trafficking. J Leukoc Biol 66:1-9.
938. Sozzani S, Ghezzi S, Iannolo G, Luini W, Borsatti A, Polentarutti N, Sica A, Locati M, Mackay C, and Wells TN, et al. (1998) Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J Exp Med 187:439-444.
939. Stadtmann A and Zarbock A (2012) CXCR2: from bench to bedside. Front Immunol 3: 263. Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, Delaney A, Jones SJ, Iqbal J, and Weisenburger DD, et al. (2010) Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 362:875-885.
940. Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, and Krieger T, et al. (2009) CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis. J Immunol 183:4693-4704.
941. Stievano L, Tosello V, Marcato N, Rosato A, Sebelin A, Chieco-Bianchi L, and Amadori A (2003) CD8+ alpha beta+ T cells that lack surface CD5 antigen expression are a major lymphotactin (XCL1) source in peripheral blood lympho- cytes. J Immunol 171:4528-4538.
942. Stillie R, Farooq SM, Gordon JR, and Stadnyk AW (2009) The functional significance behind expressing two IL-8 receptor types on PMN. J Leukoc Biol 86:529-543.
943. Stine JT, Wood C, Hill M, Epp A, Raport CJ, Schweickart VL, Endo Y, Sasaki T, Simmons G, and Boshoff C, et al. (2000) KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. Blood 95:1151-1157.
944. Streblow DN, Orloff SL, and Nelson JA (2001) Do pathogens accelerate atheroscle- rosis? J Nutr 131:2798S-2804S.
945. Streblow DN, Soderberg-Naucler C, Vieira J, Smith P, Wakabayashi E, Ruchti F, Mattison K, Altschuler Y, and Nelson JA (1999) The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 99: 511-520.
946. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, and Marriott D, et al. (1995) The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270: 27348-27357.
947. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, Orth AP, Vega RG, Sapinoso LM, and Moqrich A, et al. (2002) Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 99:4465-4470.
948. Su Y, Raghuwanshi SK, Yu Y, Nanney LB, Richardson RM, and Richmond A (2005) Altered CXCR2 signaling in beta-arrestin-2-deficient mouse models. J Immunol 175:5396-5402.
949. Sun X, Cheng G, Hao M, Zheng J, Zhou X, Zhang J, Taichman RS, Pienta KJ, and Wang J (2010) CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer pro- gression. Cancer Metastasis Rev 29:709-722.
950. Sung JH, Zhang H, Moseman EA, Alvarez D, Iannacone M, Henrickson SE, de la Torre JC, Groom JR, Luster AD, and von Andrian UH (2012) Chemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes. Cell 150:1249-1263.
951. Suzuki G, Sawa H, Kobayashi Y, Nakata Y, Nakagawa Ki, Uzawa A, Sakiyama H, Kakinuma S, Iwabuchi K, and Nagashima K (1999) Pertussis toxin-sensitive signal controls the trafficking of thymocytes across the corticomedullary junction in the thymus. J Immunol 162:5981-5985.
952. Swartzendruber JA, Byrne AJ, and Bryce PJ (2012) Cutting edge: histamine is required for IL-4-driven eosinophilic allergic responses. J Immunol 188: 536-540.
953. Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, Weissleder R, and Pittet MJ (2007) Ly-6Chi monocytes dominate hypercholesterolemia-associated mono- cytosis and give rise to macrophages in atheromata. J Clin Invest 117:195-205.
954. Szabo MC, Soo KS, Zlotnik A, and Schall TJ (1995) Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor. J Biol Chem 270: 25348-25351.
955. Szalai C, Duba J, Prohászka Z, Kalina A, Szabó T, Nagy B, Horváth L, and Császár A (2001) Involvement of polymorphisms in the chemokine system in the suscepti- bility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 158:233-239.
956. Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y, Kitamura Y, Matsushima K, Yoshida N, and Nishikawa S, et al. (1998) The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393: 591-594.
957. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J, Garin A, Liu J, Mack M, and van Rooijen N, et al. (2007) Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 117:185-194.
958. Tadagaki K, Nakano K, and Yamanishi K (2005) Human herpesvirus 7 open reading frames U12 and U51 encode functional beta-chemokine receptors. J Virol 79: 7068-7076.
959. Tadagaki K, Yamanishi K, and Mori Y (2007) Reciprocal roles of cellular chemokine receptors and human herpesvirus 7-encoded chemokine receptors, U12 and U51. J Gen Virol 88:1423-1428.
960. Tagat JR, McCombie SW, Nazareno D, Labroli MA, Xiao Y, Steensma RW, Strizki JM, Baroudy BM, Cox K, and Lachowicz J, et al. (2004) Piperazine-based CCR5 antagonists as HIV-1 inhibitors. IV. Discovery of 1-[(4,6-dimethyl-5-pyrimidinyl) carbonyl]-4-[4-[2-methoxy-1(R)-4-(trifluoromethyl)phenyl]ethyl-3(S)-methyl-1- piperazinyl]-4-methylpiperidine (Sch-417690/Sch-D), a potent, highly selec- tive, and orally bioavailable CCR5 antagonist. J Med Chem 47:2405-2408.
961. Tager AM, Kradin RL, LaCamera P, Bercury SD, Campanella GS, Leary CP, Polo- sukhin V, Zhao LH, Sakamoto H, and Blackwell TS, et al. (2004) Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10. Am J Respir Cell Mol Biol 31: 395-404.
962. Takata H, Tomiyama H, Fujiwara M, Kobayashi N, and Takiguchi M (2004) Cutting edge: expression of chemokine receptor CXCR1 on human effector CD8+ T cells. J Immunol 173:2231-2235.
963. Takatsuka S, Sekiguchi A, Tokunaga M, Fujimoto A, and Chiba J (2011) Generation of a panel of monoclonal antibodies against atypical chemokine receptor CCX-CKR by DNA immunization. J Pharmacol Toxicol Methods 63:250-257.
964. Takeda A, Baffi JZ, Kleinman ME, Cho WG, Nozaki M, Yamada K, Kaneko H, Albuquerque RJ, Dridi S, and Saito K, et al. (2009) CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature 460:225-230.
965. Tan Q, Zhu Y, Li J, Chen Z, Han GW, Kufareva I, Li T, Ma L, Fenalti G, and Li J et al. (2013) Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex. Science 341:1387-1390.
966. Tang HL and Cyster JG (1999) Chemokine up-regulation and activated T cell at- traction by maturing dendritic cells. Science 284:819-822.
967. Tanino Y, Coombe DR, Gill SE, Kett WC, Kajikawa O, Proudfoot AE, Wells TN, Parks WC, Wight TN, and Martin TR, et al. (2010) Kinetics of chemokine-glycos- aminoglycan interactions control neutrophil migration into the airspaces of the lungs. J Immunol 184:2677-2685.
968. Tassone L, Moratto D, Vermi W, De Francesco M, Notarangelo LD, Porta F, Lougaris V, Facchetti F, Plebani A, and Badolato R (2010) Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syn- drome patients. Blood 116:4870-4873.
969. Telford EA, Watson MS, Aird HC, Perry J, and Davison AJ (1995) The DNA sequence of equine herpesvirus 2. J Mol Biol 249:520-528.
970. Terashima Y, Onai N, Murai M, Enomoto M, Poonpiriya V, Hamada T, Motomura K, Suwa M, Ezaki T, and Haga T, et al. (2005) Pivotal function for cytoplasmic protein FROUNT in CCR2-mediated monocyte chemotaxis. Nat Immunol 6:827-835.
971. Thapa M and Carr DJ (2009) CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: Uncoupling of CD8+ T-cell effector function but not migration. J Virol 83:9486-9501.
972. Thapa M, Kuziel WA, and Carr DJ (2007) Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization. J Virol 81: 3704-3713.
973. Thapa M, Welner RS, Pelayo R, and Carr DJ (2008) CXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous system. J Immunol 180:1098-1106.
974. Thelen M (2001) Dancing to the tune of chemokines. Nat Immunol 2:129-134.
975. Thelen M, Muñoz LM, Rodríguez-Frade JM, and Mellado M (2010) Chemokine re- ceptor oligomerization: functional considerations. Curr Opin Pharmacol 10:38-43.
976. Thelen M and Stein JV (2008) How chemokines invite leukocytes to dance. Nat Immunol 9:953-959.
977. Thelen M and Thelen S (2008) CXCR7, CXCR4 and CXCL12: an eccentric trio? J Neuroimmunol 198:9-13.
978. Thoma G, Streiff MB, Kovarik J, Glickman F, Wagner T, Beerli C, and Zerwes HG (2008) Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo. J Med Chem 51:7915-7920.
979. Thomas SY, Hou R, Boyson JE, Means TK, Hess C, Olson DP, Strominger JL, Brenner MB, Gumperz JE, and Wilson SB, et al. (2003) CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J Immunol 171:2571-2580.
980. Tian Y, New DC, Yung LY, Allen RA, Slocombe PM, Twomey BM, Lee MM, and Wong YH (2004) Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways. Eur J Immunol 34:785-795.
981. Tiffany HL, Lautens LL, Gao JL, Pease J, Locati M, Combadiere C, Modi W, Bonner TI, and Murphy PM (1997) Identification of CCR8: a human monocyte and thymus receptor for the CC chemokine I-309. J Exp Med 186:165-170.
982. Tournamille C, Colin Y, Cartron JP, and Le Van Kim C (1995) Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy- negative individuals. Nat Genet 10:224-228.
983. Tournamille C, Filipe A, Wasniowska K, Gane P, Lisowska E, Cartron JP, Colin Y, and Le Van Kim C (2003) Structure-function analysis of the extracellular domains of the Duffy antigen/receptor for chemokines: characterization of antibody and chemokine binding sites. Br J Haematol 122:1014-1023.
984. Tournamille C, Le Van Kim C, Gane P, Blanchard D, Proudfoot AE, Cartron JP, and Colin Y (1997) Close association of the first and fourth extracellular domains of the Duffy antigen/receptor for chemokines by a disulfide bond is required for ligand binding. J Biol Chem 272:16274-16280.
985. Townson JR and Nibbs RJ (2002) Characterization of mouse CCX-CKR, a receptor for the lymphocyte-attracting chemokines TECK/mCCL25, SLC/mCCL21 and MIP- 3beta/mCCL19: comparison to human CCX-CKR. Eur J Immunol 32:1230-1241.
986. Tran EH, Kuziel WA, and Owens T (2000) Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor. Eur J Immunol 30:1410-1415.
987. Traves SL, Smith SJ, Barnes PJ, and Donnelly LE (2004) Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2. J Leukoc Biol 76:441-450.
988. Trebst C, Sørensen TL, Kivisäkk P, Cathcart MK, Hesselgesser J, Horuk R, Sell- ebjerg F, Lassmann H, and Ransohoff RM (2001) CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. Am J Pathol 159:1701-1710.
989. Trifari S, Kaplan CD, Tran EH, Crellin NK, and Spits H (2009) Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 10:864-871.
990. Tripp RA, Hamilton-Easton AM, Cardin RD, Nguyen P, Behm FG, Woodland DL, Doherty PC, and Blackman MA (1997) Pathogenesis of an infectious mono- nucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen? J Exp Med 185:1641-1650.
991. Tripp RA, Jones LP, Haynes LM, Zheng H, Murphy PM, and Anderson LJ (2001) CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol 2:732-738.
992. Trkola A, Dragic T, Arthos J, Binley JM, Olson WC, Allaway GP, Cheng-Mayer C, Robinson J, Maddon PJ, and Moore JP (1996) CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384:184-187.
993. Tuinstra RL, Peterson FC, Kutlesa S, Elgin ES, Kron MA, and Volkman BF (2008) Interconversion between two unrelated protein folds in the lymphotactin native state. Proc Natl Acad Sci USA 105:5057-5062.
994. Tuo J, Smith BC, Bojanowski CM, Meleth AD, Gery I, Csaky KG, Chew EY, and Chan CC (2004) The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J 18: 1297-1299.
995. Tyner JW, Uchida O, Kajiwara N, Kim EY, Patel AC, O'Sullivan MP, Walter MJ, Schwendener RA, Cook DN, and Danoff TM, et al. (2005) CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nat Med 11:1180-1187.
996. Uchida T, Suto H, Ra C, Ogawa H, Kobata T, and Okumura K (2002) Preferential expression of T(h)2-type chemokine and its receptor in atopic dermatitis. Int Immunol 14:1431-1438.
997. Uehara S, Grinberg A, Farber JM, and Love PE (2002) A role for CCR9 in T lym- phocyte development and migration. J Immunol 168:2811-2819.
998. Ueland JM, Gwira J, Liu ZX, and Cantley LG (2004) The chemokine KC regulates HGF-stimulated epithelial cell morphogenesis. Am J Physiol Renal Physiol 286: F581-F589.
999. Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K, Koike M, Inadera H, and Matsushima K (2000) Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 6:3282-3289.
1000. Uguccioni M, Mackay CR, Ochensberger B, Loetscher P, Rhis S, LaRosa GJ, Rao P, Ponath PD, Baggiolini M, and Dahinden CA (1997) High expression of the che- mokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest 100:1137-1143.
1001. Unutmaz D, Xiang W, Sunshine MJ, Campbell J, Butcher E, and Littman DR (2000) The primate lentiviral receptor Bonzo/STRL33 is coordinately regulated with CCR5 and its expression pattern is conserved between human and mouse. J Immunol 165:3284-3292.
1002. Upadhyaya B, Yin Y, Hill BJ, Douek DC, and Prussin C (2011) Hierarchical IL-5 expression defines a subpopulation of highly differentiated human Th2 cells. J Immunol 187:3111-3120.
1003. Urnov FD, Rebar EJ, Holmes MC, Zhang HS, and Gregory PD (2010) Genome editing with engineered zinc finger nucleases. Nat Rev Genet 11:636-646.
1004. Valentin G, Haas P, and Gilmour D (2007) The chemokine SDF1a coordinates tissue migration through the spatially restricted activation of Cxcr7 and Cxcr4b. Curr Biol 17:1026-1031.
1005. Vallet S, Raje N, Ishitsuka K, Hideshima T, Podar K, Chhetri S, Pozzi S, Breitkreutz I, Kiziltepe T, and Yasui H, et al. (2007) MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts. Blood 110:3744-3752.
1006. van Berkel V, Barrett J, Tiffany HL, Fremont DH, Murphy PM, McFadden G, Speck SH, and Virgin HW IV (2000) Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J Virol 74:6741-6747.
1007. Vancová I, Hajnická V, Slovák M, Kocáková P, Paesen GC, and Nuttall PA (2010) Evasin-3-like anti-chemokine activity in salivary gland extracts of ixodid ticks during blood-feeding: a new target for tick control. Parasite Immunol 32:460-463.
1008. Vancová I, Slovák M, Hajnická V, Labuda M, Simo L, Peterková K, Hails RS, and Nuttall PA (2007) Differential anti-chemokine activity of Amblyomma varie- gatum adult ticks during blood-feeding. Parasite Immunol 29:169-177.
1009. van der Voort R, Kramer M, Lindhout E, Torensma R, Eleveld D, van Lieshout AW, Looman M, Ruers T, Radstake TR, and Figdor CG, et al. (2005) Novel monoclonal antibodies detect elevated levels of the chemokine CCL18/DC-CK1 in serum and body fluids in pathological conditions. J Leukoc Biol 77:739-747.
1010. Van Lith LH, Oosterom J, Van Elsas A, and Zaman GJ (2009) C5a-stimulated re- cruitment of beta-arrestin2 to the nonsignaling 7-transmembrane decoy receptor C5L2. J Biomol Screen 14:1067-1075.
1011. Van Snick J, Houssiau F, Proost P, Van Damme J, and Renauld JC (1996) I-309/T cell activation gene-3 chemokine protects murine T cell lymphomas against dexa- methasone-induced apoptosis. J Immunol 157:2570-2576.
1012. Varona R, Cadenas V, Gómez L, Martínez-A C, and Márquez G (2005) CCR6 regulates CD4+ T-cell-mediated acute graft-versus-host disease responses. Blood 106:18-26.
1013. Varona R, Villares R, Carramolino L, Goya I, Zaballos A, Gutiérrez J, Torres M, Martínez-A C, and Márquez G (2001) CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitiv- ity responses. J Clin Invest 107:R37-R45.
1014. Veillard NR, Braunersreuther V, Arnaud C, Burger F, Pelli G, Steffens S, and Mach F (2006) Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages. Atherosclerosis 188:51-58.
1015. Vergunst CE, Gerlag DM, Lopatinskaya L, Klareskog L, Smith MD, van den Bosch F, Dinant HJ, Lee Y, Wyant T, and Jacobson EW, et al. (2008) Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial. Arthritis Rheum 58:1931-1939.
1016. Vergunst CE, Gerlag DM, von Moltke L, Karol M, Wyant T, Chi X, Matzkin E, Leach T, and Tak PP (2009) MLN3897 plus methotrexate in patients with rheumatoid arthritis: safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study. Arthritis Rheum 60:3572-3581.
1017. Verzijl D, Fitzsimons CP, Van Dijk M, Stewart JP, Timmerman H, Smit MJ, and Leurs R (2004) Differential activation of murine herpesvirus 68-and Kaposi's sarcoma-associated herpesvirus-encoded ORF74 G protein-coupled receptors by human and murine chemokines. J Virol 78:3343-3351.
1018. Vestergaard C, Yoneyama H, Murai M, Nakamura K, Tamaki K, Terashima Y, Imai T, Yoshie O, Irimura T, and Mizutani H, et al. (1999) Overproduction of Th2- specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 104:1097-1105.
1019. Vetrano S, Borroni EM, Sarukhan A, Savino B, Bonecchi R, Correale C, Arena V, Fantini M, Roncalli M, and Malesci A, et al. (2010) The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6. Gut 59:197-206.
1020. Vicari AP, Figueroa DJ, Hedrick JA, Foster JS, Singh KP, Menon S, Copeland NG, Gilbert DJ, Jenkins NA, and Bacon KB, et al. (1997) TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development. Immunity 7:291-301.
1021. Vieira AT, Fagundes CT, Alessandri AL, Castor MG, Guabiraba R, Borges VO, Sil- veira KD, Vieira EL, Gonçalves JL, and Silva TA, et al. (2009) Treatment with a novel chemokine-binding protein or eosinophil lineage-ablation protects mice from experimental colitis. Am J Pathol 175:2382-2391.
1022. Vieira J, Schall TJ, Corey L, and Geballe AP (1998) Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene. J Virol 72:8158-8165.
1023. Viejo-Borbolla A, Martinez-Martín N, Nel HJ, Rueda P, Martín R, Blanco S, Are- nzana-Seisdedos F, Thelen M, Fallon PG, and Alcamí A (2012) Enhancement of chemokine function as an immunomodulatory strategy employed by human her- pesviruses. PLoS Pathog 8:e1002497. Update on Chemokine Receptors
1024. Vijayanand P, Durkin K, Hartmann G, Morjaria J, Seumois G, Staples KJ, Hall D, Bessant C, Bartholomew M, and Howarth PH, et al. (2010) Chemokine receptor 4 plays a key role in T cell recruitment into the airways of asthmatic patients. J Immunol 184:4568-4574.
1025. Villares R, Cadenas V, Lozano M, Almonacid L, Zaballos A, Martínez-A C, and Varona R (2009) CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues. Eur J Immunol 39:1671-1681.
1026. Virtala R, Ekman AK, Jansson L, Westin U, and Cardell LO (2012) Airway in- flammation evaluated in a human nasal lipopolysaccharide challenge model by investigating the effect of a CXCR2 inhibitor. Clin Exp Allergy 42:590-596.
1027. Vischer HF, Hulshof JW, Hulscher S, Fratantoni SA, Verheij MH, Victorina J, Smit MJ, de Esch IJ, and Leurs R (2010) Identification of novel allosteric nonpeptidergic inhibitors of the human cytomegalovirus-encoded chemokine receptor US28. Bio- org Med Chem 18:675-688.
1028. Vremec D, Pooley J, Hochrein H, Wu L, and Shortman K (2000) CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J Immunol 164: 2978-2986.
1029. Wakugawa M, Nakamura K, Kakinuma T, Onai N, Matsushima K, and Tamaki K (2001) CC chemokine receptor 4 expression on peripheral blood CD4+ T cells reflects disease activity of atopic dermatitis. J Invest Dermatol 117:188-196.
1030. Waldhoer M, Casarosa P, Rosenkilde MM, Smit MJ, Leurs R, Whistler JL, and Schwartz TW (2003) The carboxyl terminus of human cytomegalovirus-enco- ded 7 transmembrane receptor US28 camouflages agonism by mediating consti- tutive endocytosis. J Biol Chem 278:19473-19482.
1031. Waldhoer M, Kledal TN, Farrell H, and Schwartz TW (2002) Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signaling activities. J Virol 76:8161-8168.
1032. Walters MJ, Wang Y, Lai N, Baumgart T, Zhao BN, Dairaghi DJ, Bekker P, Ertl LS, Penfold ME, and Jaen JC, et al. (2010) Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of in- flammatory bowel disease. J Pharmacol Exp Ther 335:61-69.
1033. Wang H, Beaty N, Chen S, Qi CF, Masiuk M, Shin DM, and Morse HC 3rd (2012) The CXCR7 chemokine receptor promotes B-cell retention in the splenic marginal zone and serves as a sink for CXCL12. Blood 119:465-468.
1034. Wang J, Lu Y, Wang J, Koch AE, Zhang J, and Taichman RS (2008) CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway. Cancer Res 68:10367-10376.
1035. Wang K, Zhang H, Kugathasan S, Annese V, Bradfield JP, Russell RK, Sleiman PM, Imielinski M, Glessner J, and Hou C, et al. (2009) Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. Am J Hum Genet 84: 399-405.
1036. Wang W, Soto H, Oldham ER, Buchanan ME, Homey B, Catron D, Jenkins N, Copeland NG, Gilbert DJ, and Nguyen N, et al. (2000) Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2). J Biol Chem 275:22313-22323.
1037. Wang Y, Li G, Stanco A, Long JE, Crawford D, Potter GB, Pleasure SJ, Behrens T, and Rubenstein JL (2011) CXCR4 and CXCR7 have distinct functions in regulating interneuron migration. Neuron 69:61-76.
1038. Waugh DJ and Wilson C (2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14:6735-6741.
1039. Weber M, Blair E, Simpson CV, O'Hara M, Blackburn PE, Rot A, Graham GJ, and Nibbs RJ (2004) The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol Biol Cell 15: 2492-2508.
1040. Weber M, Hauschild R, Schwarz J, Moussion C, de Vries I, Legler DF, Luther SA, Bollenbach T, and Sixt M (2013) Interstitial dendritic cell guidance by haptotactic chemokine gradients. Science 339:328-332.
1041. Wehrli N, Legler DF, Finke D, Toellner KM, Loetscher P, Baggiolini M, MacLennan IC, and Acha-Orbea H (2001) Changing responsiveness to chemokines allows medullary plasmablasts to leave lymph nodes. Eur J Immunol 31:609-616.
1042. Wei L, Vahedi G, Sun HW, Watford WT, Takatori H, Ramos HL, Takahashi H, Liang J, Gutierrez-Cruz G, and Zang C, et al. (2010) Discrete roles of STAT4 and STAT6 transcription factors in tuning epigenetic modifications and transcription during T helper cell differentiation. Immunity 32:840-851.
1043. Wells TN and Schwartz TW (1997) Plagiarism of the host immune system: lessons about chemokine immunology from viruses. Curr Opin Biotechnol 8:741-748.
1044. Wendland M, Czeloth N, Mach N, Malissen B, Kremmer E, Pabst O, and Förster R (2007) CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine. Proc Natl Acad Sci USA 104:6347-6352.
1045. Wendland M, Willenzon S, Kocks J, Davalos-Misslitz AC, Hammerschmidt SI, Schumann K, Kremmer E, Sixt M, Hoffmeyer A, and Pabst O, et al. (2011) Lymph node T cell homeostasis relies on steady state homing of dendritic cells. Immunity 35:945-957.
1046. Weng Y, Siciliano SJ, Waldburger KE, Sirotina-Meisher A, Staruch MJ, Daugherty BL, Gould SL, Springer MS, and DeMartino JA (1998) Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J Biol Chem 273:18288-18291.
1047. Werry TD, Wilkinson GF, and Willars GB (2003) Cross-talk between P2Y2 nucleotide receptors and CXC chemokine receptor 2 resulting in enhanced Ca 2+ signaling involves enhancement of phospholipase C activity and is enabled by incremental Ca 2+ release in human embryonic kidney cells. J Pharmacol Exp Ther 307: 661-669.
1048. White GE and Greaves DR (2012) Fractalkine: a survivor's guide: chemokines as antiapoptotic mediators. Arterioscler Thromb Vasc Biol 32:589-594.
1049. White JR, Lee JM, Young PR, Hertzberg RP, Jurewicz AJ, Chaikin MA, Widdowson K, Foley JJ, Martin LD, and Griswold DE, et al. (1998) Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neu- trophil migration. J Biol Chem 273:10095-10098.
1050. Whitehead GS, Wang T, DeGraff LM, Card JW, Lira SA, Graham GJ, and Cook DN (2007) The chemokine receptor D6 has opposing effects on allergic inflammation and airway reactivity. Am J Respir Crit Care Med 175:243-249.
1051. Widdowson KL, Elliott JD, Veber DF, Nie H, Rutledge MC, McCleland BW, Xiang JN, Jurewicz AJ, Hertzberg RP, and Foley JJ, et al. (2004) Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptor. J Med Chem 47:1319-1321.
1052. Wiederholt T, von Westernhagen M, Zaldivar MM, Berres M-L, Schmitz P, Heller- brand C, Müller T, Berg T, Trautwein C, and Wasmuth HE (2008) Genetic var- iations of the chemokine scavenger receptor D6 are associated with liver inflammation in chronic hepatitis C. Hum Immunol 69:861-866.
1053. Wiekowski MT, Chen SC, Zalamea P, Wilburn BP, Kinsley DJ, Sharif WW, Jensen KK, Hedrick JA, Manfra D, and Lira SA (2001) Disruption of neutrophil migration in a conditional transgenic model: evidence for CXCR2 desensitization in vivo. J Immunol 167:7102-7110.
1054. Wilbanks A, Zondlo SC, Murphy K, Mak S, Soler D, Langdon P, Andrew DP, Wu L, and Briskin M (2001) Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines. J Immunol 166:5145-5154.
1055. Wilen CB, Tilton JC, and Doms RW (2012) Molecular mechanisms of HIV entry. Adv Exp Med Biol 726:223-242.
1056. Willems LI and Ijzerman AP (2010) Small molecule antagonists for chemokine CCR3 receptors. Med Res Rev 30:778-817.
1057. Willimann K, Legler DF, Loetscher M, Roos RS, Delgado MB, Clark-Lewis I, Bag- giolini M, and Moser B (1998) The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. Eur J Immunol 28:2025-2034.
1058. Wong LM, Myers SJ, Tsou CL, Gosling J, Arai H, and Charo IF (1997) Organization and differential expression of the human monocyte chemoattractant protein 1 re- ceptor gene. Evidence for the role of the carboxyl-terminal tail in receptor traf- ficking. J Biol Chem 272:1038-1045.
1059. Wood A and Armour D (2005) The discovery of the CCR5 receptor antagonist, UK- 427,857, a new agent for the treatment of HIV infection and AIDS. Prog Med Chem 43:239-271.
1060. Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V, Abagyan R, Brooun A, Wells P, and Bi FC, et al. (2010) Structures of the CXCR4 chemokine GPCR with small- molecule and cyclic peptide antagonists. Science 330:1066-1071.
1061. Wu FY, Ou ZL, Feng LY, Luo JM, Wang LP, Shen ZZ, and Shao ZM (2008) Che- mokine decoy receptor d6 plays a negative role in human breast cancer. Mol Cancer Res 6:1276-1288.
1062. Wu Y and Yoder A (2009) Chemokine coreceptor signaling in HIV-1 infection and pathogenesis. PLoS Pathog 5:e1000520.
1063. Wurbel MA, Malissen M, Guy-Grand D, Meffre E, Nussenzweig MC, Richelme M, Carrier A, and Malissen B (2001) Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T-and B-cell development and a reduction in T- cell receptor gammadelta(+) gut intraepithelial lymphocytes. Blood 98:2626-2632.
1064. Wurbel MA, Philippe JM, Nguyen C, Victorero G, Freeman T, Wooding P, Miazek A, Mattei MG, Malissen M, and Jordan BR, et al. (2000) The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double-and single- positive thymocytes expressing the TECK receptor CCR9. Eur J Immunol 30:262-271.
1065. Wyatt LS, Rodriguez WJ, Balachandran N, and Frenkel N (1991) Human herpesvi- rus 7: antigenic properties and prevalence in children and adults. J Virol 65: 6260-6265.
1066. Wysocki CA, Jiang Q, Panoskaltsis-Mortari A, Taylor PA, McKinnon KP, Su L, Blazar BR, and Serody JS (2005) Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease. Blood 106: 3300-3307.
1067. Xie JH, Nomura N, Lu M, Chen SL, Koch GE, Weng Y, Rosa R, Di Salvo J, Mudgett J, and Peterson LB, et al. (2003) Antibody-mediated blockade of the CXCR3 chemo- kine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation. J Leukoc Biol 73:771-780.
1068. Xu L, Khandaker MH, Barlic J, Ran L, Borja ML, Madrenas J, Rahimpour R, Chen K, Mitchell G, and Tan CM, et al. (2000) Identification of a novel mechanism for endotoxin-mediated down-modulation of CC chemokine receptor expression. Eur J Immunol 30:227-235.
1069. Xu L, Rahimpour R, Ran L, Kong C, Biragyn A, Andrews J, Devries M, Wang JM, and Kelvin DJ (1997) Regulation of CCR2 chemokine receptor mRNA stability. J Leukoc Biol 62:653-660.
1070. Xue C, Feng H, Cao G, Huang T, Glenn J, Anand R, Meloni D, Zhang K, Kong L, and Wang A, et al. (2011) Discovery of INCB3284, a potent, selective, and orally bioavailable hCCR2 antagonist. ACS Med Chem Lett 2:450-454.
1071. Yamamoto J, Adachi Y, Onoue Y, Adachi YS, Okabe Y, Itazawa T, Toyoda M, Seki T, Morohashi M, and Matsushima K, et al. (2000) Differential expression of the chemokine receptors by the Th1-and Th2-type effector populations within circu- lating CD4+ T cells. J Leukoc Biol 68:568-574.
1072. Yamamoto K, Utsunomiya A, Tobinai K, Tsukasaki K, Uike N, Uozumi K, Yama- guchi K, Yamada Y, Hanada S, and Tamura K, et al. (2010) Phase I study of KW- 0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol 28: 1591-1598.
1073. Yanagihara S, Komura E, Nagafune J, Watarai H, and Yamaguchi Y (1998) EBI1/ CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J Immunol 161:3096-3102.
1074. Yang AG, Bai X, Huang XF, Yao C, and Chen S (1997) Phenotypic knockout of HIV type 1 chemokine coreceptor CCR-5 by intrakines as potential therapeutic ap- proach for HIV-1 infection. Proc Natl Acad Sci USA 94:11567-11572.
1075. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schröder JM, Wang JM, and Howard OM, et al. (1999) Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286: 525-528.
1076. Yang TY, Chen SC, Leach MW, Manfra D, Homey B, Wiekowski M, Sullivan L, Jenh CH, Narula SK, and Chensue SW, et al. (2000) Transgenic expression of the che- mokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med 191:445-454.
1077. Yang X, Walton W, Cook DN, Hua X, Tilley S, Haskell CA, Horuk R, Blackstock AW, and Kirby SL (2011) The chemokine, CCL3, and its receptor, CCR1, mediate tho- racic radiation-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 45:127-135.
1078. Yang Y, Loy J, Ryseck RP, Carrasco D, and Bravo R (1998) Antigen-induced eosin- ophilic lung inflammation develops in mice deficient in chemokine eotaxin. Blood 92:3912-3923.
1079. Yellin M, Paliienko I, Balanescu A, Ter-Vartanian S, Tseluyko V, Xu LA, Tao X, Cardarelli PM, Leblanc H, and Nichol G, et al. (2012) A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX- 1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 64: 1730-1739.
1080. Yi T, Wang X, Kelly LM, An J, Xu Y, Sailer AW, Gustafsson JA, Russell DW, and Cyster JG (2012) Oxysterol gradient generation by lymphoid stromal cells guides activated B cell movement during humoral responses. Immunity 37: 535-548.
1081. Ying S, O'Connor B, Ratoff J, Meng Q, Mallett K, Cousins D, Robinson D, Zhang G, Zhao J, and Lee TH, et al. (2005) Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol 174:8183-8190.
1082. Ying S, Robinson DS, Meng Q, Barata LT, McEuen AR, Buckley MG, Walls AF, Askenase PW, and Kay AB (1999) C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES). J Immunol 163: 3976-3984.
1083. Ying S, Zhang G, Gu S, and Zhao J (2006) How much do we know about atopic asthma: where are we now? Cell Mol Immunol 3:321-332.
1084. Yoshida R, Imai T, Hieshima K, Kusuda J, Baba M, Kitaura M, Nishimura M, Kakizaki M, Nomiyama H, and Yoshie O (1997) Molecular cloning of a novel hu- man CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J Biol Chem 272:13803-13809.
1085. Yoshida R, Nagira M, Kitaura M, Imagawa N, Imai T, and Yoshie O (1998a) Sec- ondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. J Biol Chem 273:7118-7122.
1086. Yoshida T, Imai T, Kakizaki M, Nishimura M, Takagi S, and Yoshie O (1998b) Identification of single C motif-1/lymphotactin receptor XCR1. J Biol Chem 273: 16551-16554.
1087. Yoshida T, Imai T, Kakizaki M, Nishimura M, and Yoshie O (1995) Molecular cloning of a novel C or gamma type chemokine, SCM-1. FEBS Lett 360:155-159.
1088. Yoshida T, Imai T, Takagi S, Nishimura M, Ishikawa I, Yaoi T, and Yoshie O (1996) Structure and expression of two highly related genes encoding SCM-1/human lymphotactin. FEBS Lett 395:82-88.
1089. Yoshida T, Izawa D, Nakayama T, Nakahara K, Kakizaki M, Imai T, Suzuki R, Miyasaka M, and Yoshie O (1999) Molecular cloning of mXCR1, the murine SCM-1/ lymphotactin receptor. FEBS Lett 458:37-40.
1090. Yoshie O, Fujisawa R, Nakayama T, Harasawa H, Tago H, Izawa D, Hieshima K, Tatsumi Y, Matsushima K, and Hasegawa H, et al. (2002) Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-trans- formed T cells. Blood 99:1505-1511.
1091. Yoshimura T and Oppenheim JJ (2011) Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties. Exp Cell Res 317:674-684.
1092. Yu S, Crawford D, Tsuchihashi T, Behrens TW, and Srivastava D (2011) The che- mokine receptor CXCR7 functions to regulate cardiac valve remodeling. Dev Dyn 240:384-393.
1093. Yuan Q, Bromley SK, Means TK, Jones KJ, Hayashi F, Bhan AK, and Luster AD (2007) CCR4-dependent regulatory T cell function in inflammatory bowel disease. J Exp Med 204:1327-1334.
1094. Yurchenko E, Tritt M, Hay V, Shevach EM, Belkaid Y, and Piccirillo CA (2006) CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J Exp Med 203: 2451-2460.
1095. Zaballos A, Gutiérrez J, Varona R, Ardavín C, and Márquez G (1999) Cutting edge: identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK. J Immunol 162:5671-5675.
1096. Zaballos A, Varona R, Gutiérrez J, Lind P, and Márquez G (1996) Molecular cloning and RNA expression of two new human chemokine receptor-like genes. Biochem Biophys Res Commun 227:846-853.
1097. Zabel BA, Lewén S, Berahovich RD, Jaén JC, and Schall TJ (2011) The novel che- mokine receptor CXCR7 regulates trans-endothelial migration of cancer cells. Mol Cancer 10:73.
1098. Zabel BA, Nakae S, Zúñiga L, Kim JY, Ohyama T, Alt C, Pan J, Suto H, Soler D, and Allen SJ, et al. (2008) Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J Exp Med 205:2207-2220.
1099. Zabel BA, Wang Y, Lewén S, Berahovich RD, Penfold ME, Zhang P, Powers J, Summers BC, Miao Z, and Zhao B, et al. (2009) Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J Immunol 183:3204-3211.
1100. Zamilpa R, Kanakia R, Cigarroa J 4th, Dai Q, Escobar GP, Martinez H, Jimenez F, Ahuja SS, and Lindsey ML (2011) CC chemokine receptor 5 deletion impairs macrophage activation and induces adverse remodeling following myocardial in- farction. Am J Physiol Heart Circ Physiol 300:H1418-H1426.
1101. Zarbock A, Allegretti M, and Ley K (2008) Therapeutic inhibition of CXCR2 by Reparixin attenuates acute lung injury in mice. Br J Pharmacol 155:357-364.
1102. Zarbock A, Schmolke M, Bockhorn SG, Scharte M, Buschmann K, Ley K, and Singbartl K (2007) The Duffy antigen receptor for chemokines in acute renal failure: A facilitator of renal chemokine presentation. Crit Care Med 35:2156-2163.
1103. Zeng XH, Ou ZL, Yu KD, Feng LY, Yin WJ, Li J, Shen ZZ, and Shao ZM (2011) Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes. Breast Cancer Res Treat 125:715-727.
1104. Zernecke A, Shagdarsuren E, and Weber C (2008) Chemokines in atherosclerosis: an update. Arterioscler Thromb Vasc Biol 28:1897-1908.
1105. Zhang J and Patel JM (2010) Role of the CX3CL1-CX3CR1 axis in chronic in- flammatory lung diseases. Int J Clin Exp Med 3:233-244.
1106. Zhang J, Shi XQ, Echeverry S, Mogil JS, De Koninck Y, and Rivest S (2007) Ex- pression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J Neurosci 27:12396-12406.
1107. Zhang X, Schmudde I, Laumonnier Y, Pandey MK, Clark JR, König P, Gerard NP, Gerard C, Wills-Karp M, and Köhl J (2010) A critical role for C5L2 in the patho- genesis of experimental allergic asthma. J Immunol 185:6741-6752.
1108. Zhang X, Yu S, Hoffmann K, Yu K, and Förster R (2012) Neonatal lymph node stromal cells drive myelodendritic lineage cells into a distinct population of CX3CR1+CD11b+F4/80+ regulatory macrophages in mice. Blood 119:3975-3986.
1109. Zhang XW, Liu Q, Wang Y, and Thorlacius H (2001a) CXC chemokines, MIP-2 and KC, induce P-selectin-dependent neutrophil rolling and extravascular migration in vivo. Br J Pharmacol 133:413-421.
1110. Zhang YJ, Zhang L, Ketas T, Korber BT, and Moore JP (2001b) HIV type 1 molecular clones able to use the Bonzo/STRL-33 coreceptor for virus entry. AIDS Res Hum Retroviruses 17:217-227.
1111. Zhen Z, Bradel-Tretheway B, Sumagin S, Bidlack JM, and Dewhurst S (2005) The human herpesvirus 6 G protein-coupled receptor homolog U51 positively regulates virus replication and enhances cell-cell fusion in vitro. J Virol 79:11914-11924.
1112. Zheng C, Cao G, Xia M, Feng H, Glenn J, Anand R, Zhang K, Huang T, Wang A, and Kong L, et al. (2011) Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonist. Bioorg Med Chem Lett 21:1442-1446.
1113. Zheng X, Nakamura K, Furukawa H, Nishibu A, Takahashi M, Tojo M, Kaneko F, Kakinuma T, and Tamaki K (2003) Demonstration of TARC and CCR4 mRNA expression and distribution using in situ RT-PCR in the lesional skin of atopic dermatitis. J Dermatol 30:26-32.
1114. Zheng Y, Chaudhry A, Kas A, deRoos P, Kim JM, Chu TT, Corcoran L, Treuting P, Klein U, and Rudensky AY (2009) Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458:351-356.
1115. Zhou J, Kang N, Cui L, Ba D, and He W (2012) Anti-gd TCR antibody-expanded gd T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies. Cell Mol Immunol 9:34-44.
1116. Zhou N, Luo Z, Hall JW, Luo J, Han X, and Huang Z (2000) Molecular modeling and site-directed mutagenesis of CCR5 reveal residues critical for chemokine binding and signal transduction. Eur J Immunol 30:164-173.
1117. Zhou Y, Kurihara T, Ryseck RP, Yang Y, Ryan C, Loy J, Warr G, and Bravo R (1998) Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J Immunol 160:4018-4025.
1118. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, Leenen PJ, Liu YJ, MacPherson G, and Randolph GJ, et al. (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116:e74-e80.
1119. Zimmerman PA, Buckler-White A, Alkhatib G, Spalding T, Kubofcik J, Combadiere C, Weissman D, Cohen O, Rubbert A, and Lam G, et al. (1997) Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial back- ground, and quantified risk. Mol Med 3:23-36.
1120. Zingoni A, Soto H, Hedrick JA, Stoppacciaro A, Storlazzi CT, Sinigaglia F, D'Ambrosio D, O'Garra A, Robinson D, and Rocchi M, et al. (1998) The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol 161:547-551.
1121. Zlotnik A, Burkhardt AM, and Homey B (2011) Homeostatic chemokine receptors and organ-specific metastasis. Nat Rev Immunol 11:597-606.
1122. Zlotnik A and Yoshie O (2012) The chemokine superfamily revisited. Immunity 36: 705-716.
1123. Zlotnik A, Yoshie O, and Nomiyama H (2006) The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol 7:243.
1124. Zou P, Isegawa Y, Nakano K, Haque M, Horiguchi Y, and Yamanishi K (1999) Hu- man herpesvirus 6 open reading frame U83 encodes a functional chemokine. J Virol 73:5926-5933.
1125. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, and Littman DR (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393:595-599.
1126. Zuurman MW, Heeroma J, Brouwer N, Boddeke HW, and Biber K (2003) LPS-in- duced expression of a novel chemokine receptor (L-CCR) in mouse glial cells in vitro and in vivo. Glia 41:327-336.
1127. Update on Chemokine Receptors